data_2liq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2liq _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.024 0.916 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 122.436 1.112 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 122.192 0.996 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 122.469 1.128 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.065 0.46 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 122.477 1.132 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.655 0.264 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.984 0.421 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.402 0.62 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.444 ' CG ' ' H ' ' A' ' 102' ' ' ASN . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 101' ' ' ASN . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.4 ' CD1' HD23 ' A' ' 107' ' ' LEU . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 75' ' ' TRP . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 122.436 1.112 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.899 0.381 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.524 HD22 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.524 ' CG2' HD22 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 122.331 1.062 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 122.299 1.047 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' HD21 ' A' ' 107' ' ' LEU . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 75' ' ' TRP . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.847 1.308 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.689 0.281 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CD1' HD21 ' A' ' 107' ' ' LEU . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 75' ' ' TRP . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.405 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 122.637 1.208 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.016 0.436 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.408 ' CD1' HD22 ' A' ' 107' ' ' LEU . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 75' ' ' TRP . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.907 0.384 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 122.179 0.99 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.086 0.469 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 122.594 1.188 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.441 HD22 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.348 0.594 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' CG2' HD22 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.856 0.836 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.105 0.478 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 122.402 1.096 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.22 47.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.105 0.86 . . . . 0.0 113.334 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.16 171.1 17.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 112.092 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -154.36 179.47 8.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.439 1.496 . . . . 0.0 110.856 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -132.8 2.62 3.72 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.319 1.448 . . . . 0.0 114.161 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -127.49 -18.71 4.35 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.973 1.309 . . . . 0.0 113.907 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -133.16 3.9 3.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.85 1.26 . . . . 0.0 114.157 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -146.81 167.04 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.764 1.625 . . . . 0.0 111.144 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -152.95 168.63 25.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.952 1.301 . . . . 0.0 112.235 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -129.56 -36.2 1.67 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.881 1.272 . . . . 0.0 112.272 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 p -62.55 -4.06 1.77 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.1 2.16 . . . . 0.0 116.522 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.19 16.99 3.39 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.905 1.717 . . . . 0.0 114.598 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -142.92 -6.27 0.86 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -154.69 152.63 26.2 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.61 1.164 . . . . 0.0 111.36 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.54 160.94 3.23 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.132 3.221 . . . . 0.0 115.43 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.53 11.72 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.135 1.374 . . . . 0.0 113.759 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.89 162.65 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.07 1.348 . . . . 0.0 111.969 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -148.54 154.11 39.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.276 1.431 . . . . 0.0 109.684 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.97 150.69 42.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.83 0.824 . . . . 0.0 111.762 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -156.11 172.48 18.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.079 1.752 . . . . 0.0 110.189 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -116.37 6.39 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.9 mt 52.68 -144.55 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.144 . . . . 0.0 111.548 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.5 p -143.65 163.87 33.75 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.88 1.272 . . . . 0.0 112.127 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.05 -16.5 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.123 3.215 . . . . 0.0 115.799 170.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -71.24 -8.37 53.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.939 1.296 . . . . 0.0 113.697 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 22.14 69.71 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.42 1.01 . . . . 0.0 113.411 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -144.15 160.51 40.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.235 -172.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.21 149.78 9.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.06 1.344 . . . . 0.0 112.677 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -123.11 95.35 4.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.233 1.813 . . . . 0.0 107.961 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -96.7 144.0 27.12 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 p -135.29 169.93 16.71 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.645 1.578 . . . . 0.0 111.334 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -57.34 -6.84 0.48 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.01 31.89 0.32 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.571 1.081 . . . . 0.0 114.752 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.34 -173.03 45.87 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.535 1.668 . . . . 0.0 115.268 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.15 158.43 38.05 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.516 1.526 . . . . 0.0 111.891 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.83 -159.49 23.96 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.08 150.31 17.46 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 117.896 0.848 . . . . 0.0 111.809 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.51 159.26 18.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.79 0.805 . . . . 0.0 112.694 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.98 130.38 15.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.474 1.11 . . . . 0.0 111.656 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 t -55.0 -33.31 62.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.33 7.31 5.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.601 1.16 . . . . 0.0 113.899 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -144.0 6.18 1.35 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 1.66 0.19 Allowed Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.88 21.4 1.96 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.442 1.497 . . . . 0.0 111.745 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -132.92 -8.16 3.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.948 1.299 . . . . 0.0 114.188 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -145.65 5.09 1.03 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.393 1.877 . . . . 0.0 113.086 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -84.11 168.79 15.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.292 1.837 . . . . 0.0 113.21 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -133.9 16.19 3.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.812 1.245 . . . . 0.0 113.425 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -70.29 1.98 4.29 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.497 1.519 . . . . 0.0 114.474 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.92 169.62 17.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.552 1.941 . . . . 0.0 111.577 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -135.63 -17.8 1.7 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.881 1.272 . . . . 0.0 113.626 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -134.24 12.52 3.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.991 1.716 . . . . 0.0 112.044 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.88 85.97 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.808 1.194 . . . . 0.0 114.581 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.98 152.7 37.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.043 1.737 . . . . 0.0 111.043 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.3 p -144.2 160.89 47.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.805 1.642 . . . . 0.0 112.236 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -49.43 154.17 4.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.156 3.237 . . . . 0.0 115.279 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.69 60.95 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.26 163.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.812 2.045 . . . . 0.0 112.059 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -144.01 163.95 32.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.734 1.614 . . . . 0.0 111.402 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.97 140.88 49.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.572 1.949 . . . . 0.0 108.261 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -158.65 171.56 19.88 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.836 1.254 . . . . 0.0 110.474 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.0 1.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mp 54.4 -142.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.736 1.215 . . . . 0.0 110.915 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.4 p -146.52 155.71 49.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.942 1.297 . . . . 0.0 112.144 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -68.16 -9.41 25.71 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.414 2.743 . . . . 0.0 113.657 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -62.72 -24.79 67.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.673 1.589 . . . . 0.0 112.851 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.99 14.99 27.46 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.188 1.375 . . . . 0.0 114.147 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -134.71 161.75 34.28 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.348 . . . . 0.0 111.996 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.75 164.93 11.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.341 1.456 . . . . 0.0 111.009 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt -133.43 128.54 35.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 109.712 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.03 147.45 23.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -134.36 174.96 9.96 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.851 1.66 . . . . 0.0 111.951 174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.6 m -59.61 -6.47 1.14 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.76 30.18 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.062 -0.854 . . . . 0.0 115.189 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 -173.35 46.12 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.299 1.549 . . . . 0.0 114.858 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -125.96 159.34 32.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.385 1.474 . . . . 0.0 112.007 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.13 -166.84 33.5 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.23 158.64 5.15 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 118.049 0.925 . . . . 0.0 113.133 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -55.91 152.57 9.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.458 1.103 . . . . 0.0 112.539 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.53 150.43 47.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.827 1.651 . . . . 0.0 111.399 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -49.94 -39.95 42.01 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.752 1.621 . . . . 0.0 114.829 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -151.42 -27.21 0.2 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p -72.73 1.61 8.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.285 1.434 . . . . 0.0 114.753 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.09 8.32 0.09 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.003 1.161 . . . . 0.0 116.003 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -142.82 10.78 1.8 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.501 1.52 . . . . 0.0 112.649 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -70.25 -14.51 62.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 113.907 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -148.49 162.46 39.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.471 1.909 . . . . 0.0 110.878 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -150.55 169.17 22.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 112.095 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -147.04 172.13 14.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.756 1.222 . . . . 0.0 111.665 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -60.01 159.94 8.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.998 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -145.69 159.91 42.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -59.9 153.94 19.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.888 1.275 . . . . 0.0 113.093 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.1 p -71.22 -0.48 9.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 -12.34 20.5 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.275 1.893 . . . . 0.0 115.868 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.1 -23.17 66.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.632 1.173 . . . . 0.0 113.431 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.1 p -65.97 158.39 76.09 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.393 1.077 . . . . 0.0 113.204 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.36 159.72 4.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.967 3.111 . . . . 0.0 116.143 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.69 9.4 2.86 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.504 1.522 . . . . 0.0 113.666 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.84 161.47 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.819 1.247 . . . . 0.0 113.389 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -156.02 169.72 23.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 109.996 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.7 mt -122.7 145.83 48.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.931 1.692 . . . . 0.0 111.256 170.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -157.65 173.56 16.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.906 2.082 . . . . 0.0 110.318 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.68 128.2 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 169.46 3.45 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 111.275 168.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.1 t -125.81 147.9 60.41 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.499 1.12 . . . . 0.0 112.402 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.28 -18.74 5.49 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.423 3.416 . . . . 0.0 115.173 168.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -57.04 -21.65 32.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.316 1.446 . . . . 0.0 113.629 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.33 -3.01 40.09 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.758 1.647 . . . . 0.0 114.698 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -140.89 170.2 16.2 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.313 1.445 . . . . 0.0 112.507 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.68 151.36 42.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.952 1.301 . . . . 0.0 110.759 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.03 123.64 49.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.368 1.067 . . . . 0.0 109.835 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp -65.13 150.84 47.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 p -133.38 -178.32 4.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.528 1.531 . . . . 0.0 112.07 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -62.61 -3.09 1.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.91 23.75 0.1 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.61 -172.34 43.6 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.383 1.592 . . . . 0.0 113.635 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.5 161.99 26.69 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.468 1.507 . . . . 0.0 112.065 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.13 -158.26 22.97 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.46 150.62 18.28 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.75 -0.853 . . . . 0.0 111.801 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.42 159.78 17.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.359 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.72 131.38 20.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.602 1.161 . . . . 0.0 111.469 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -57.34 -26.95 61.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.669 1.588 . . . . 0.0 115.207 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -128.37 -7.05 5.28 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p -137.14 8.91 2.97 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.895 1.225 . . . . 0.0 114.233 -172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.07 179.85 48.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.098 0.856 . . . . 0.0 113.479 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -69.85 -10.39 58.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 114.485 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -146.55 162.53 38.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.133 1.773 . . . . 0.0 111.13 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -150.36 167.4 27.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.644 1.578 . . . . 0.0 111.802 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -146.75 161.72 40.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.351 1.061 . . . . 0.0 111.5 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -149.47 163.58 37.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.084 1.354 . . . . 0.0 111.43 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.92 157.79 45.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 111.799 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -149.94 171.67 16.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.118 1.367 . . . . 0.0 111.516 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -127.38 -10.56 5.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.747 1.219 . . . . 0.0 114.221 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -96.48 13.93 26.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.854 1.262 . . . . 0.0 112.663 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.86 13.33 0.13 Allowed Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.347 1.451 . . . . 0.0 115.167 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.68 25.48 1.32 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.665 1.586 . . . . 0.0 111.733 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 149.59 29.17 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.983 1.713 . . . . 0.0 110.648 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.03 165.87 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.005 3.137 . . . . 0.0 115.734 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.98 14.71 5.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.48 1.512 . . . . 0.0 113.625 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.69 163.41 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.314 1.846 . . . . 0.0 112.267 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.1 p -143.91 162.26 36.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.777 1.631 . . . . 0.0 111.746 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.612 167.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 t -158.3 171.67 19.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.058 1.743 . . . . 0.0 109.211 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.98 -14.86 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.2 mt 52.48 -155.97 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.719 1.207 . . . . 0.0 111.478 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -134.63 142.98 44.64 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.04 -1.037 . . . . 0.0 111.868 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.46 -16.67 3.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.657 3.571 . . . . 0.0 115.485 169.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -62.29 -12.56 21.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.771 1.229 . . . . 0.0 113.985 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.89 14.74 57.52 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.347 1.451 . . . . 0.0 113.691 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.1 169.87 17.01 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.859 1.664 . . . . 0.0 111.779 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.16 146.84 49.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 111.761 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -108.86 84.83 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.369 1.468 . . . . 0.0 109.599 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.16 148.35 23.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.6 p -131.11 174.61 9.85 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.503 1.521 . . . . 0.0 111.157 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -59.81 -8.58 2.22 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.12 23.16 0.27 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.24 46.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.035 1.418 . . . . 0.0 114.229 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.91 165.55 17.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.476 1.511 . . . . 0.0 112.11 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.22 175.93 38.65 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -40.74 80.32 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.475 1.138 . . . . 0.0 113.308 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -165.3 173.93 10.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.67 2.388 . . . . 0.0 109.731 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.51 153.73 42.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.622 1.169 . . . . 0.0 111.64 169.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -55.29 -40.01 70.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.192 1.397 . . . . 0.0 114.526 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -158.06 -24.4 0.08 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.265 1.426 . . . . 0.0 113.729 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -72.26 1.3 7.93 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.32 -9.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -144.93 171.69 14.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.511 1.524 . . . . 0.0 111.907 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -149.47 169.12 21.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.351 1.46 . . . . 0.0 111.76 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -150.43 171.89 16.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.089 1.356 . . . . 0.0 111.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -150.84 167.11 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.0 1.32 . . . . 0.0 112.084 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -147.4 -17.99 0.38 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -140.83 5.64 1.97 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.954 1.301 . . . . 0.0 113.872 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -150.11 168.65 23.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.58 1.552 . . . . 0.0 112.175 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.26 173.23 15.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.066 1.346 . . . . 0.0 110.512 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.2 m -135.18 6.19 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.453 1.901 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.11 18.42 1.74 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.994 1.283 . . . . 0.0 115.037 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -151.34 -25.83 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.643 1.177 . . . . 0.0 113.735 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.1 p -141.6 162.76 45.12 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.814 1.646 . . . . 0.0 112.117 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -50.09 157.7 2.75 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.553 3.502 . . . . 0.0 116.145 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.77 -14.55 1.41 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.71 163.34 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.263 1.425 . . . . 0.0 111.493 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -155.67 156.25 34.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.567 1.547 . . . . 0.0 109.525 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.85 159.37 34.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.067 0.936 . . . . 0.0 111.536 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -150.61 170.1 19.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.399 1.479 . . . . 0.0 110.876 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t -105.59 119.66 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 mt -56.48 148.98 18.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.8 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -70.16 163.19 63.89 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.51 -18.08 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.063 3.175 . . . . 0.0 115.417 168.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -69.61 -18.32 63.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.929 0.891 . . . . 0.0 113.118 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.32 22.05 28.07 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.461 1.505 . . . . 0.0 113.822 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -140.98 161.5 37.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.436 1.094 . . . . 0.0 112.332 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.76 145.34 49.98 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.912 1.285 . . . . 0.0 111.278 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -126.67 110.48 13.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.72 1.608 . . . . 0.0 108.751 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.49 152.03 36.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 p -132.3 -179.48 5.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.412 1.885 . . . . 0.0 111.226 169.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.3 p -61.27 -10.1 6.28 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.47 27.86 0.25 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.11 -178.78 44.13 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 118.909 1.355 . . . . 0.0 113.543 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -117.45 165.37 13.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.353 1.461 . . . . 0.0 112.53 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.79 173.77 40.71 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.01 73.42 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.51 175.3 7.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.269 2.228 . . . . 0.0 109.992 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.69 154.24 44.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 111.38 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.5 t -54.93 -38.55 67.82 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.908 1.283 . . . . 0.0 114.127 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.56 -28.68 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.685 1.594 . . . . 0.0 112.746 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m -63.66 5.46 0.2 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.762 2.025 . . . . 0.0 116.215 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.518 0.199 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.56 175.87 46.72 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.229 0.919 . . . . 0.0 113.33 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -141.27 3.87 1.78 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.13 1.372 . . . . 0.0 113.796 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.94 -12.97 61.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.095 1.758 . . . . 0.0 114.142 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -148.32 165.26 31.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.117 2.167 . . . . 0.0 110.764 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -155.29 174.05 15.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.473 1.109 . . . . 0.0 111.495 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -139.06 -5.39 1.47 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.029 1.732 . . . . 0.0 114.261 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -140.1 19.18 2.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.232 1.813 . . . . 0.0 112.169 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -146.11 172.3 13.62 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.782 1.633 . . . . 0.0 111.153 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 53.3 23.72 3.39 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.624 1.97 . . . . 0.0 115.974 -169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 t -134.65 31.17 3.4 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.837 1.655 . . . . 0.0 110.452 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.52 26.78 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.972 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.71 -7.32 10.34 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -137.09 78.16 41.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 120.86 -1.15 . . . . 0.0 112.225 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.69 177.02 0.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.8 3.0 . . . . 0.0 114.33 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.3 -63.86 0.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 111.643 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 t -144.24 -63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 125.889 1.676 . . . . 0.0 109.788 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -170.05 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.122 1.769 . . . . 0.0 111.022 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.49 140.76 39.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.431 1.092 . . . . 0.0 111.886 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t -155.64 159.01 39.25 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.168 1.387 . . . . 0.0 110.401 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.99 2.97 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.7 mt 54.79 -136.98 1.23 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.679 1.591 . . . . 0.0 111.717 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -134.89 155.09 79.56 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 124.188 0.995 . . . . 0.0 112.712 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.69 -9.49 25.04 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.181 2.587 . . . . 0.0 113.505 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.57 -22.05 66.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.866 1.266 . . . . 0.0 113.171 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.18 15.51 21.45 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.38 1.467 . . . . 0.0 113.821 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.43 159.49 40.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.103 1.361 . . . . 0.0 111.939 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.42 164.88 20.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.229 1.412 . . . . 0.0 112.593 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -137.11 134.76 36.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.139 1.376 . . . . 0.0 110.758 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.52 138.65 36.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.9 p -130.08 176.41 8.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.888 1.675 . . . . 0.0 110.639 170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.74 -4.04 0.39 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -127.6 -7.38 4.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.263 1.411 . . . . 0.0 115.718 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.31 30.05 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.181 1.99 . . . . 0.0 114.018 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -70.94 160.17 33.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' HO3' ' A' ' 156' ' ' FUC . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.07 -163.22 27.13 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.32 160.51 5.12 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.769 -0.842 . . . . 0.0 112.863 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.41 154.77 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.351 1.06 . . . . 0.0 112.96 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.64 159.87 41.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.974 1.71 . . . . 0.0 112.095 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -92.02 -25.79 18.66 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -137.23 -1.26 2.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p -133.5 9.26 3.98 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.657 1.183 . . . . 0.0 114.152 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . 0.413 ' HO3' ' HD3' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 175.45 40.49 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.968 0.794 . . . . 0.0 113.845 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -140.22 -1.31 1.55 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.021 1.328 . . . . 0.0 114.004 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -149.78 166.89 28.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.339 1.456 . . . . 0.0 111.357 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -63.19 159.71 17.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.783 1.233 . . . . 0.0 112.523 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -147.54 168.4 22.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.322 1.449 . . . . 0.0 111.043 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.49 144.13 43.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.371 0.668 . . . . 0.0 111.776 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -150.49 161.42 42.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.165 1.386 . . . . 0.0 110.903 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 32.7 t60 57.19 -170.86 0.09 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.021 1.728 . . . . 0.0 113.705 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.494 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 2.0 t60 -148.1 174.72 11.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.898 1.279 . . . . 0.0 111.626 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -138.71 11.32 2.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.897 1.679 . . . . 0.0 112.947 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.07 0.6 6.11 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.099 1.333 . . . . 0.0 115.759 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -144.4 -4.23 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.944 1.297 . . . . 0.0 113.818 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -146.05 159.42 46.26 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.123 1.769 . . . . 0.0 112.346 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.0 161.25 5.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.209 3.273 . . . . 0.0 115.405 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.32 10.17 5.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.254 1.422 . . . . 0.0 113.621 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -60.79 158.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.481 1.512 . . . . 0.0 114.403 -170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 t -132.33 8.91 4.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.415 1.086 . . . . 0.0 113.369 173.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.9 mt -55.17 152.26 8.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.834 1.253 . . . . 0.0 112.139 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -150.15 173.04 14.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.46 -23.35 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp 50.29 -153.39 0.15 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.795 1.238 . . . . 0.0 111.539 -173.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -148.18 152.72 40.12 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 120.457 -1.402 . . . . 0.0 112.313 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.93 -12.55 34.7 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.186 2.591 . . . . 0.0 114.239 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -72.26 -8.92 57.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.52 25.64 17.83 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.413 1.006 . . . . 0.0 113.865 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.54 -178.77 5.21 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.932 1.693 . . . . 0.0 111.253 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.94 163.23 20.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.263 1.425 . . . . 0.0 111.777 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.51 139.01 51.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.407 1.083 . . . . 0.0 110.289 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.444 ' CG ' ' H ' ' A' ' 102' ' ' ASN . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 101' ' ' ASN . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp -111.05 136.27 50.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.8 p -128.82 -178.3 4.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.591 1.557 . . . . 0.0 111.402 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.8 p -62.09 -7.4 3.96 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.85 -21.76 2.85 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.605 1.098 . . . . 0.0 115.711 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -178.89 41.76 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 119.199 1.5 . . . . 0.0 114.111 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -73.77 163.85 27.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.79 -159.58 24.13 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.51 160.52 4.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.408 0.623 . . . . 0.0 112.493 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -60.15 156.81 14.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.976 0.894 . . . . 0.0 112.856 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.78 167.92 20.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.645 1.978 . . . . 0.0 111.277 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.88 -22.05 12.6 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -129.41 -16.48 3.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p -128.15 0.88 5.83 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.56 -7.19 0.1 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -60.22 -21.51 61.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.43 1.492 . . . . 0.0 114.63 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.18 170.19 20.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.651 1.98 . . . . 0.0 111.157 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -149.54 166.94 27.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.734 1.214 . . . . 0.0 111.497 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -141.15 6.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.446 1.498 . . . . 0.0 114.125 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.436 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 8.6 t60 -140.59 177.17 8.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.406 1.482 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.436 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 53.5 t60 60.69 -8.7 0.07 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.683 2.393 . . . . 0.0 116.611 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -133.59 -0.49 3.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.516 1.926 . . . . 0.0 113.515 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -146.7 -28.76 0.39 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.122 1.369 . . . . 0.0 113.942 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 m -128.94 12.8 6.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.376 1.471 . . . . 0.0 113.396 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.65 30.32 0.76 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.342 . . . . 0.0 114.083 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -134.13 9.44 3.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.201 1.4 . . . . 0.0 113.186 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -154.47 144.6 15.68 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.726 1.611 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.03 159.64 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.845 3.03 . . . . 0.0 116.012 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.21 2.92 1.52 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.85 1.26 . . . . 0.0 114.396 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -56.54 157.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.759 1.223 . . . . 0.0 114.03 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -129.25 12.29 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.165 1.386 . . . . 0.0 112.524 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -54.86 154.69 4.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -149.7 167.16 27.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.493 1.117 . . . . 0.0 111.117 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -123.48 107.8 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -57.06 160.0 3.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.754 1.622 . . . . 0.0 112.33 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -57.88 164.31 3.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.726 1.21 . . . . 0.0 113.662 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -8.99 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.584 3.523 . . . . 0.0 116.616 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -119.56 -2.43 10.5 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.62 32.79 5.84 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.189 0.9 . . . . 0.0 115.157 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -128.82 155.66 44.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.621 1.211 . . . . 0.0 112.029 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.86 144.31 56.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.457 -0.777 . . . . 0.0 111.557 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -120.78 110.79 16.77 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.538 1.535 . . . . 0.0 108.511 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.4 ' CD1' HD23 ' A' ' 107' ' ' LEU . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 75' ' ' TRP . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp -87.92 149.32 24.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -126.77 178.09 6.16 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.621 1.568 . . . . 0.0 111.536 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -59.5 -8.46 1.88 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.97 29.44 0.2 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.058 0.844 . . . . 0.0 115.108 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.08 -172.35 44.48 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 118.946 1.373 . . . . 0.0 113.807 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -127.24 163.25 24.31 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.791 1.636 . . . . 0.0 112.095 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.68 -161.54 21.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.22 160.17 6.75 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.683 0.754 . . . . 0.0 112.989 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.14 149.17 45.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.616 1.166 . . . . 0.0 113.114 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.76 149.09 32.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.425 1.09 . . . . 0.0 113.092 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -85.47 -27.21 25.83 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -131.51 -4.56 3.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p -130.23 9.15 5.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.227 1.411 . . . . 0.0 113.374 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.26 -14.06 0.08 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -146.32 173.07 12.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.163 1.785 . . . . 0.0 111.305 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -146.79 155.37 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.283 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -155.25 171.62 19.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 111.828 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -146.56 163.62 35.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.742 1.217 . . . . 0.0 111.246 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -135.13 0.16 2.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.282 1.433 . . . . 0.0 113.818 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -128.98 14.31 6.3 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -64.1 156.76 27.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.859 0.863 . . . . 0.0 112.341 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -152.31 175.12 13.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.743 1.217 . . . . 0.0 111.959 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.8 m -127.87 4.61 6.0 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.072 1.349 . . . . 0.0 114.407 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.35 3.17 0.86 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.886 1.708 . . . . 0.0 114.904 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -138.57 2.99 2.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.009 1.724 . . . . 0.0 112.953 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.7 t -154.59 147.06 17.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.099 1.76 . . . . 0.0 110.44 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.78 159.1 5.33 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.694 2.929 . . . . 0.0 116.224 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.56 6.99 1.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.83 1.252 . . . . 0.0 113.898 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.89 175.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.089 1.756 . . . . 0.0 111.813 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.94 -179.29 6.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.22 1.808 . . . . 0.0 109.86 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.02 152.36 45.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.047 2.139 . . . . 0.0 111.688 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p -154.6 176.62 12.18 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.645 1.978 . . . . 0.0 110.735 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.524 HD22 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.69 -6.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.1 mt 50.08 -127.02 2.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.076 1.351 . . . . 0.0 111.692 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.4 p -149.62 158.49 37.61 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-N 119.657 1.117 . . . . 0.0 112.86 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.28 -6.35 18.66 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.191 2.594 . . . . 0.0 113.591 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -73.0 -8.06 54.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.192 1.397 . . . . 0.0 113.409 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.59 61.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.492 1.044 . . . . 0.0 113.966 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -142.26 155.72 45.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.153 1.381 . . . . 0.0 111.555 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -68.1 159.01 31.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.851 1.26 . . . . 0.0 112.524 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.77 138.71 50.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.327 1.451 . . . . 0.0 110.314 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.524 ' CG2' HD22 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.13 158.04 33.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -131.87 179.49 6.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.491 1.916 . . . . 0.0 111.565 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 57.5 p -58.53 -10.93 2.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.99 26.67 0.16 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.37 0.987 . . . . 0.0 115.1 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.95 -159.75 24.27 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.309 1.055 . . . . 0.0 113.307 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -133.71 162.75 31.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.341 1.857 . . . . 0.0 112.796 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.53 -161.86 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.77 156.56 6.37 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.027 -0.69 . . . . 0.0 112.36 169.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.72 159.66 13.12 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.275 1.036 . . . . 0.0 113.556 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.39 176.86 9.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.946 1.698 . . . . 0.0 110.62 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.3 t -113.5 -28.64 7.45 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -126.63 -3.09 6.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.049 1.339 . . . . 0.0 113.537 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p -136.48 5.94 2.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 114.084 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.7 -24.05 0.1 OUTLIER Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.831 0.729 . . . . 0.0 114.791 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -147.29 142.88 27.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.456 1.502 . . . . 0.0 110.87 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -148.9 -2.53 0.47 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.152 1.381 . . . . 0.0 113.669 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -70.89 164.02 26.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.791 1.636 . . . . 0.0 113.435 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -131.77 1.76 4.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.994 1.317 . . . . 0.0 113.088 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -134.81 11.17 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.19 1.796 . . . . 0.0 112.637 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.33 164.46 13.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.43 1.492 . . . . 0.0 112.446 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 25.3 t60 -150.25 179.45 8.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.517 1.127 . . . . 0.0 111.861 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.427 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 16.5 t-80 -139.7 177.32 8.03 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.095 1.358 . . . . 0.0 112.392 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 m -141.2 8.23 2.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.11 4.34 2.88 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.283 1.421 . . . . 0.0 115.157 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.79 -7.79 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.731 1.612 . . . . 0.0 113.383 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.8 p -150.58 163.16 25.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.389 1.876 . . . . 0.0 112.287 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.73 161.41 2.16 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.463 3.442 . . . . 0.0 115.78 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.72 2.99 5.46 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.601 1.16 . . . . 0.0 114.105 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.47 159.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.619 1.168 . . . . 0.0 112.614 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -128.66 8.29 5.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.223 1.009 . . . . 0.0 112.69 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.86 152.45 5.54 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.436 1.094 . . . . 0.0 111.237 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -150.08 170.79 18.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.461 1.104 . . . . 0.0 110.676 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.17 116.04 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.5 162.98 7.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.549 1.539 . . . . 0.0 112.273 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.9 p -59.08 160.87 10.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.925 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.79 -2.12 7.12 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.257 2.638 . . . . 0.0 113.712 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -101.33 -12.33 18.73 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.074 1.75 . . . . 0.0 113.034 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.61 26.9 6.61 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.515 1.055 . . . . 0.0 115.174 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -133.11 151.66 51.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.995 1.397 . . . . 0.0 112.378 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.19 150.54 48.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.679 0.791 . . . . 0.0 111.55 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.26 122.49 37.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.533 1.533 . . . . 0.0 109.233 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.04 147.16 23.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.0 p -134.37 172.0 13.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.204 1.802 . . . . 0.0 111.571 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 m -59.42 -3.96 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.26 27.41 0.21 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.252 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.76 -176.33 46.98 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.588 1.694 . . . . 0.0 114.587 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -120.11 164.52 16.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.735 1.614 . . . . 0.0 112.243 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.28 -162.02 25.86 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.28 159.95 5.59 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.578 0.704 . . . . 0.0 112.824 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 155.83 17.2 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.695 1.198 . . . . 0.0 113.135 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.58 153.63 40.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.236 1.415 . . . . 0.0 112.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 t -87.94 -22.46 24.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -138.25 -3.19 1.77 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -130.75 9.87 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.995 1.318 . . . . 0.0 113.59 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.62 47.04 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.359 0.981 . . . . 0.0 113.084 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -152.38 172.15 16.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.203 1.401 . . . . 0.0 112.171 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -143.81 139.03 29.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.327 1.451 . . . . 0.0 110.51 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.3 -32.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.938 1.295 . . . . 0.0 113.046 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -142.8 -1.79 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.949 1.3 . . . . 0.0 114.149 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -65.51 161.19 20.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.013 1.725 . . . . 0.0 113.045 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -150.04 168.82 22.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.588 1.155 . . . . 0.0 112.566 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -142.52 13.0 1.94 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 112.654 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.27 172.25 16.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.279 1.432 . . . . 0.0 112.03 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.5 m -134.13 9.46 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.012 1.325 . . . . 0.0 113.904 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.82 82.1 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.783 1.182 . . . . 0.0 114.505 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -153.13 169.39 23.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.56 1.944 . . . . 0.0 110.898 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -149.32 153.1 37.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.572 1.549 . . . . 0.0 111.287 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.88 168.11 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.017 3.145 . . . . 0.0 115.146 169.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.64 -36.5 35.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.607 1.563 . . . . 0.0 114.802 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.6 t -142.9 -58.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.35 1.86 . . . . 0.0 109.514 169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -169.44 18.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.319 1.447 . . . . 0.0 111.545 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -52.73 145.23 12.55 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.448 1.099 . . . . 0.0 111.702 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t -151.74 165.09 35.5 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.791 1.236 . . . . 0.0 110.85 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.06 -3.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt 54.7 -152.64 0.33 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.425 1.09 . . . . 0.0 111.575 -172.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -132.07 155.96 80.7 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.97 1.308 . . . . 0.0 111.698 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.33 -10.99 30.54 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.06 2.507 . . . . 0.0 113.756 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -63.35 -27.04 69.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.454 1.101 . . . . 0.0 112.932 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.17 20.22 9.94 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.146 1.355 . . . . 0.0 113.821 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.05 160.71 39.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.714 1.605 . . . . 0.0 111.003 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -54.48 149.31 10.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.788 1.235 . . . . 0.0 111.79 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp -117.92 101.52 8.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.113 1.365 . . . . 0.0 109.004 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' HD21 ' A' ' 107' ' ' LEU . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 75' ' ' TRP . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.3 144.58 44.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.2 p -136.1 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.133 1.773 . . . . 0.0 111.661 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.9 p -60.23 -6.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.0 -9.09 2.53 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.044 -1.42 . . . . 0.0 116.505 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.29 38.48 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 120.395 2.098 . . . . 0.0 114.727 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.67 161.59 23.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.98 -163.42 27.39 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.4 161.41 5.74 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.548 -0.972 . . . . 0.0 112.859 170.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 150.3 16.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.4 1.08 . . . . 0.0 112.148 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.45 152.02 41.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.919 1.688 . . . . 0.0 111.31 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -50.03 -39.57 42.03 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -149.97 -32.7 0.19 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.958 1.303 . . . . 0.0 113.202 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p -67.85 1.94 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.692 . . . . 0.0 115.081 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 118.69 -0.672 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.25 10.93 0.55 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.555 1.07 . . . . 0.0 114.697 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -146.56 1.94 0.82 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.585 1.954 . . . . 0.0 113.163 -172.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -71.61 -8.13 52.15 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.574 1.949 . . . . 0.0 114.041 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -146.59 165.96 27.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -151.48 160.61 43.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.726 1.611 . . . . 0.0 111.251 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.47 -13.69 62.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -148.38 150.93 34.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.565 1.546 . . . . 0.0 111.377 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -146.34 158.12 43.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.647 1.579 . . . . 0.0 111.126 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -149.29 -30.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m 60.28 13.9 4.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.178 1.791 . . . . 0.0 115.785 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.53 19.66 0.31 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.856 1.217 . . . . 0.0 114.646 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.92 -28.58 63.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.226 1.013 . . . . 0.0 112.969 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 t -63.59 122.97 79.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.914 1.285 . . . . 0.0 111.525 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.24 163.31 3.51 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.16 3.24 . . . . 0.0 115.975 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.17 -7.16 2.05 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.531 1.532 . . . . 0.0 113.731 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.69 172.15 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.928 2.491 . . . . 0.0 109.87 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 p -137.02 152.6 50.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.576 1.15 . . . . 0.0 113.235 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.26 145.83 52.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.872 2.069 . . . . 0.0 108.671 168.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -156.54 172.72 18.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.791 1.636 . . . . 0.0 109.712 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.48 117.29 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.2 mt -56.76 153.38 10.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.692 1.197 . . . . 0.0 111.823 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -65.91 158.56 75.03 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 121.595 -0.691 . . . . 0.0 112.709 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.67 -21.56 19.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.986 3.124 . . . . 0.0 115.186 169.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -66.08 -24.97 66.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.9 1.28 . . . . 0.0 112.98 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.94 26.9 9.27 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.595 1.569 . . . . 0.0 113.399 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -135.75 157.9 45.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.45 1.1 . . . . 0.0 112.479 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.38 142.54 57.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 0.0 110.8 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp -133.32 114.8 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.219 1.408 . . . . 0.0 108.989 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.67 148.08 49.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -140.23 168.82 18.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.245 1.418 . . . . 0.0 110.958 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 m -57.97 -3.88 0.27 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 -168.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.0 32.94 0.23 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.758 1.17 . . . . 0.0 114.01 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.69 39.89 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 118.559 1.18 . . . . 0.0 113.637 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.63 166.04 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.315 1.446 . . . . 0.0 112.541 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.0 -153.6 18.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.7 143.42 41.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 117.578 0.689 . . . . 0.0 111.208 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.24 167.71 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.854 0.862 . . . . 0.0 112.921 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.71 139.79 29.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.351 1.06 . . . . 0.0 112.508 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -60.02 -31.38 69.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -169.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -128.56 -5.79 5.25 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p -131.54 9.84 4.72 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.108 1.363 . . . . 0.0 113.5 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.405 0.145 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 175.57 47.53 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.108 0.861 . . . . 0.0 113.345 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -137.55 -3.22 1.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.922 1.289 . . . . 0.0 114.12 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -138.16 -3.18 1.79 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.188 1.795 . . . . 0.0 113.8 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.91 168.18 26.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.106 1.762 . . . . 0.0 110.516 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.64 9.88 7.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.08 1.752 . . . . 0.0 112.702 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.475 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 28.2 t-80 -147.54 -169.71 3.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.794 2.038 . . . . 0.0 110.227 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.475 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 33.4 p80 -122.82 -0.89 8.98 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.76 1.624 . . . . 0.0 113.42 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.487 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 23.6 t-80 -143.38 -160.63 1.13 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.164 2.186 . . . . 0.0 109.747 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.487 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 66.1 t60 -67.97 6.03 0.79 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.136 2.174 . . . . 0.0 114.766 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m 54.95 26.38 7.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.76 1.624 . . . . 0.0 114.195 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.31 20.78 1.07 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.279 1.419 . . . . 0.0 114.332 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.95 -11.59 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.95 1.7 . . . . 0.0 114.405 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -135.61 159.83 69.99 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.89 2.076 . . . . 0.0 112.749 -174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.46 158.71 7.26 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.041 3.16 . . . . 0.0 116.142 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.9 12.55 1.44 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.729 1.611 . . . . 0.0 113.165 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -68.81 166.91 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.683 1.593 . . . . 0.0 113.709 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -142.51 172.09 13.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.791 1.636 . . . . 0.0 110.525 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -119.71 158.33 26.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.98 2.112 . . . . 0.0 111.496 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -151.9 170.04 20.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.058 1.743 . . . . 0.0 110.796 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.74 3.63 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.3 mt 57.1 -156.18 0.31 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.391 1.076 . . . . 0.0 111.169 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -129.44 143.59 49.51 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.572 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.09 -16.51 4.63 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.443 3.429 . . . . 0.0 115.631 169.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -61.72 -14.48 32.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.706 1.202 . . . . 0.0 114.027 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.73 13.12 51.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.397 1.475 . . . . 0.0 114.003 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.62 169.43 17.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.091 1.756 . . . . 0.0 111.324 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -56.88 149.98 17.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 112.121 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.16 84.17 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.255 1.422 . . . . 0.0 109.348 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CD1' HD21 ' A' ' 107' ' ' LEU . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 75' ' ' TRP . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.44 142.34 32.97 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.1 p -139.94 175.38 9.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.596 1.558 . . . . 0.0 111.463 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 p -61.53 -6.27 2.31 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.54 6.81 3.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.772 1.177 . . . . 0.0 115.781 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.42 -175.05 34.18 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.536 1.668 . . . . 0.0 114.549 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -84.65 160.43 20.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.8 -161.57 24.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.06 157.57 7.86 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 121.779 -0.836 . . . . 0.0 112.975 171.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.24 151.89 26.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.213 1.405 . . . . 0.0 113.03 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.17 159.71 44.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.129 1.372 . . . . 0.0 112.601 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.2 t -101.93 -22.96 14.2 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -133.2 6.34 3.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.018 1.327 . . . . 0.0 113.5 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -142.13 -5.99 0.97 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.643 -1.286 . . . . 0.0 114.046 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.94 -29.1 0.02 OUTLIER Glycine 0 N--CA 1.476 1.359 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -128.56 5.41 5.62 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.226 1.41 . . . . 0.0 112.78 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -75.3 179.57 5.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.121 2.568 . . . . 0.0 112.801 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -132.45 19.59 4.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.133 1.373 . . . . 0.0 112.75 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -130.2 12.82 5.61 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.311 1.444 . . . . 0.0 113.702 -169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -128.41 5.15 5.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.216 1.807 . . . . 0.0 113.527 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -145.58 168.76 19.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.192 1.797 . . . . 0.0 111.386 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -149.13 166.24 29.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.429 1.092 . . . . 0.0 111.93 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -137.25 -7.13 1.78 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.214 1.806 . . . . 0.0 114.414 -173.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 m 49.69 27.58 2.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 -26.19 1.36 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.9 1.714 . . . . 0.0 115.141 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.8 134.42 12.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.692 1.597 . . . . 0.0 111.395 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.1 p -148.36 160.38 36.87 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.925 1.69 . . . . 0.0 112.151 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.97 157.91 7.35 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.136 3.224 . . . . 0.0 115.724 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 4.15 2.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.958 1.303 . . . . 0.0 114.206 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 m -140.3 165.07 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.467 1.507 . . . . 0.0 111.811 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -147.81 153.77 39.6 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.25 1.42 . . . . 0.0 109.576 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.8 mt -72.29 149.48 44.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.887 0.851 . . . . 0.0 111.85 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -155.53 171.3 20.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.032 1.733 . . . . 0.0 110.269 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.6 -27.22 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.3 mt 57.25 -161.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.705 1.602 . . . . 0.0 111.874 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 p -148.22 155.13 43.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.31 -1.07 9.09 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.878 3.052 . . . . 0.0 113.938 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.37 -20.49 63.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.558 1.143 . . . . 0.0 112.868 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.35 13.7 56.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.805 1.193 . . . . 0.0 113.639 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.53 159.98 41.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.224 1.81 . . . . 0.0 110.187 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -57.46 153.37 12.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.143 0.977 . . . . 0.0 111.191 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.4 111.22 17.88 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.149 1.38 . . . . 0.0 108.13 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.405 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp -65.14 148.58 51.42 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.5 p -137.09 176.16 8.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.971 1.709 . . . . 0.0 110.752 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.9 m -61.1 -11.46 8.79 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.16 26.34 0.55 Allowed Glycine 0 CA--C 1.538 1.471 0 CA-C-N 119.35 0.977 . . . . 0.0 115.272 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.91 -173.5 45.11 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.534 1.167 . . . . 0.0 113.783 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.61 165.08 16.25 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.578 1.551 . . . . 0.0 112.028 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.32 -165.72 32.46 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.71 162.88 3.64 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.971 -0.723 . . . . 0.0 112.835 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.16 154.04 6.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.679 1.192 . . . . 0.0 113.518 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.04 157.14 45.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.204 1.401 . . . . 0.0 112.279 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -59.79 -39.81 86.21 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.159 1.384 . . . . 0.0 113.829 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -152.54 -27.61 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p -67.98 4.33 1.24 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . 0.401 ' C7 ' ' H1 ' ' A' ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . 0.401 ' H1 ' ' C7 ' ' A' ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.43 19.23 0.07 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -156.8 171.72 19.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.634 1.574 . . . . 0.0 111.706 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -137.54 0.65 2.29 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.827 1.251 . . . . 0.0 113.757 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.34 -5.31 31.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.537 1.935 . . . . 0.0 114.94 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -57.22 151.1 16.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.325 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -144.25 151.19 39.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.545 1.138 . . . . 0.0 111.934 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -154.96 166.19 34.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.787 1.635 . . . . 0.0 110.942 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -139.12 171.68 13.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 112.592 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CG ' ' H ' ' A' ' 11' ' ' SER . 10.2 t60 -137.96 173.25 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.944 1.298 . . . . 0.0 111.509 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' H ' ' CG ' ' A' ' 10' ' ' HIS . 25.4 m 60.19 8.74 1.62 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.887 2.075 . . . . 0.0 115.247 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.48 27.9 0.18 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.636 1.589 . . . . 0.0 113.775 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.63 -24.94 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.129 0.965 . . . . 0.0 112.722 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -150.05 146.36 20.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.425 1.89 . . . . 0.0 109.807 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.93 160.11 4.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.086 3.19 . . . . 0.0 115.349 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -34.12 73.54 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.331 1.052 . . . . 0.0 113.241 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.4 -57.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.676 1.99 . . . . 0.0 109.65 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 t -167.1 2.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 113.041 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.0 mt -53.16 134.58 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.927 -1.108 . . . . 0.0 111.15 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -152.91 172.3 16.99 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.766 1.226 . . . . 0.0 110.674 -168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.18 -6.17 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 mt 54.18 -144.52 0.66 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.916 1.286 . . . . 0.0 110.525 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p -147.56 160.2 39.38 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 119.806 1.185 . . . . 0.0 113.665 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -54.17 -18.67 14.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.456 . . . . 0.0 115.809 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -61.78 -21.07 64.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.286 1.434 . . . . 0.0 113.234 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.83 16.09 62.07 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.97 1.271 . . . . 0.0 113.274 -172.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.39 164.34 28.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.522 1.529 . . . . 0.0 112.252 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -59.7 141.16 55.7 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.448 1.499 . . . . 0.0 111.772 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp -111.08 84.19 1.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.658 1.583 . . . . 0.0 109.812 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.408 ' CD1' HD22 ' A' ' 107' ' ' LEU . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 75' ' ' TRP . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -86.27 137.67 32.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.5 p -132.38 175.12 9.56 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.641 1.577 . . . . 0.0 110.961 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.01 -4.82 0.53 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -173.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.0 -5.76 4.69 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.126 -1.374 . . . . 0.0 115.743 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.88 179.42 33.71 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.001 1.901 . . . . 0.0 114.267 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.91 160.71 30.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.82 -162.43 27.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.91 158.9 6.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 170.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.96 160.48 14.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.342 1.057 . . . . 0.0 113.52 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.9 170.41 18.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.345 1.458 . . . . 0.0 112.299 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 t -105.22 -27.08 11.77 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -131.35 0.97 4.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.095 1.358 . . . . 0.0 113.881 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p -140.66 4.74 1.96 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -172.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.24 14.99 0.07 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -141.57 4.63 1.76 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.687 1.195 . . . . 0.0 113.771 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -142.5 9.45 1.81 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.157 1.383 . . . . 0.0 113.473 -171.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -139.1 7.29 2.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.768 1.227 . . . . 0.0 113.752 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -0.83 2.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.446 1.498 . . . . 0.0 113.983 -174.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -155.66 174.08 15.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.339 1.855 . . . . 0.0 110.666 -176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -58.28 154.15 13.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.872 1.269 . . . . 0.0 112.823 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -148.58 166.5 28.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.506 1.122 . . . . 0.0 113.001 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.58 147.81 27.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.817 1.647 . . . . 0.0 110.582 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -149.53 18.98 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.24 -27.87 4.42 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.515 2.007 . . . . 0.0 110.51 -169.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -153.23 172.95 16.19 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.537 1.935 . . . . 0.0 110.233 169.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.9 p -146.1 164.42 25.18 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.145 1.778 . . . . 0.0 112.152 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.14 159.83 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.264 3.31 . . . . 0.0 115.44 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.87 61.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.065 1.346 . . . . 0.0 114.279 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.31 -60.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 108.848 169.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -168.33 16.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.213 1.805 . . . . 0.0 110.793 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.79 148.82 23.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.817 1.247 . . . . 0.0 111.223 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -151.93 166.63 30.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.67 1.188 . . . . 0.0 110.429 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.0 12.72 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.8 mt 58.79 -154.74 0.36 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.059 1.344 . . . . 0.0 112.219 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -137.62 163.22 50.0 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.244 1.417 . . . . 0.0 112.902 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.84 -20.01 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 115.741 170.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -65.2 -17.79 64.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.577 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.52 63.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.038 1.304 . . . . 0.0 113.791 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -137.09 167.74 20.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.644 1.578 . . . . 0.0 111.925 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.74 146.63 10.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.984 1.313 . . . . 0.0 111.653 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -119.71 84.23 2.17 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.854 1.662 . . . . 0.0 109.215 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp -98.9 150.8 21.54 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 178.71 5.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.404 1.481 . . . . 0.0 111.221 169.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.9 p -60.53 -8.92 3.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.48 32.97 0.22 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.153 0.888 . . . . 0.0 115.025 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.8 47.2 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.817 1.308 . . . . 0.0 113.792 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.59 162.84 23.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.677 1.591 . . . . 0.0 112.259 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.11 -164.81 30.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.17 158.34 9.08 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.986 -0.714 . . . . 0.0 112.856 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.36 144.31 36.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.547 1.139 . . . . 0.0 112.554 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.9 130.52 31.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 111.999 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 t -58.29 -31.49 67.53 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.631 1.572 . . . . 0.0 114.971 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -131.91 -3.42 3.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p -133.86 8.23 3.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.438 0.161 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.63 178.38 47.21 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.127 0.87 . . . . 0.0 113.506 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.66 0.45 2.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.048 1.339 . . . . 0.0 113.91 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -67.51 -19.54 65.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.849 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.82 2.65 2.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.903 1.681 . . . . 0.0 113.497 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -148.14 164.45 33.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.81 1.644 . . . . 0.0 111.84 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.59 166.07 29.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.579 1.151 . . . . 0.0 112.237 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -150.03 151.31 33.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.395 1.478 . . . . 0.0 110.848 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -161.53 -45.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.074 2.149 . . . . 0.0 110.574 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -151.9 -13.17 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.347 1.859 . . . . 0.0 113.216 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.7 p -62.99 -2.05 1.11 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.82 18.63 3.37 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.791 2.139 . . . . 0.0 114.075 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.93 157.62 30.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.381 1.072 . . . . 0.0 112.796 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -153.02 150.08 23.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.757 1.223 . . . . 0.0 111.356 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.17 159.05 4.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.819 3.013 . . . . 0.0 114.984 169.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.49 14.2 2.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 m -60.9 161.28 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 171.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -57.25 146.4 28.6 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.025 0.916 . . . . 0.0 110.553 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.1 mt -77.86 161.61 27.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.494 1.518 . . . . 0.0 112.361 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -149.88 173.54 13.67 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.251 1.82 . . . . 0.0 110.148 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -66.92 -20.82 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.99 -165.46 0.06 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.697 1.199 . . . . 0.0 111.232 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -123.1 137.66 28.58 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 120.201 -1.562 . . . . 0.0 112.325 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -52.07 -19.06 8.09 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.585 3.523 . . . . 0.0 115.675 170.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -63.79 -19.65 65.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.553 1.541 . . . . 0.0 113.442 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.51 16.15 23.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.34 1.924 . . . . 0.0 113.625 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.88 177.69 7.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.381 1.872 . . . . 0.0 111.256 -171.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.85 157.91 29.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.235 1.014 . . . . 0.0 111.566 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp -120.08 84.05 2.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.847 1.659 . . . . 0.0 108.787 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp -63.67 149.16 47.21 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 p -131.68 179.46 6.04 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.269 1.428 . . . . 0.0 111.314 171.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.6 p -61.87 -8.47 5.02 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.04 23.28 0.21 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.596 0.999 . . . . 0.0 115.596 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.9 -170.13 41.1 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.054 1.427 . . . . 0.0 113.735 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -130.14 163.78 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.723 1.609 . . . . 0.0 112.29 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.94 -162.64 24.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.01 157.66 4.39 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.49 160.69 8.5 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.761 1.224 . . . . 0.0 113.921 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.22 155.76 43.45 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.207 1.403 . . . . 0.0 112.266 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -86.86 -21.95 26.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.27 -19.3 2.49 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p -130.05 1.71 4.76 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.59 179.14 45.93 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.36 0.981 . . . . 0.0 113.13 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -131.82 -2.97 3.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.66 1.184 . . . . 0.0 113.907 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.93 153.02 40.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.701 . . . . 0.0 110.938 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.77 -0.22 2.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.777 1.231 . . . . 0.0 113.594 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -158.34 170.37 22.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.65 1.98 . . . . 0.0 110.856 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -139.31 24.08 2.51 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 112.043 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.49 -0.59 4.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.156 1.382 . . . . 0.0 114.276 -168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -146.49 159.25 43.65 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.469 1.907 . . . . 0.0 109.52 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t60 61.07 -23.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.975 2.51 . . . . 0.0 116.766 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -133.79 10.8 3.98 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.161 2.584 . . . . 0.0 112.026 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.78 0.7 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.726 1.631 . . . . 0.0 114.438 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.1 152.69 32.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.132 1.773 . . . . 0.0 110.471 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 t -156.44 147.29 16.36 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.228 1.011 . . . . 0.0 111.99 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.81 163.78 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.536 3.491 . . . . 0.0 115.73 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.15 -8.22 20.64 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.61 163.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.607 1.163 . . . . 0.0 112.834 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -132.54 7.54 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.181 1.393 . . . . 0.0 112.671 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.99 154.48 12.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -150.39 173.82 13.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 111.211 -170.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.441 HD22 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.13 -19.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.1 mt 56.63 -159.43 0.23 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.926 1.29 . . . . 0.0 111.074 -169.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.5 t -117.87 139.85 26.99 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.102 0.961 . . . . 0.0 111.656 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.33 -19.18 6.22 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.746 3.631 . . . . 0.0 115.659 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -60.9 -22.65 64.55 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.596 1.158 . . . . 0.0 113.795 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.5 15.92 17.61 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.951 1.739 . . . . 0.0 114.019 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.44 167.89 20.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.684 1.594 . . . . 0.0 111.692 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.03 152.46 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 0.0 111.645 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.08 86.57 2.57 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.649 1.58 . . . . 0.0 109.454 -172.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' CG2' HD22 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.86 142.33 44.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.6 p -140.45 172.63 12.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.017 1.727 . . . . 0.0 111.855 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -6.7 2.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -131.05 4.95 5.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.163 1.363 . . . . 0.0 115.644 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.07 -176.22 26.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.163 1.481 . . . . 0.0 114.128 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -78.84 162.18 26.25 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 168.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.41 174.79 38.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.54 73.1 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -168.62 167.8 11.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.067 2.547 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.83 139.83 26.65 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.356 -0.84 . . . . 0.0 112.429 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -81.33 -22.79 38.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.97 -12.48 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p -135.13 7.35 3.4 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.54 175.21 46.19 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.009 0.814 . . . . 0.0 113.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -139.71 -0.79 1.7 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.127 1.371 . . . . 0.0 114.324 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -71.47 -6.27 39.19 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 114.089 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.99 170.49 17.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.406 2.282 . . . . 0.0 111.168 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -155.68 163.66 39.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 110.318 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -55.73 -20.54 14.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.461 1.904 . . . . 0.0 115.476 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -114.02 11.21 17.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.17 1.788 . . . . 0.0 112.985 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -131.65 3.37 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.871 1.668 . . . . 0.0 113.484 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -62.62 161.96 11.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.577 1.151 . . . . 0.0 112.83 169.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -130.95 8.2 4.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.738 1.215 . . . . 0.0 114.143 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.86 23.8 0.2 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.829 1.204 . . . . 0.0 114.297 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.38 -27.0 0.2 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -153.26 146.95 18.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 125.148 1.379 . . . . 0.0 110.827 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.86 168.22 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.212 3.275 . . . . 0.0 115.601 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.42 5.15 2.46 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.001 1.32 . . . . 0.0 114.091 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.42 162.05 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 0.0 111.266 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -152.95 159.89 42.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.393 1.477 . . . . 0.0 109.972 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.35 141.16 39.15 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.295 1.438 . . . . 0.0 110.687 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -159.02 168.72 26.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.69 2.396 . . . . 0.0 109.771 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.49 -25.03 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mp 55.67 -157.22 0.24 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.109 1.764 . . . . 0.0 111.059 -172.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.3 t -128.74 140.34 38.24 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.4 1.08 . . . . 0.0 111.876 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.31 -8.27 18.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.681 2.921 . . . . 0.0 113.757 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtp-105 -59.34 -25.56 64.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.287 1.035 . . . . 0.0 113.052 168.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.74 9.77 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.655 1.598 . . . . 0.0 114.261 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.07 163.93 29.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.586 1.554 . . . . 0.0 111.405 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -65.48 158.16 27.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 0.0 111.571 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp -131.54 114.55 15.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.502 1.521 . . . . 0.0 108.74 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp -87.26 147.96 25.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -131.63 177.25 7.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.28 1.432 . . . . 0.0 111.322 169.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.4 p -62.99 -8.28 6.95 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.76 26.41 0.39 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.937 -0.924 . . . . 0.0 115.38 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.65 45.31 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 118.823 1.312 . . . . 0.0 114.088 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -123.03 164.31 18.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.236 1.814 . . . . 0.0 111.039 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.438 ' HE2' ' H62' ' A' ' 154' ' ' NAG . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.37 37.75 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.4 80.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.7 166.28 11.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.4 2.28 . . . . 0.0 111.126 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.61 142.97 23.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.926 0.891 . . . . 0.0 112.096 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -85.75 -24.96 26.68 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -170.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -128.19 -8.81 5.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -133.62 3.99 3.59 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . 0.438 ' H62' ' HE2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.507 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 -175.95 45.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.453 1.025 . . . . 0.0 112.688 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -63.52 -15.69 58.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.64 1.176 . . . . 0.0 114.092 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -144.72 145.42 31.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.186 1.794 . . . . 0.0 110.769 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -157.53 -27.53 0.09 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.661 1.184 . . . . 0.0 113.937 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -147.3 161.73 40.38 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.433 . . . . 0.0 111.611 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.27 166.3 29.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.937 1.295 . . . . 0.0 112.825 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -140.51 8.89 2.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.628 1.571 . . . . 0.0 113.227 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -151.26 157.39 42.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.591 1.556 . . . . 0.0 111.536 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -152.97 175.5 12.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.958 1.303 . . . . 0.0 111.986 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 m -130.93 5.55 4.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.33 0.11 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.243 1.401 . . . . 0.0 115.064 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -137.8 5.44 2.62 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.707 1.603 . . . . 0.0 112.978 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -155.34 151.13 21.93 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.957 1.703 . . . . 0.0 110.146 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -49.67 156.68 2.89 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.015 3.144 . . . . 0.0 116.042 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.27 -3.59 0.93 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.97 167.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 126.112 1.765 . . . . 0.0 111.219 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -147.7 170.2 18.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.039 1.336 . . . . 0.0 110.683 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.99 158.0 30.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.164 2.185 . . . . 0.0 111.523 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -154.62 173.49 16.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.938 1.695 . . . . 0.0 110.983 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.74 -19.69 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.6 mt 58.18 -159.27 0.28 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 111.548 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.6 p -147.9 162.5 31.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.985 0.914 . . . . 0.0 112.971 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -54.52 -16.17 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.351 3.367 . . . . 0.0 115.99 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.57 -17.64 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.234 1.413 . . . . 0.0 113.685 172.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.94 11.37 65.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.999 1.285 . . . . 0.0 113.484 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.57 171.15 14.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.027 1.731 . . . . 0.0 111.481 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.03 154.72 12.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.82 1.248 . . . . 0.0 111.436 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp -121.99 109.77 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.024 1.33 . . . . 0.0 108.879 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.16 147.38 29.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.3 p -133.52 173.45 11.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 111.962 174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -63.34 2.39 0.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.23 15.37 0.2 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.23 -174.41 46.99 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.614 1.707 . . . . 0.0 114.88 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -119.52 161.84 19.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.737 1.615 . . . . 0.0 111.964 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.03 -166.57 32.36 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.04 156.46 3.89 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.19 159.63 9.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.537 1.135 . . . . 0.0 113.531 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.04 165.71 27.43 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.717 1.207 . . . . 0.0 112.532 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -100.39 -25.24 14.29 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -137.82 6.25 2.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.919 1.287 . . . . 0.0 114.072 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -145.16 9.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -173.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 114' ' ' TYR . 2.6 tm? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' A' ' 109' ' ' LEU . 7.1 m-85 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.024 0.916 . . . . 0.0 111.891 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 122.436 1.112 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.414 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 96.4 p . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.414 ' HH ' ' N ' ' A' ' 20' ' ' SER . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 122.192 0.996 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.407 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 15.1 t . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' HH ' ' N ' ' A' ' 20' ' ' SER . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 114' ' ' TYR . 57.2 tp . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CZ ' HD13 ' A' ' 109' ' ' LEU . 16.4 m-85 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 122.469 1.128 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.065 0.46 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 122.477 1.132 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.655 0.264 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.984 0.421 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.402 0.62 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 122.436 1.112 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.899 0.381 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.534 HD21 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 122.331 1.062 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 122.299 1.047 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 121' ' ' ARG . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.847 1.308 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.689 0.281 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 122.637 1.208 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.447 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 9.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.016 0.436 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.447 ' HH ' ' N ' ' A' ' 20' ' ' SER . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 52' ' ' VAL . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.907 0.384 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 122.179 0.99 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.488 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 82.8 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.086 0.469 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.488 ' HH ' ' N ' ' A' ' 20' ' ' SER . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 122.594 1.188 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.438 HD21 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.348 0.594 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' HD21 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.856 0.836 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.105 0.478 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 114' ' ' TYR . 2.3 tm? . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.413 ' CZ ' HD23 ' A' ' 109' ' ' LEU . 14.9 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 122.402 1.096 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.22 47.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.105 0.86 . . . . 0.0 113.334 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.16 171.1 17.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 112.092 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -154.36 179.47 8.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.439 1.496 . . . . 0.0 110.856 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -132.8 2.62 3.72 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.319 1.448 . . . . 0.0 114.161 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -127.49 -18.71 4.35 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.973 1.309 . . . . 0.0 113.907 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -133.16 3.9 3.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.85 1.26 . . . . 0.0 114.157 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -146.81 167.04 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.764 1.625 . . . . 0.0 111.144 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -152.95 168.63 25.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.952 1.301 . . . . 0.0 112.235 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -129.56 -36.2 1.67 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.881 1.272 . . . . 0.0 112.272 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 p -62.55 -4.06 1.77 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.1 2.16 . . . . 0.0 116.522 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.19 16.99 3.39 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.905 1.717 . . . . 0.0 114.598 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -142.92 -6.27 0.86 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -154.69 152.63 26.2 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.61 1.164 . . . . 0.0 111.36 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.54 160.94 3.23 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.132 3.221 . . . . 0.0 115.43 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.53 11.72 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.135 1.374 . . . . 0.0 113.759 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.89 162.65 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.07 1.348 . . . . 0.0 111.969 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -148.54 154.11 39.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.276 1.431 . . . . 0.0 109.684 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.97 150.69 42.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.83 0.824 . . . . 0.0 111.762 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -156.11 172.48 18.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.079 1.752 . . . . 0.0 110.189 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -116.37 6.39 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.9 mt 52.68 -144.55 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.144 . . . . 0.0 111.548 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.5 p -143.65 163.87 33.75 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.88 1.272 . . . . 0.0 112.127 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.05 -16.5 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.123 3.215 . . . . 0.0 115.799 170.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -71.24 -8.37 53.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.939 1.296 . . . . 0.0 113.697 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 22.14 69.71 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.42 1.01 . . . . 0.0 113.411 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -144.15 160.51 40.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.235 -172.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.21 149.78 9.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.06 1.344 . . . . 0.0 112.677 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -123.11 95.35 4.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.233 1.813 . . . . 0.0 107.961 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 114' ' ' TYR . 2.6 tm? -96.7 144.0 27.12 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 p -135.29 169.93 16.71 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.645 1.578 . . . . 0.0 111.334 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -57.34 -6.84 0.48 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.01 31.89 0.32 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.571 1.081 . . . . 0.0 114.752 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.34 -173.03 45.87 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.535 1.668 . . . . 0.0 115.268 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' A' ' 109' ' ' LEU . 7.1 m-85 -128.15 158.43 38.05 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.516 1.526 . . . . 0.0 111.891 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.83 -159.49 23.96 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.08 150.31 17.46 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 117.896 0.848 . . . . 0.0 111.809 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.51 159.26 18.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.79 0.805 . . . . 0.0 112.694 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.98 130.38 15.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.474 1.11 . . . . 0.0 111.656 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 t -55.0 -33.31 62.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.33 7.31 5.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.601 1.16 . . . . 0.0 113.899 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -144.0 6.18 1.35 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 1.66 0.19 Allowed Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.88 21.4 1.96 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.442 1.497 . . . . 0.0 111.745 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -132.92 -8.16 3.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.948 1.299 . . . . 0.0 114.188 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -145.65 5.09 1.03 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.393 1.877 . . . . 0.0 113.086 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -84.11 168.79 15.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.292 1.837 . . . . 0.0 113.21 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -133.9 16.19 3.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.812 1.245 . . . . 0.0 113.425 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -70.29 1.98 4.29 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.497 1.519 . . . . 0.0 114.474 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.92 169.62 17.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.552 1.941 . . . . 0.0 111.577 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -135.63 -17.8 1.7 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.881 1.272 . . . . 0.0 113.626 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -134.24 12.52 3.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.991 1.716 . . . . 0.0 112.044 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.88 85.97 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.808 1.194 . . . . 0.0 114.581 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.98 152.7 37.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.043 1.737 . . . . 0.0 111.043 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.3 p -144.2 160.89 47.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.805 1.642 . . . . 0.0 112.236 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -49.43 154.17 4.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.156 3.237 . . . . 0.0 115.279 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.69 60.95 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.26 163.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.812 2.045 . . . . 0.0 112.059 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -144.01 163.95 32.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.734 1.614 . . . . 0.0 111.402 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.97 140.88 49.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.572 1.949 . . . . 0.0 108.261 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -158.65 171.56 19.88 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.836 1.254 . . . . 0.0 110.474 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.0 1.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mp 54.4 -142.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.736 1.215 . . . . 0.0 110.915 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.4 p -146.52 155.71 49.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.942 1.297 . . . . 0.0 112.144 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -68.16 -9.41 25.71 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.414 2.743 . . . . 0.0 113.657 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -62.72 -24.79 67.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.673 1.589 . . . . 0.0 112.851 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.99 14.99 27.46 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.188 1.375 . . . . 0.0 114.147 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -134.71 161.75 34.28 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.348 . . . . 0.0 111.996 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.75 164.93 11.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.341 1.456 . . . . 0.0 111.009 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt -133.43 128.54 35.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 109.712 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.03 147.45 23.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -134.36 174.96 9.96 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.851 1.66 . . . . 0.0 111.951 174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.6 m -59.61 -6.47 1.14 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.76 30.18 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.062 -0.854 . . . . 0.0 115.189 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 -173.35 46.12 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.299 1.549 . . . . 0.0 114.858 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -125.96 159.34 32.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.385 1.474 . . . . 0.0 112.007 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.13 -166.84 33.5 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.23 158.64 5.15 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 118.049 0.925 . . . . 0.0 113.133 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -55.91 152.57 9.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.458 1.103 . . . . 0.0 112.539 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.53 150.43 47.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.827 1.651 . . . . 0.0 111.399 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -49.94 -39.95 42.01 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.752 1.621 . . . . 0.0 114.829 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -151.42 -27.21 0.2 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p -72.73 1.61 8.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.285 1.434 . . . . 0.0 114.753 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.09 8.32 0.09 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.003 1.161 . . . . 0.0 116.003 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -142.82 10.78 1.8 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.501 1.52 . . . . 0.0 112.649 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -70.25 -14.51 62.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 113.907 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -148.49 162.46 39.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.471 1.909 . . . . 0.0 110.878 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -150.55 169.17 22.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 112.095 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -147.04 172.13 14.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.756 1.222 . . . . 0.0 111.665 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -60.01 159.94 8.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.998 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -145.69 159.91 42.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -59.9 153.94 19.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.888 1.275 . . . . 0.0 113.093 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.1 p -71.22 -0.48 9.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 -12.34 20.5 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.275 1.893 . . . . 0.0 115.868 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.1 -23.17 66.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.632 1.173 . . . . 0.0 113.431 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.1 p -65.97 158.39 76.09 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.393 1.077 . . . . 0.0 113.204 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.36 159.72 4.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.967 3.111 . . . . 0.0 116.143 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.69 9.4 2.86 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.504 1.522 . . . . 0.0 113.666 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.84 161.47 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.819 1.247 . . . . 0.0 113.389 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -156.02 169.72 23.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 109.996 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.7 mt -122.7 145.83 48.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.931 1.692 . . . . 0.0 111.256 170.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -157.65 173.56 16.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.906 2.082 . . . . 0.0 110.318 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.68 128.2 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 169.46 3.45 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 111.275 168.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.1 t -125.81 147.9 60.41 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.499 1.12 . . . . 0.0 112.402 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.28 -18.74 5.49 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.423 3.416 . . . . 0.0 115.173 168.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -57.04 -21.65 32.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.316 1.446 . . . . 0.0 113.629 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.33 -3.01 40.09 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.758 1.647 . . . . 0.0 114.698 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -140.89 170.2 16.2 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.313 1.445 . . . . 0.0 112.507 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.68 151.36 42.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.952 1.301 . . . . 0.0 110.759 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.03 123.64 49.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.368 1.067 . . . . 0.0 109.835 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp -65.13 150.84 47.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 p -133.38 -178.32 4.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.528 1.531 . . . . 0.0 112.07 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -62.61 -3.09 1.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.91 23.75 0.1 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.61 -172.34 43.6 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.383 1.592 . . . . 0.0 113.635 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.5 161.99 26.69 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.468 1.507 . . . . 0.0 112.065 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.13 -158.26 22.97 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.46 150.62 18.28 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.75 -0.853 . . . . 0.0 111.801 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.42 159.78 17.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.359 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.72 131.38 20.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.602 1.161 . . . . 0.0 111.469 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -57.34 -26.95 61.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.669 1.588 . . . . 0.0 115.207 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -128.37 -7.05 5.28 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p -137.14 8.91 2.97 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.895 1.225 . . . . 0.0 114.233 -172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.07 179.85 48.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.098 0.856 . . . . 0.0 113.479 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -69.85 -10.39 58.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 114.485 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -146.55 162.53 38.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.133 1.773 . . . . 0.0 111.13 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -150.36 167.4 27.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.644 1.578 . . . . 0.0 111.802 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -146.75 161.72 40.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.351 1.061 . . . . 0.0 111.5 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -149.47 163.58 37.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.084 1.354 . . . . 0.0 111.43 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.92 157.79 45.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 111.799 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -149.94 171.67 16.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.118 1.367 . . . . 0.0 111.516 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -127.38 -10.56 5.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.747 1.219 . . . . 0.0 114.221 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -96.48 13.93 26.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.854 1.262 . . . . 0.0 112.663 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.86 13.33 0.13 Allowed Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.347 1.451 . . . . 0.0 115.167 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.68 25.48 1.32 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.665 1.586 . . . . 0.0 111.733 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 149.59 29.17 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.983 1.713 . . . . 0.0 110.648 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.03 165.87 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.005 3.137 . . . . 0.0 115.734 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.98 14.71 5.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.48 1.512 . . . . 0.0 113.625 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.69 163.41 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.314 1.846 . . . . 0.0 112.267 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.1 p -143.91 162.26 36.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.777 1.631 . . . . 0.0 111.746 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.612 167.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 t -158.3 171.67 19.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.058 1.743 . . . . 0.0 109.211 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.98 -14.86 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.2 mt 52.48 -155.97 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.719 1.207 . . . . 0.0 111.478 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -134.63 142.98 44.64 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.04 -1.037 . . . . 0.0 111.868 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.46 -16.67 3.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.657 3.571 . . . . 0.0 115.485 169.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -62.29 -12.56 21.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.771 1.229 . . . . 0.0 113.985 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.89 14.74 57.52 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.347 1.451 . . . . 0.0 113.691 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.1 169.87 17.01 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.859 1.664 . . . . 0.0 111.779 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.16 146.84 49.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 111.761 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -108.86 84.83 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.369 1.468 . . . . 0.0 109.599 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 114' ' ' TYR . 57.2 tp -97.16 148.35 23.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.6 p -131.11 174.61 9.85 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.503 1.521 . . . . 0.0 111.157 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -59.81 -8.58 2.22 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.12 23.16 0.27 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.24 46.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.035 1.418 . . . . 0.0 114.229 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CZ ' HD13 ' A' ' 109' ' ' LEU . 16.4 m-85 -124.91 165.55 17.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.476 1.511 . . . . 0.0 112.11 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.22 175.93 38.65 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -40.74 80.32 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.475 1.138 . . . . 0.0 113.308 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -165.3 173.93 10.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.67 2.388 . . . . 0.0 109.731 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.51 153.73 42.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.622 1.169 . . . . 0.0 111.64 169.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -55.29 -40.01 70.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.192 1.397 . . . . 0.0 114.526 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -158.06 -24.4 0.08 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.265 1.426 . . . . 0.0 113.729 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -72.26 1.3 7.93 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.32 -9.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -144.93 171.69 14.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.511 1.524 . . . . 0.0 111.907 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -149.47 169.12 21.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.351 1.46 . . . . 0.0 111.76 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -150.43 171.89 16.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.089 1.356 . . . . 0.0 111.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -150.84 167.11 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.0 1.32 . . . . 0.0 112.084 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -147.4 -17.99 0.38 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -140.83 5.64 1.97 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.954 1.301 . . . . 0.0 113.872 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -150.11 168.65 23.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.58 1.552 . . . . 0.0 112.175 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.26 173.23 15.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.066 1.346 . . . . 0.0 110.512 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.2 m -135.18 6.19 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.453 1.901 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.11 18.42 1.74 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.994 1.283 . . . . 0.0 115.037 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -151.34 -25.83 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.643 1.177 . . . . 0.0 113.735 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.1 p -141.6 162.76 45.12 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.814 1.646 . . . . 0.0 112.117 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -50.09 157.7 2.75 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.553 3.502 . . . . 0.0 116.145 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.77 -14.55 1.41 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.71 163.34 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.263 1.425 . . . . 0.0 111.493 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -155.67 156.25 34.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.567 1.547 . . . . 0.0 109.525 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.85 159.37 34.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.067 0.936 . . . . 0.0 111.536 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -150.61 170.1 19.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.399 1.479 . . . . 0.0 110.876 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t -105.59 119.66 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 mt -56.48 148.98 18.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.8 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -70.16 163.19 63.89 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.51 -18.08 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.063 3.175 . . . . 0.0 115.417 168.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -69.61 -18.32 63.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.929 0.891 . . . . 0.0 113.118 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.32 22.05 28.07 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.461 1.505 . . . . 0.0 113.822 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -140.98 161.5 37.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.436 1.094 . . . . 0.0 112.332 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.76 145.34 49.98 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.912 1.285 . . . . 0.0 111.278 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -126.67 110.48 13.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.72 1.608 . . . . 0.0 108.751 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.49 152.03 36.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 p -132.3 -179.48 5.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.412 1.885 . . . . 0.0 111.226 169.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.3 p -61.27 -10.1 6.28 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.47 27.86 0.25 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.11 -178.78 44.13 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 118.909 1.355 . . . . 0.0 113.543 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -117.45 165.37 13.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.353 1.461 . . . . 0.0 112.53 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.79 173.77 40.71 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.01 73.42 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.51 175.3 7.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.269 2.228 . . . . 0.0 109.992 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.69 154.24 44.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 111.38 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.5 t -54.93 -38.55 67.82 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.908 1.283 . . . . 0.0 114.127 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.56 -28.68 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.685 1.594 . . . . 0.0 112.746 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m -63.66 5.46 0.2 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.762 2.025 . . . . 0.0 116.215 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.518 0.199 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.56 175.87 46.72 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.229 0.919 . . . . 0.0 113.33 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -141.27 3.87 1.78 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.13 1.372 . . . . 0.0 113.796 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.94 -12.97 61.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.095 1.758 . . . . 0.0 114.142 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -148.32 165.26 31.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.117 2.167 . . . . 0.0 110.764 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -155.29 174.05 15.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.473 1.109 . . . . 0.0 111.495 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -139.06 -5.39 1.47 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.029 1.732 . . . . 0.0 114.261 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -140.1 19.18 2.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.232 1.813 . . . . 0.0 112.169 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -146.11 172.3 13.62 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.782 1.633 . . . . 0.0 111.153 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 53.3 23.72 3.39 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.624 1.97 . . . . 0.0 115.974 -169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 t -134.65 31.17 3.4 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.837 1.655 . . . . 0.0 110.452 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.52 26.78 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.972 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.71 -7.32 10.34 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -137.09 78.16 41.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 120.86 -1.15 . . . . 0.0 112.225 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.69 177.02 0.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.8 3.0 . . . . 0.0 114.33 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.3 -63.86 0.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 111.643 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 t -144.24 -63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 125.889 1.676 . . . . 0.0 109.788 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -170.05 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.122 1.769 . . . . 0.0 111.022 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.49 140.76 39.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.431 1.092 . . . . 0.0 111.886 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t -155.64 159.01 39.25 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.168 1.387 . . . . 0.0 110.401 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.99 2.97 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.7 mt 54.79 -136.98 1.23 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.679 1.591 . . . . 0.0 111.717 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -134.89 155.09 79.56 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 124.188 0.995 . . . . 0.0 112.712 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.69 -9.49 25.04 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.181 2.587 . . . . 0.0 113.505 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.57 -22.05 66.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.866 1.266 . . . . 0.0 113.171 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.18 15.51 21.45 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.38 1.467 . . . . 0.0 113.821 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.43 159.49 40.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.103 1.361 . . . . 0.0 111.939 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.42 164.88 20.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.229 1.412 . . . . 0.0 112.593 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -137.11 134.76 36.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.139 1.376 . . . . 0.0 110.758 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.52 138.65 36.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.9 p -130.08 176.41 8.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.888 1.675 . . . . 0.0 110.639 170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.74 -4.04 0.39 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -127.6 -7.38 4.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.263 1.411 . . . . 0.0 115.718 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.31 30.05 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.181 1.99 . . . . 0.0 114.018 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -70.94 160.17 33.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.07 -163.22 27.13 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.32 160.51 5.12 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.769 -0.842 . . . . 0.0 112.863 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.41 154.77 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.351 1.06 . . . . 0.0 112.96 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.64 159.87 41.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.974 1.71 . . . . 0.0 112.095 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -92.02 -25.79 18.66 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -137.23 -1.26 2.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p -133.5 9.26 3.98 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.657 1.183 . . . . 0.0 114.152 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 175.45 40.49 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.968 0.794 . . . . 0.0 113.845 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -140.22 -1.31 1.55 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.021 1.328 . . . . 0.0 114.004 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -149.78 166.89 28.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.339 1.456 . . . . 0.0 111.357 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -63.19 159.71 17.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.783 1.233 . . . . 0.0 112.523 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -147.54 168.4 22.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.322 1.449 . . . . 0.0 111.043 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.49 144.13 43.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.371 0.668 . . . . 0.0 111.776 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -150.49 161.42 42.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.165 1.386 . . . . 0.0 110.903 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.447 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 32.7 t60 57.19 -170.86 0.09 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.021 1.728 . . . . 0.0 113.705 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 2.0 t60 -148.1 174.72 11.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.898 1.279 . . . . 0.0 111.626 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -138.71 11.32 2.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.897 1.679 . . . . 0.0 112.947 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.07 0.6 6.11 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.099 1.333 . . . . 0.0 115.759 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -144.4 -4.23 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.944 1.297 . . . . 0.0 113.818 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -146.05 159.42 46.26 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.123 1.769 . . . . 0.0 112.346 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.0 161.25 5.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.209 3.273 . . . . 0.0 115.405 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.32 10.17 5.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.254 1.422 . . . . 0.0 113.621 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -60.79 158.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.481 1.512 . . . . 0.0 114.403 -170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 t -132.33 8.91 4.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.415 1.086 . . . . 0.0 113.369 173.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.9 mt -55.17 152.26 8.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.834 1.253 . . . . 0.0 112.139 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -150.15 173.04 14.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.46 -23.35 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp 50.29 -153.39 0.15 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.795 1.238 . . . . 0.0 111.539 -173.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -148.18 152.72 40.12 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 120.457 -1.402 . . . . 0.0 112.313 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.93 -12.55 34.7 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.186 2.591 . . . . 0.0 114.239 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -72.26 -8.92 57.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.52 25.64 17.83 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.413 1.006 . . . . 0.0 113.865 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.54 -178.77 5.21 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.932 1.693 . . . . 0.0 111.253 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.94 163.23 20.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.263 1.425 . . . . 0.0 111.777 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.51 139.01 51.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.407 1.083 . . . . 0.0 110.289 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp -111.05 136.27 50.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.8 p -128.82 -178.3 4.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.591 1.557 . . . . 0.0 111.402 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.8 p -62.09 -7.4 3.96 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.85 -21.76 2.85 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.605 1.098 . . . . 0.0 115.711 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -178.89 41.76 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 119.199 1.5 . . . . 0.0 114.111 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -73.77 163.85 27.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.79 -159.58 24.13 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.51 160.52 4.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.408 0.623 . . . . 0.0 112.493 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -60.15 156.81 14.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.976 0.894 . . . . 0.0 112.856 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.78 167.92 20.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.645 1.978 . . . . 0.0 111.277 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.88 -22.05 12.6 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -129.41 -16.48 3.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p -128.15 0.88 5.83 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.56 -7.19 0.1 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -60.22 -21.51 61.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.43 1.492 . . . . 0.0 114.63 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.18 170.19 20.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.651 1.98 . . . . 0.0 111.157 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -149.54 166.94 27.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.734 1.214 . . . . 0.0 111.497 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -141.15 6.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.446 1.498 . . . . 0.0 114.125 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -140.59 177.17 8.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.406 1.482 . . . . 0.0 111.0 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.5 t60 60.69 -8.7 0.07 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.683 2.393 . . . . 0.0 116.611 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -133.59 -0.49 3.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.516 1.926 . . . . 0.0 113.515 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -146.7 -28.76 0.39 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.122 1.369 . . . . 0.0 113.942 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 m -128.94 12.8 6.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.376 1.471 . . . . 0.0 113.396 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.65 30.32 0.76 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.342 . . . . 0.0 114.083 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -134.13 9.44 3.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.201 1.4 . . . . 0.0 113.186 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -154.47 144.6 15.68 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.726 1.611 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.03 159.64 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.845 3.03 . . . . 0.0 116.012 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.21 2.92 1.52 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.85 1.26 . . . . 0.0 114.396 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -56.54 157.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.759 1.223 . . . . 0.0 114.03 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -129.25 12.29 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.165 1.386 . . . . 0.0 112.524 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -54.86 154.69 4.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -149.7 167.16 27.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.493 1.117 . . . . 0.0 111.117 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -123.48 107.8 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 31' ' ' LEU . 2.7 mm? -57.06 160.0 3.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.754 1.622 . . . . 0.0 112.33 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -57.88 164.31 3.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.726 1.21 . . . . 0.0 113.662 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -8.99 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.584 3.523 . . . . 0.0 116.616 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -119.56 -2.43 10.5 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.62 32.79 5.84 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.189 0.9 . . . . 0.0 115.157 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -128.82 155.66 44.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.621 1.211 . . . . 0.0 112.029 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.86 144.31 56.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.457 -0.777 . . . . 0.0 111.557 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -120.78 110.79 16.77 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.538 1.535 . . . . 0.0 108.511 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.461 ' O ' ' H82' ' A' ' 154' ' ' NAG . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.424 ' CE1' ' H83' ' A' ' 154' ' ' NAG . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp -87.92 149.32 24.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -126.77 178.09 6.16 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.621 1.568 . . . . 0.0 111.536 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -59.5 -8.46 1.88 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.97 29.44 0.2 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.058 0.844 . . . . 0.0 115.108 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.08 -172.35 44.48 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 118.946 1.373 . . . . 0.0 113.807 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -127.24 163.25 24.31 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.791 1.636 . . . . 0.0 112.095 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.68 -161.54 21.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.22 160.17 6.75 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.683 0.754 . . . . 0.0 112.989 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.14 149.17 45.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.616 1.166 . . . . 0.0 113.114 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.76 149.09 32.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.425 1.09 . . . . 0.0 113.092 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -85.47 -27.21 25.83 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -131.51 -4.56 3.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p -130.23 9.15 5.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.227 1.411 . . . . 0.0 113.374 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' NAG . . . . . 0.461 ' H82' ' O ' ' A' ' 89' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.26 -14.06 0.08 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -146.32 173.07 12.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.163 1.785 . . . . 0.0 111.305 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -146.79 155.37 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.283 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -155.25 171.62 19.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 111.828 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -146.56 163.62 35.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.742 1.217 . . . . 0.0 111.246 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -135.13 0.16 2.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.282 1.433 . . . . 0.0 113.818 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -128.98 14.31 6.3 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -64.1 156.76 27.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.859 0.863 . . . . 0.0 112.341 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -152.31 175.12 13.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.743 1.217 . . . . 0.0 111.959 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.8 m -127.87 4.61 6.0 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.072 1.349 . . . . 0.0 114.407 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.35 3.17 0.86 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.886 1.708 . . . . 0.0 114.904 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -138.57 2.99 2.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.009 1.724 . . . . 0.0 112.953 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.7 t -154.59 147.06 17.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.099 1.76 . . . . 0.0 110.44 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.78 159.1 5.33 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.694 2.929 . . . . 0.0 116.224 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.56 6.99 1.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.83 1.252 . . . . 0.0 113.898 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.89 175.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.089 1.756 . . . . 0.0 111.813 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.94 -179.29 6.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.22 1.808 . . . . 0.0 109.86 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.02 152.36 45.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.047 2.139 . . . . 0.0 111.688 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p -154.6 176.62 12.18 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.645 1.978 . . . . 0.0 110.735 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.534 HD21 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.69 -6.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.1 mt 50.08 -127.02 2.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.076 1.351 . . . . 0.0 111.692 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.4 p -149.62 158.49 37.61 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-N 119.657 1.117 . . . . 0.0 112.86 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.28 -6.35 18.66 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.191 2.594 . . . . 0.0 113.591 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -73.0 -8.06 54.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.192 1.397 . . . . 0.0 113.409 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.59 61.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.492 1.044 . . . . 0.0 113.966 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -142.26 155.72 45.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.153 1.381 . . . . 0.0 111.555 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -68.1 159.01 31.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.851 1.26 . . . . 0.0 112.524 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.77 138.71 50.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.327 1.451 . . . . 0.0 110.314 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.13 158.04 33.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -131.87 179.49 6.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.491 1.916 . . . . 0.0 111.565 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 57.5 p -58.53 -10.93 2.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.99 26.67 0.16 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.37 0.987 . . . . 0.0 115.1 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.95 -159.75 24.27 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.309 1.055 . . . . 0.0 113.307 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -133.71 162.75 31.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.341 1.857 . . . . 0.0 112.796 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.53 -161.86 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.77 156.56 6.37 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.027 -0.69 . . . . 0.0 112.36 169.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.72 159.66 13.12 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.275 1.036 . . . . 0.0 113.556 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.39 176.86 9.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.946 1.698 . . . . 0.0 110.62 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.3 t -113.5 -28.64 7.45 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -126.63 -3.09 6.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.049 1.339 . . . . 0.0 113.537 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p -136.48 5.94 2.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 114.084 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.7 -24.05 0.1 OUTLIER Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.831 0.729 . . . . 0.0 114.791 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -147.29 142.88 27.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.456 1.502 . . . . 0.0 110.87 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -148.9 -2.53 0.47 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.152 1.381 . . . . 0.0 113.669 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -70.89 164.02 26.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.791 1.636 . . . . 0.0 113.435 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -131.77 1.76 4.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.994 1.317 . . . . 0.0 113.088 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -134.81 11.17 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.19 1.796 . . . . 0.0 112.637 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.33 164.46 13.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.43 1.492 . . . . 0.0 112.446 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -150.25 179.45 8.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.517 1.127 . . . . 0.0 111.861 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -139.7 177.32 8.03 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.095 1.358 . . . . 0.0 112.392 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 m -141.2 8.23 2.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.11 4.34 2.88 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.283 1.421 . . . . 0.0 115.157 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.79 -7.79 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.731 1.612 . . . . 0.0 113.383 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.8 p -150.58 163.16 25.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.389 1.876 . . . . 0.0 112.287 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.73 161.41 2.16 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.463 3.442 . . . . 0.0 115.78 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.72 2.99 5.46 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.601 1.16 . . . . 0.0 114.105 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.47 159.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.619 1.168 . . . . 0.0 112.614 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -128.66 8.29 5.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.223 1.009 . . . . 0.0 112.69 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.86 152.45 5.54 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.436 1.094 . . . . 0.0 111.237 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -150.08 170.79 18.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.461 1.104 . . . . 0.0 110.676 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.17 116.04 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.5 162.98 7.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.549 1.539 . . . . 0.0 112.273 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.9 p -59.08 160.87 10.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.925 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.79 -2.12 7.12 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.257 2.638 . . . . 0.0 113.712 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -101.33 -12.33 18.73 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.074 1.75 . . . . 0.0 113.034 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.61 26.9 6.61 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.515 1.055 . . . . 0.0 115.174 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -133.11 151.66 51.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.995 1.397 . . . . 0.0 112.378 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.19 150.54 48.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.679 0.791 . . . . 0.0 111.55 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.26 122.49 37.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.533 1.533 . . . . 0.0 109.233 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.04 147.16 23.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.0 p -134.37 172.0 13.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.204 1.802 . . . . 0.0 111.571 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 m -59.42 -3.96 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.26 27.41 0.21 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.252 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.76 -176.33 46.98 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.588 1.694 . . . . 0.0 114.587 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -120.11 164.52 16.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.735 1.614 . . . . 0.0 112.243 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.28 -162.02 25.86 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.28 159.95 5.59 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.578 0.704 . . . . 0.0 112.824 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 155.83 17.2 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.695 1.198 . . . . 0.0 113.135 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.58 153.63 40.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.236 1.415 . . . . 0.0 112.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 t -87.94 -22.46 24.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -138.25 -3.19 1.77 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -130.75 9.87 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.995 1.318 . . . . 0.0 113.59 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.62 47.04 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.359 0.981 . . . . 0.0 113.084 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -152.38 172.15 16.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.203 1.401 . . . . 0.0 112.171 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -143.81 139.03 29.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.327 1.451 . . . . 0.0 110.51 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.3 -32.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.938 1.295 . . . . 0.0 113.046 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -142.8 -1.79 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.949 1.3 . . . . 0.0 114.149 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -65.51 161.19 20.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.013 1.725 . . . . 0.0 113.045 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -150.04 168.82 22.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.588 1.155 . . . . 0.0 112.566 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -142.52 13.0 1.94 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 112.654 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.27 172.25 16.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.279 1.432 . . . . 0.0 112.03 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.5 m -134.13 9.46 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.012 1.325 . . . . 0.0 113.904 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.82 82.1 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.783 1.182 . . . . 0.0 114.505 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -153.13 169.39 23.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.56 1.944 . . . . 0.0 110.898 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -149.32 153.1 37.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.572 1.549 . . . . 0.0 111.287 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.88 168.11 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.017 3.145 . . . . 0.0 115.146 169.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.64 -36.5 35.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.607 1.563 . . . . 0.0 114.802 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.6 t -142.9 -58.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.35 1.86 . . . . 0.0 109.514 169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -169.44 18.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.319 1.447 . . . . 0.0 111.545 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -52.73 145.23 12.55 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.448 1.099 . . . . 0.0 111.702 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t -151.74 165.09 35.5 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.791 1.236 . . . . 0.0 110.85 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.06 -3.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt 54.7 -152.64 0.33 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.425 1.09 . . . . 0.0 111.575 -172.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -132.07 155.96 80.7 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.97 1.308 . . . . 0.0 111.698 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.33 -10.99 30.54 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.06 2.507 . . . . 0.0 113.756 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -63.35 -27.04 69.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.454 1.101 . . . . 0.0 112.932 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.17 20.22 9.94 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.146 1.355 . . . . 0.0 113.821 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.05 160.71 39.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.714 1.605 . . . . 0.0 111.003 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -54.48 149.31 10.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.788 1.235 . . . . 0.0 111.79 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp -117.92 101.52 8.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.113 1.365 . . . . 0.0 109.004 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 121' ' ' ARG . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 110' ' ' THR . 2.6 tm? -117.3 144.58 44.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.449 ' H ' HD22 ' A' ' 109' ' ' LEU . 54.2 p -136.1 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.133 1.773 . . . . 0.0 111.661 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.9 p -60.23 -6.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.0 -9.09 2.53 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.044 -1.42 . . . . 0.0 116.505 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.29 38.48 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 120.395 2.098 . . . . 0.0 114.727 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.67 161.59 23.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.98 -163.42 27.39 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.4 161.41 5.74 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.548 -0.972 . . . . 0.0 112.859 170.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 150.3 16.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.4 1.08 . . . . 0.0 112.148 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.45 152.02 41.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.919 1.688 . . . . 0.0 111.31 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -50.03 -39.57 42.03 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -149.97 -32.7 0.19 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.958 1.303 . . . . 0.0 113.202 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p -67.85 1.94 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.692 . . . . 0.0 115.081 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 118.69 -0.672 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.25 10.93 0.55 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.555 1.07 . . . . 0.0 114.697 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -146.56 1.94 0.82 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.585 1.954 . . . . 0.0 113.163 -172.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -71.61 -8.13 52.15 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.574 1.949 . . . . 0.0 114.041 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -146.59 165.96 27.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -151.48 160.61 43.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.726 1.611 . . . . 0.0 111.251 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.47 -13.69 62.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -148.38 150.93 34.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.565 1.546 . . . . 0.0 111.377 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -146.34 158.12 43.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.647 1.579 . . . . 0.0 111.126 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -149.29 -30.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m 60.28 13.9 4.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.178 1.791 . . . . 0.0 115.785 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.53 19.66 0.31 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.856 1.217 . . . . 0.0 114.646 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.92 -28.58 63.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.226 1.013 . . . . 0.0 112.969 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 t -63.59 122.97 79.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.914 1.285 . . . . 0.0 111.525 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.24 163.31 3.51 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.16 3.24 . . . . 0.0 115.975 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.17 -7.16 2.05 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.531 1.532 . . . . 0.0 113.731 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.69 172.15 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.928 2.491 . . . . 0.0 109.87 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 p -137.02 152.6 50.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.576 1.15 . . . . 0.0 113.235 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.26 145.83 52.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.872 2.069 . . . . 0.0 108.671 168.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -156.54 172.72 18.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.791 1.636 . . . . 0.0 109.712 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.48 117.29 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.2 mt -56.76 153.38 10.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.692 1.197 . . . . 0.0 111.823 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -65.91 158.56 75.03 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 121.595 -0.691 . . . . 0.0 112.709 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.67 -21.56 19.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.986 3.124 . . . . 0.0 115.186 169.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -66.08 -24.97 66.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.9 1.28 . . . . 0.0 112.98 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.94 26.9 9.27 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.595 1.569 . . . . 0.0 113.399 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -135.75 157.9 45.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.45 1.1 . . . . 0.0 112.479 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.38 142.54 57.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 0.0 110.8 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp -133.32 114.8 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.219 1.408 . . . . 0.0 108.989 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.67 148.08 49.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -140.23 168.82 18.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.245 1.418 . . . . 0.0 110.958 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 m -57.97 -3.88 0.27 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 -168.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.0 32.94 0.23 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.758 1.17 . . . . 0.0 114.01 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.69 39.89 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 118.559 1.18 . . . . 0.0 113.637 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.63 166.04 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.315 1.446 . . . . 0.0 112.541 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.0 -153.6 18.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.7 143.42 41.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 117.578 0.689 . . . . 0.0 111.208 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.24 167.71 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.854 0.862 . . . . 0.0 112.921 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.71 139.79 29.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.351 1.06 . . . . 0.0 112.508 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -60.02 -31.38 69.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -169.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -128.56 -5.79 5.25 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p -131.54 9.84 4.72 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.108 1.363 . . . . 0.0 113.5 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.405 0.145 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 175.57 47.53 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.108 0.861 . . . . 0.0 113.345 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -137.55 -3.22 1.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.922 1.289 . . . . 0.0 114.12 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -138.16 -3.18 1.79 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.188 1.795 . . . . 0.0 113.8 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.91 168.18 26.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.106 1.762 . . . . 0.0 110.516 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.64 9.88 7.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.08 1.752 . . . . 0.0 112.702 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 28.2 t-80 -147.54 -169.71 3.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.794 2.038 . . . . 0.0 110.227 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 33.4 p80 -122.82 -0.89 8.98 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.76 1.624 . . . . 0.0 113.42 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 23.6 t-80 -143.38 -160.63 1.13 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.164 2.186 . . . . 0.0 109.747 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 66.1 t60 -67.97 6.03 0.79 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.136 2.174 . . . . 0.0 114.766 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m 54.95 26.38 7.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.76 1.624 . . . . 0.0 114.195 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.31 20.78 1.07 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.279 1.419 . . . . 0.0 114.332 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.95 -11.59 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.95 1.7 . . . . 0.0 114.405 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -135.61 159.83 69.99 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.89 2.076 . . . . 0.0 112.749 -174.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.46 158.71 7.26 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.041 3.16 . . . . 0.0 116.142 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.9 12.55 1.44 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.729 1.611 . . . . 0.0 113.165 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -68.81 166.91 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.683 1.593 . . . . 0.0 113.709 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -142.51 172.09 13.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.791 1.636 . . . . 0.0 110.525 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -119.71 158.33 26.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.98 2.112 . . . . 0.0 111.496 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -151.9 170.04 20.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.058 1.743 . . . . 0.0 110.796 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.74 3.63 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.3 mt 57.1 -156.18 0.31 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.391 1.076 . . . . 0.0 111.169 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -129.44 143.59 49.51 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.572 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.09 -16.51 4.63 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.443 3.429 . . . . 0.0 115.631 169.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -61.72 -14.48 32.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.706 1.202 . . . . 0.0 114.027 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.73 13.12 51.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.397 1.475 . . . . 0.0 114.003 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.62 169.43 17.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.091 1.756 . . . . 0.0 111.324 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -56.88 149.98 17.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 112.121 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.16 84.17 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.255 1.422 . . . . 0.0 109.348 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.44 142.34 32.97 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.1 p -139.94 175.38 9.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.596 1.558 . . . . 0.0 111.463 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 p -61.53 -6.27 2.31 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.54 6.81 3.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.772 1.177 . . . . 0.0 115.781 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.42 -175.05 34.18 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.536 1.668 . . . . 0.0 114.549 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -84.65 160.43 20.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.8 -161.57 24.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.06 157.57 7.86 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 121.779 -0.836 . . . . 0.0 112.975 171.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.24 151.89 26.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.213 1.405 . . . . 0.0 113.03 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.17 159.71 44.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.129 1.372 . . . . 0.0 112.601 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.2 t -101.93 -22.96 14.2 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -133.2 6.34 3.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.018 1.327 . . . . 0.0 113.5 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -142.13 -5.99 0.97 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.643 -1.286 . . . . 0.0 114.046 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.94 -29.1 0.02 OUTLIER Glycine 0 N--CA 1.476 1.359 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -128.56 5.41 5.62 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.226 1.41 . . . . 0.0 112.78 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -75.3 179.57 5.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.121 2.568 . . . . 0.0 112.801 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -132.45 19.59 4.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.133 1.373 . . . . 0.0 112.75 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -130.2 12.82 5.61 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.311 1.444 . . . . 0.0 113.702 -169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -128.41 5.15 5.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.216 1.807 . . . . 0.0 113.527 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -145.58 168.76 19.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.192 1.797 . . . . 0.0 111.386 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -149.13 166.24 29.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.429 1.092 . . . . 0.0 111.93 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -137.25 -7.13 1.78 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.214 1.806 . . . . 0.0 114.414 -173.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 m 49.69 27.58 2.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 -26.19 1.36 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.9 1.714 . . . . 0.0 115.141 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.8 134.42 12.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.692 1.597 . . . . 0.0 111.395 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.1 p -148.36 160.38 36.87 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.925 1.69 . . . . 0.0 112.151 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.97 157.91 7.35 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.136 3.224 . . . . 0.0 115.724 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 4.15 2.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.958 1.303 . . . . 0.0 114.206 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 m -140.3 165.07 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.467 1.507 . . . . 0.0 111.811 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -147.81 153.77 39.6 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.25 1.42 . . . . 0.0 109.576 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.8 mt -72.29 149.48 44.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.887 0.851 . . . . 0.0 111.85 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -155.53 171.3 20.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.032 1.733 . . . . 0.0 110.269 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.6 -27.22 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.3 mt 57.25 -161.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.705 1.602 . . . . 0.0 111.874 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 p -148.22 155.13 43.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.31 -1.07 9.09 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.878 3.052 . . . . 0.0 113.938 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.37 -20.49 63.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.558 1.143 . . . . 0.0 112.868 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.35 13.7 56.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.805 1.193 . . . . 0.0 113.639 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.53 159.98 41.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.224 1.81 . . . . 0.0 110.187 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -57.46 153.37 12.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.143 0.977 . . . . 0.0 111.191 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.4 111.22 17.88 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.149 1.38 . . . . 0.0 108.13 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp -65.14 148.58 51.42 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.5 p -137.09 176.16 8.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.971 1.709 . . . . 0.0 110.752 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.9 m -61.1 -11.46 8.79 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.16 26.34 0.55 Allowed Glycine 0 CA--C 1.538 1.471 0 CA-C-N 119.35 0.977 . . . . 0.0 115.272 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.91 -173.5 45.11 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.534 1.167 . . . . 0.0 113.783 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.61 165.08 16.25 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.578 1.551 . . . . 0.0 112.028 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.32 -165.72 32.46 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.71 162.88 3.64 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.971 -0.723 . . . . 0.0 112.835 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.16 154.04 6.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.679 1.192 . . . . 0.0 113.518 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.04 157.14 45.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.204 1.401 . . . . 0.0 112.279 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -59.79 -39.81 86.21 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.159 1.384 . . . . 0.0 113.829 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -152.54 -27.61 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p -67.98 4.33 1.24 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.43 19.23 0.07 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -156.8 171.72 19.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.634 1.574 . . . . 0.0 111.706 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -137.54 0.65 2.29 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.827 1.251 . . . . 0.0 113.757 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.34 -5.31 31.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.537 1.935 . . . . 0.0 114.94 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -57.22 151.1 16.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.325 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -144.25 151.19 39.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.545 1.138 . . . . 0.0 111.934 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -154.96 166.19 34.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.787 1.635 . . . . 0.0 110.942 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -139.12 171.68 13.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 112.592 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -137.96 173.25 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.944 1.298 . . . . 0.0 111.509 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 m 60.19 8.74 1.62 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.887 2.075 . . . . 0.0 115.247 -172.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.48 27.9 0.18 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.636 1.589 . . . . 0.0 113.775 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.63 -24.94 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.129 0.965 . . . . 0.0 112.722 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -150.05 146.36 20.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.425 1.89 . . . . 0.0 109.807 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.93 160.11 4.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.086 3.19 . . . . 0.0 115.349 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -34.12 73.54 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.331 1.052 . . . . 0.0 113.241 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.4 -57.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.676 1.99 . . . . 0.0 109.65 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 t -167.1 2.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 113.041 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.0 mt -53.16 134.58 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.927 -1.108 . . . . 0.0 111.15 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -152.91 172.3 16.99 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.766 1.226 . . . . 0.0 110.674 -168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.18 -6.17 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 mt 54.18 -144.52 0.66 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.916 1.286 . . . . 0.0 110.525 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p -147.56 160.2 39.38 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 119.806 1.185 . . . . 0.0 113.665 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -54.17 -18.67 14.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.456 . . . . 0.0 115.809 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -61.78 -21.07 64.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.286 1.434 . . . . 0.0 113.234 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.83 16.09 62.07 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.97 1.271 . . . . 0.0 113.274 -172.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.39 164.34 28.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.522 1.529 . . . . 0.0 112.252 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -59.7 141.16 55.7 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.448 1.499 . . . . 0.0 111.772 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp -111.08 84.19 1.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.658 1.583 . . . . 0.0 109.812 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 52' ' ' VAL . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -86.27 137.67 32.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.5 p -132.38 175.12 9.56 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.641 1.577 . . . . 0.0 110.961 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.01 -4.82 0.53 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -173.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.0 -5.76 4.69 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.126 -1.374 . . . . 0.0 115.743 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.88 179.42 33.71 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.001 1.901 . . . . 0.0 114.267 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.91 160.71 30.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.82 -162.43 27.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.91 158.9 6.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 170.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.96 160.48 14.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.342 1.057 . . . . 0.0 113.52 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.9 170.41 18.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.345 1.458 . . . . 0.0 112.299 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 t -105.22 -27.08 11.77 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -131.35 0.97 4.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.095 1.358 . . . . 0.0 113.881 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p -140.66 4.74 1.96 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -172.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.24 14.99 0.07 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -141.57 4.63 1.76 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.687 1.195 . . . . 0.0 113.771 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -142.5 9.45 1.81 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.157 1.383 . . . . 0.0 113.473 -171.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -139.1 7.29 2.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.768 1.227 . . . . 0.0 113.752 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -0.83 2.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.446 1.498 . . . . 0.0 113.983 -174.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -155.66 174.08 15.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.339 1.855 . . . . 0.0 110.666 -176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -58.28 154.15 13.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.872 1.269 . . . . 0.0 112.823 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -148.58 166.5 28.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.506 1.122 . . . . 0.0 113.001 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.58 147.81 27.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.817 1.647 . . . . 0.0 110.582 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -149.53 18.98 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.24 -27.87 4.42 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.515 2.007 . . . . 0.0 110.51 -169.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -153.23 172.95 16.19 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.537 1.935 . . . . 0.0 110.233 169.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.9 p -146.1 164.42 25.18 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.145 1.778 . . . . 0.0 112.152 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.14 159.83 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.264 3.31 . . . . 0.0 115.44 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.87 61.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.065 1.346 . . . . 0.0 114.279 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.31 -60.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 108.848 169.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -168.33 16.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.213 1.805 . . . . 0.0 110.793 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.79 148.82 23.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.817 1.247 . . . . 0.0 111.223 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -151.93 166.63 30.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.67 1.188 . . . . 0.0 110.429 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.0 12.72 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.8 mt 58.79 -154.74 0.36 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.059 1.344 . . . . 0.0 112.219 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -137.62 163.22 50.0 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.244 1.417 . . . . 0.0 112.902 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.84 -20.01 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 115.741 170.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -65.2 -17.79 64.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.577 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.52 63.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.038 1.304 . . . . 0.0 113.791 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -137.09 167.74 20.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.644 1.578 . . . . 0.0 111.925 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.74 146.63 10.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.984 1.313 . . . . 0.0 111.653 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -119.71 84.23 2.17 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.854 1.662 . . . . 0.0 109.215 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp -98.9 150.8 21.54 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 178.71 5.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.404 1.481 . . . . 0.0 111.221 169.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.9 p -60.53 -8.92 3.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.48 32.97 0.22 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.153 0.888 . . . . 0.0 115.025 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.8 47.2 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.817 1.308 . . . . 0.0 113.792 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.59 162.84 23.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.677 1.591 . . . . 0.0 112.259 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.11 -164.81 30.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.17 158.34 9.08 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.986 -0.714 . . . . 0.0 112.856 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.36 144.31 36.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.547 1.139 . . . . 0.0 112.554 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.9 130.52 31.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 111.999 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 t -58.29 -31.49 67.53 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.631 1.572 . . . . 0.0 114.971 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -131.91 -3.42 3.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p -133.86 8.23 3.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.438 0.161 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.63 178.38 47.21 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.127 0.87 . . . . 0.0 113.506 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.66 0.45 2.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.048 1.339 . . . . 0.0 113.91 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -67.51 -19.54 65.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.849 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.82 2.65 2.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.903 1.681 . . . . 0.0 113.497 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -148.14 164.45 33.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.81 1.644 . . . . 0.0 111.84 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.59 166.07 29.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.579 1.151 . . . . 0.0 112.237 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -150.03 151.31 33.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.395 1.478 . . . . 0.0 110.848 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -161.53 -45.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.074 2.149 . . . . 0.0 110.574 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -151.9 -13.17 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.347 1.859 . . . . 0.0 113.216 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.7 p -62.99 -2.05 1.11 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.82 18.63 3.37 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.791 2.139 . . . . 0.0 114.075 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.93 157.62 30.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.381 1.072 . . . . 0.0 112.796 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -153.02 150.08 23.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.757 1.223 . . . . 0.0 111.356 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.17 159.05 4.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.819 3.013 . . . . 0.0 114.984 169.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.49 14.2 2.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 m -60.9 161.28 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 171.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -57.25 146.4 28.6 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.025 0.916 . . . . 0.0 110.553 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.1 mt -77.86 161.61 27.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.494 1.518 . . . . 0.0 112.361 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -149.88 173.54 13.67 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.251 1.82 . . . . 0.0 110.148 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -66.92 -20.82 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.99 -165.46 0.06 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.697 1.199 . . . . 0.0 111.232 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -123.1 137.66 28.58 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 120.201 -1.562 . . . . 0.0 112.325 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -52.07 -19.06 8.09 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.585 3.523 . . . . 0.0 115.675 170.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -63.79 -19.65 65.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.553 1.541 . . . . 0.0 113.442 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.51 16.15 23.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.34 1.924 . . . . 0.0 113.625 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.88 177.69 7.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.381 1.872 . . . . 0.0 111.256 -171.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.85 157.91 29.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.235 1.014 . . . . 0.0 111.566 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp -120.08 84.05 2.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.847 1.659 . . . . 0.0 108.787 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.536 ' O ' ' H82' ' A' ' 154' ' ' NAG . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CE1' ' H83' ' A' ' 154' ' ' NAG . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp -63.67 149.16 47.21 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 p -131.68 179.46 6.04 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.269 1.428 . . . . 0.0 111.314 171.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.6 p -61.87 -8.47 5.02 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.04 23.28 0.21 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.596 0.999 . . . . 0.0 115.596 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.9 -170.13 41.1 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.054 1.427 . . . . 0.0 113.735 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -130.14 163.78 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.723 1.609 . . . . 0.0 112.29 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.94 -162.64 24.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.01 157.66 4.39 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.49 160.69 8.5 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.761 1.224 . . . . 0.0 113.921 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.22 155.76 43.45 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.207 1.403 . . . . 0.0 112.266 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -86.86 -21.95 26.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.27 -19.3 2.49 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p -130.05 1.71 4.76 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' NAG . . . . . 0.536 ' H82' ' O ' ' A' ' 89' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.59 179.14 45.93 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.36 0.981 . . . . 0.0 113.13 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -131.82 -2.97 3.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.66 1.184 . . . . 0.0 113.907 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.93 153.02 40.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.701 . . . . 0.0 110.938 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.77 -0.22 2.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.777 1.231 . . . . 0.0 113.594 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -158.34 170.37 22.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.65 1.98 . . . . 0.0 110.856 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -139.31 24.08 2.51 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 112.043 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.49 -0.59 4.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.156 1.382 . . . . 0.0 114.276 -168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -146.49 159.25 43.65 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.469 1.907 . . . . 0.0 109.52 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t60 61.07 -23.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.975 2.51 . . . . 0.0 116.766 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -133.79 10.8 3.98 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.161 2.584 . . . . 0.0 112.026 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.78 0.7 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.726 1.631 . . . . 0.0 114.438 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.1 152.69 32.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.132 1.773 . . . . 0.0 110.471 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 t -156.44 147.29 16.36 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.228 1.011 . . . . 0.0 111.99 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.81 163.78 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.536 3.491 . . . . 0.0 115.73 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.15 -8.22 20.64 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.61 163.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.607 1.163 . . . . 0.0 112.834 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -132.54 7.54 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.181 1.393 . . . . 0.0 112.671 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.99 154.48 12.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -150.39 173.82 13.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 111.211 -170.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.438 HD21 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.13 -19.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.1 mt 56.63 -159.43 0.23 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.926 1.29 . . . . 0.0 111.074 -169.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.5 t -117.87 139.85 26.99 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.102 0.961 . . . . 0.0 111.656 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.33 -19.18 6.22 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.746 3.631 . . . . 0.0 115.659 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -60.9 -22.65 64.55 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.596 1.158 . . . . 0.0 113.795 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.5 15.92 17.61 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.951 1.739 . . . . 0.0 114.019 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.44 167.89 20.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.684 1.594 . . . . 0.0 111.692 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.03 152.46 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 0.0 111.645 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.08 86.57 2.57 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.649 1.58 . . . . 0.0 109.454 -172.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' HD21 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.86 142.33 44.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.6 p -140.45 172.63 12.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.017 1.727 . . . . 0.0 111.855 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -6.7 2.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -131.05 4.95 5.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.163 1.363 . . . . 0.0 115.644 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.07 -176.22 26.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.163 1.481 . . . . 0.0 114.128 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -78.84 162.18 26.25 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 168.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.41 174.79 38.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.54 73.1 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -168.62 167.8 11.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.067 2.547 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.83 139.83 26.65 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.356 -0.84 . . . . 0.0 112.429 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -81.33 -22.79 38.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.97 -12.48 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p -135.13 7.35 3.4 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -167.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.54 175.21 46.19 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.009 0.814 . . . . 0.0 113.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -139.71 -0.79 1.7 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.127 1.371 . . . . 0.0 114.324 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -71.47 -6.27 39.19 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 114.089 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.99 170.49 17.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.406 2.282 . . . . 0.0 111.168 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -155.68 163.66 39.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 110.318 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -55.73 -20.54 14.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.461 1.904 . . . . 0.0 115.476 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -114.02 11.21 17.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.17 1.788 . . . . 0.0 112.985 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -131.65 3.37 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.871 1.668 . . . . 0.0 113.484 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -62.62 161.96 11.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.577 1.151 . . . . 0.0 112.83 169.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -130.95 8.2 4.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.738 1.215 . . . . 0.0 114.143 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.86 23.8 0.2 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.829 1.204 . . . . 0.0 114.297 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.38 -27.0 0.2 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -153.26 146.95 18.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 125.148 1.379 . . . . 0.0 110.827 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.86 168.22 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.212 3.275 . . . . 0.0 115.601 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.42 5.15 2.46 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.001 1.32 . . . . 0.0 114.091 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.42 162.05 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 0.0 111.266 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -152.95 159.89 42.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.393 1.477 . . . . 0.0 109.972 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.35 141.16 39.15 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.295 1.438 . . . . 0.0 110.687 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -159.02 168.72 26.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.69 2.396 . . . . 0.0 109.771 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.49 -25.03 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mp 55.67 -157.22 0.24 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.109 1.764 . . . . 0.0 111.059 -172.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.3 t -128.74 140.34 38.24 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.4 1.08 . . . . 0.0 111.876 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.31 -8.27 18.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.681 2.921 . . . . 0.0 113.757 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtp-105 -59.34 -25.56 64.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.287 1.035 . . . . 0.0 113.052 168.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.74 9.77 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.655 1.598 . . . . 0.0 114.261 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.07 163.93 29.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.586 1.554 . . . . 0.0 111.405 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -65.48 158.16 27.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 0.0 111.571 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp -131.54 114.55 15.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.502 1.521 . . . . 0.0 108.74 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HB3' ' H82' ' A' ' 155' ' ' MAG . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp -87.26 147.96 25.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -131.63 177.25 7.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.28 1.432 . . . . 0.0 111.322 169.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.4 p -62.99 -8.28 6.95 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.76 26.41 0.39 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.937 -0.924 . . . . 0.0 115.38 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.65 45.31 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 118.823 1.312 . . . . 0.0 114.088 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -123.03 164.31 18.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.236 1.814 . . . . 0.0 111.039 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HE2' ' H61' ' A' ' 154' ' ' NAG . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.37 37.75 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.4 80.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.7 166.28 11.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.4 2.28 . . . . 0.0 111.126 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.61 142.97 23.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.926 0.891 . . . . 0.0 112.096 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -85.75 -24.96 26.68 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -170.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -128.19 -8.81 5.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -133.62 3.99 3.59 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' NAG . . . . . 0.474 ' H61' ' HE2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MAG . . . . . 0.547 ' H82' ' HB3' ' A' ' 102' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.507 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 -175.95 45.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.453 1.025 . . . . 0.0 112.688 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -63.52 -15.69 58.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.64 1.176 . . . . 0.0 114.092 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -144.72 145.42 31.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.186 1.794 . . . . 0.0 110.769 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -157.53 -27.53 0.09 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.661 1.184 . . . . 0.0 113.937 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -147.3 161.73 40.38 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.433 . . . . 0.0 111.611 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.27 166.3 29.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.937 1.295 . . . . 0.0 112.825 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -140.51 8.89 2.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.628 1.571 . . . . 0.0 113.227 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -151.26 157.39 42.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.591 1.556 . . . . 0.0 111.536 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -152.97 175.5 12.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.958 1.303 . . . . 0.0 111.986 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 m -130.93 5.55 4.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.33 0.11 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.243 1.401 . . . . 0.0 115.064 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -137.8 5.44 2.62 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.707 1.603 . . . . 0.0 112.978 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -155.34 151.13 21.93 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.957 1.703 . . . . 0.0 110.146 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -49.67 156.68 2.89 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.015 3.144 . . . . 0.0 116.042 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.27 -3.59 0.93 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.97 167.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 126.112 1.765 . . . . 0.0 111.219 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -147.7 170.2 18.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.039 1.336 . . . . 0.0 110.683 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.99 158.0 30.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.164 2.185 . . . . 0.0 111.523 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -154.62 173.49 16.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.938 1.695 . . . . 0.0 110.983 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.74 -19.69 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.6 mt 58.18 -159.27 0.28 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 111.548 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.6 p -147.9 162.5 31.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.985 0.914 . . . . 0.0 112.971 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -54.52 -16.17 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.351 3.367 . . . . 0.0 115.99 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.57 -17.64 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.234 1.413 . . . . 0.0 113.685 172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.94 11.37 65.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.999 1.285 . . . . 0.0 113.484 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.57 171.15 14.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.027 1.731 . . . . 0.0 111.481 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.03 154.72 12.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.82 1.248 . . . . 0.0 111.436 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp -121.99 109.77 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.024 1.33 . . . . 0.0 108.879 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 110' ' ' THR . 2.3 tm? -106.16 147.38 29.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.461 ' H ' HD22 ' A' ' 109' ' ' LEU . 27.3 p -133.52 173.45 11.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 111.962 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -63.34 2.39 0.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.23 15.37 0.2 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.23 -174.41 46.99 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.614 1.707 . . . . 0.0 114.88 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.413 ' CZ ' HD23 ' A' ' 109' ' ' LEU . 14.9 m-85 -119.52 161.84 19.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.737 1.615 . . . . 0.0 111.964 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.03 -166.57 32.36 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.04 156.46 3.89 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.19 159.63 9.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.537 1.135 . . . . 0.0 113.531 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.04 165.71 27.43 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.717 1.207 . . . . 0.0 112.532 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -100.39 -25.24 14.29 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -137.82 6.25 2.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.919 1.287 . . . . 0.0 114.072 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -145.16 9.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -173.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 114' ' ' TYR . 2.6 tm? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' A' ' 109' ' ' LEU . 7.1 m-85 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.024 0.916 . . . . 0.0 111.891 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 122.436 1.112 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.414 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 96.4 p . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.414 ' HH ' ' N ' ' A' ' 20' ' ' SER . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 122.192 0.996 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.407 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 15.1 t . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' HH ' ' N ' ' A' ' 20' ' ' SER . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 114' ' ' TYR . 57.2 tp . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CZ ' HD13 ' A' ' 109' ' ' LEU . 16.4 m-85 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 122.469 1.128 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.065 0.46 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 122.477 1.132 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.655 0.264 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.984 0.421 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.402 0.62 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 122.436 1.112 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.899 0.381 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.534 HD21 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 122.331 1.062 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 122.299 1.047 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 121' ' ' ARG . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.847 1.308 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.689 0.281 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 122.637 1.208 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.447 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 9.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.016 0.436 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.447 ' HH ' ' N ' ' A' ' 20' ' ' SER . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 52' ' ' VAL . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.907 0.384 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 122.179 0.99 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.488 ' N ' ' HH ' ' A' ' 24' ' ' TYR . 82.8 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.086 0.469 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.488 ' HH ' ' N ' ' A' ' 20' ' ' SER . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 122.594 1.188 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.438 HD21 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.348 0.594 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' HD21 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.856 0.836 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.105 0.478 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 114' ' ' TYR . 2.3 tm? . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.413 ' CZ ' HD23 ' A' ' 109' ' ' LEU . 14.9 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 122.402 1.096 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.22 47.64 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.105 0.86 . . . . 0.0 113.334 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.16 171.1 17.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 112.092 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -154.36 179.47 8.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.439 1.496 . . . . 0.0 110.856 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -132.8 2.62 3.72 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.319 1.448 . . . . 0.0 114.161 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -127.49 -18.71 4.35 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.973 1.309 . . . . 0.0 113.907 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -133.16 3.9 3.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.85 1.26 . . . . 0.0 114.157 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -146.81 167.04 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.764 1.625 . . . . 0.0 111.144 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -152.95 168.63 25.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.952 1.301 . . . . 0.0 112.235 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -129.56 -36.2 1.67 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.881 1.272 . . . . 0.0 112.272 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 p -62.55 -4.06 1.77 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.1 2.16 . . . . 0.0 116.522 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.19 16.99 3.39 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.905 1.717 . . . . 0.0 114.598 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -142.92 -6.27 0.86 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -154.69 152.63 26.2 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.61 1.164 . . . . 0.0 111.36 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.54 160.94 3.23 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.132 3.221 . . . . 0.0 115.43 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.53 11.72 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.135 1.374 . . . . 0.0 113.759 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.89 162.65 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.07 1.348 . . . . 0.0 111.969 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -148.54 154.11 39.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.276 1.431 . . . . 0.0 109.684 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.97 150.69 42.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.83 0.824 . . . . 0.0 111.762 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -156.11 172.48 18.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.079 1.752 . . . . 0.0 110.189 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.5 110.46 3.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 111.426 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -168.54 41.51 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.598 -0.689 . . . . 0.0 114.655 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.16 136.41 36.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.03 1.332 . . . . 0.0 110.249 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -142.97 169.87 16.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.439 1.496 . . . . 0.0 111.686 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 pt -126.49 148.66 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.243 1.817 . . . . 0.0 109.117 169.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.33 124.52 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.748 1.219 . . . . 0.0 108.468 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -143.27 156.06 44.64 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.675 0.79 . . . . 0.0 112.908 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.98 143.59 55.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.775 -0.578 . . . . 0.0 111.907 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.2 -3.08 5.0 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -116.37 6.39 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.361 1.864 . . . . 0.0 114.428 -173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.9 mt 52.68 -144.55 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.144 . . . . 0.0 111.548 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.5 p -143.65 163.87 33.75 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 124.88 1.272 . . . . 0.0 112.127 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.05 -16.5 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.123 3.215 . . . . 0.0 115.799 170.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -71.24 -8.37 53.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.939 1.296 . . . . 0.0 113.697 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.88 22.14 69.71 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.42 1.01 . . . . 0.0 113.411 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -144.15 160.51 40.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.235 -172.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.21 149.78 9.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.06 1.344 . . . . 0.0 112.677 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -123.11 95.35 4.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.233 1.813 . . . . 0.0 107.961 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.68 151.47 27.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.984 1.314 . . . . 0.0 114.196 -167.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.58 132.42 53.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.974 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.8 m -138.55 138.64 38.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.498 1.119 . . . . 0.0 110.405 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.52 131.25 92.53 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.032 1.333 . . . . 0.0 110.803 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -73.05 -5.0 16.42 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.54 2.827 . . . . 0.0 114.461 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.1 53.94 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.636 1.589 . . . . 0.0 114.692 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.85 177.95 9.9 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.315 1.446 . . . . 0.0 112.35 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -83.38 165.67 19.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.097 1.359 . . . . 0.0 112.4 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 59.45 33.84 22.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.8 p -131.9 154.39 81.73 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.64 146.99 82.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.655 2.903 . . . . 0.0 114.204 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.51 148.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.712 -0.617 . . . . 0.0 109.889 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -121.88 163.96 18.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.638 1.175 . . . . 0.0 110.162 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.26 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.293 -0.879 . . . . 0.0 111.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -154.5 173.08 5.09 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.552 1.541 . . . . 0.0 111.299 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.86 167.34 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.711 2.274 . . . . 0.0 112.935 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.3 tp -123.48 133.51 54.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.112 0.965 . . . . 0.0 112.077 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -133.04 -12.03 2.89 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.508 1.923 . . . . 0.0 112.159 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.29 58.6 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.308 1.432 . . . . 0.0 114.343 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -65.54 158.92 25.74 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.837 1.255 . . . . 0.0 112.796 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.3 p -59.54 -17.97 36.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.725 1.61 . . . . 0.0 115.325 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -97.0 -3.95 40.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.921 1.288 . . . . 0.0 112.997 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -115.09 -10.85 12.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.09 1.756 . . . . 0.0 112.721 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.71 150.12 25.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 111.105 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -136.97 175.92 9.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 111.365 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.2 pt -125.64 155.38 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.265 1.426 . . . . 0.0 110.289 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.1 mt -125.16 133.09 52.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.856 1.663 . . . . 0.0 108.131 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -139.37 133.57 31.28 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.045 1.338 . . . . 0.0 109.907 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -66.08 147.06 53.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.023 0.529 . . . . 0.0 111.819 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -126.51 -39.01 2.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.999 0.92 . . . . 0.0 112.362 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.44 173.14 13.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.97 0.908 . . . . 0.0 111.651 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -130.39 -24.58 2.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.619 1.968 . . . . 0.0 113.054 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -71.24 -20.42 62.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.849 1.26 . . . . 0.0 112.682 171.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -125.21 1.56 7.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.699 1.6 . . . . 0.0 113.655 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 50.43 43.85 26.93 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 113.337 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 p -107.34 143.3 35.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.683 1.593 . . . . 0.0 112.853 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.97 171.93 13.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.838 2.055 . . . . 0.0 109.737 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -120.88 153.31 37.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.546 1.138 . . . . 0.0 110.101 169.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 mt -137.67 130.76 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.611 1.164 . . . . 0.0 109.688 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -140.86 150.72 60.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 123.717 0.807 . . . . 0.0 111.749 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.39 144.89 29.53 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.748 2.299 . . . . 0.0 110.702 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.23 -23.33 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.4 -19.24 57.34 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.506 1.051 . . . . 0.0 114.98 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.4 m -140.32 55.89 6.75 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.691 1.196 . . . . 0.0 112.724 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -69.31 -4.66 14.17 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.654 2.903 . . . . 0.0 113.981 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.04 -6.19 16.17 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.809 1.244 . . . . 0.0 113.092 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -141.87 168.71 19.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.632 2.373 . . . . 0.0 111.207 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.65 165.29 28.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 111.871 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -70.53 130.14 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.658 -0.651 . . . . 0.0 109.968 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.3 -171.58 12.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.932 2.206 . . . . 0.0 111.028 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -125.82 120.52 30.76 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.517 -0.99 . . . . 0.0 110.206 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.01 13.78 6.9 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.949 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.73 0.08 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.38 2.672 . . . . 0.0 116.42 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.09 34.84 5.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.549 2.499 . . . . 0.0 112.89 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 56.52 30.17 16.74 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.945 1.698 . . . . 0.0 114.947 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.66 143.95 34.36 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.107 1.363 . . . . 0.0 111.002 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.87 151.05 24.17 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.655 2.237 . . . . 0.0 110.374 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.55 173.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.966 2.106 . . . . 0.0 110.477 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.27 126.26 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.501 -0.749 . . . . 0.0 109.675 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 tp -148.29 148.28 28.54 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.596 1.159 . . . . 0.0 111.455 -168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.23 150.06 15.2 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.405 2.736 . . . . 0.0 113.704 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.88 148.7 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.963 2.442 . . . . 0.0 113.026 -171.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -147.0 -78.52 0.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.993 1.717 . . . . 0.0 108.047 171.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -152.81 14.88 0.56 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.241 1.416 . . . . 0.0 112.304 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -66.43 131.8 46.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.194 -1.566 . . . . 0.0 110.655 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.27 164.08 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.43 1.092 . . . . 0.0 111.97 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -139.89 154.58 47.3 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.007 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.1 m -104.42 133.41 49.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.916 1.286 . . . . 0.0 109.386 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.82 145.18 43.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.13 0.572 . . . . 0.0 110.284 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 m -139.09 134.17 32.56 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.769 -0.582 . . . . 0.0 111.617 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 114' ' ' TYR . 2.6 tm? -96.7 144.0 27.12 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.888 1.275 . . . . 0.0 110.384 174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 p -135.29 169.93 16.71 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.645 1.578 . . . . 0.0 111.334 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -57.34 -6.84 0.48 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.01 31.89 0.32 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.571 1.081 . . . . 0.0 114.752 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.34 -173.03 45.87 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.535 1.668 . . . . 0.0 115.268 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' A' ' 109' ' ' LEU . 7.1 m-85 -128.15 158.43 38.05 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.516 1.526 . . . . 0.0 111.891 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -135.27 156.72 48.49 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.895 1.278 . . . . 0.0 111.67 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.75 118.51 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.306 1.442 . . . . 0.0 109.606 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.09 165.61 26.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 112.904 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.48 165.67 22.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.542 1.537 . . . . 0.0 113.243 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.77 -4.01 9.37 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -121.89 1.51 9.89 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.352 1.861 . . . . 0.0 112.849 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 54.14 18.43 1.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.461 2.304 . . . . 0.0 115.416 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.1 p -73.07 -19.74 61.1 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.741 1.155 . . . . 0.0 113.115 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.98 175.96 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.934 1.694 . . . . 0.0 111.958 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 t -144.91 154.17 42.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.347 2.259 . . . . 0.0 110.1 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -72.88 128.5 35.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.006 0.522 . . . . 0.0 110.795 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -145.52 174.04 11.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.413 1.085 . . . . 0.0 113.067 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.8 mt -130.09 174.26 9.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.546 2.338 . . . . 0.0 111.046 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -125.6 -25.72 3.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.123 . . . . 0.0 113.899 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -126.03 -10.44 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.447 1.499 . . . . 0.0 112.441 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.4 46.09 27.0 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.598 1.559 . . . . 0.0 113.475 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -138.37 161.45 36.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.838 1.655 . . . . 0.0 112.217 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 145.64 46.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.181 0.992 . . . . 0.0 113.408 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.97 -8.93 64.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.158 1.361 . . . . 0.0 114.491 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -69.85 135.2 49.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.798 1.299 . . . . 0.0 111.667 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -73.05 133.46 44.23 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.712 -0.617 . . . . 0.0 109.982 170.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.24 150.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.019 0.928 . . . . 0.0 110.578 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 t -132.05 167.89 18.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.508 1.123 . . . . 0.0 112.293 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.58 133.36 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.785 1.634 . . . . 0.0 109.179 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.83 -159.49 23.96 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.326 0.965 . . . . 0.0 111.703 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.08 150.31 17.46 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 117.896 0.848 . . . . 0.0 111.809 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.51 159.26 18.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.79 0.805 . . . . 0.0 112.694 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.98 130.38 15.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.474 1.11 . . . . 0.0 111.656 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 t -55.0 -33.31 62.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.33 7.31 5.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.601 1.16 . . . . 0.0 113.899 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -144.0 6.18 1.35 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.52 33.33 2.23 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.614 1.578 . . . . 0.0 113.399 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -137.22 153.59 50.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.627 1.971 . . . . 0.0 110.518 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -136.28 175.14 9.87 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.433 1.111 . . . . 0.0 112.743 -168.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.59 143.83 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 127.21 2.204 . . . . 0.0 107.359 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.17 140.45 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.634 1.174 . . . . 0.0 109.027 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.16 146.45 35.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -84.53 144.37 28.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.897 1.279 . . . . 0.0 110.709 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 125.521 1.528 . . . . 0.0 114.62 -178.336 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 1.66 0.19 Allowed Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.88 21.4 1.96 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.442 1.497 . . . . 0.0 111.745 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -132.92 -8.16 3.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.948 1.299 . . . . 0.0 114.188 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -145.65 5.09 1.03 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.393 1.877 . . . . 0.0 113.086 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -84.11 168.79 15.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.292 1.837 . . . . 0.0 113.21 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -133.9 16.19 3.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.812 1.245 . . . . 0.0 113.425 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -70.29 1.98 4.29 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.497 1.519 . . . . 0.0 114.474 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.92 169.62 17.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.552 1.941 . . . . 0.0 111.577 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -135.63 -17.8 1.7 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.881 1.272 . . . . 0.0 113.626 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -134.24 12.52 3.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.991 1.716 . . . . 0.0 112.044 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.88 85.97 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.808 1.194 . . . . 0.0 114.581 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.98 152.7 37.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.043 1.737 . . . . 0.0 111.043 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.3 p -144.2 160.89 47.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.805 1.642 . . . . 0.0 112.236 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -49.43 154.17 4.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.156 3.237 . . . . 0.0 115.279 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.69 60.95 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.26 163.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.812 2.045 . . . . 0.0 112.059 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -144.01 163.95 32.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.734 1.614 . . . . 0.0 111.402 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.97 140.88 49.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.572 1.949 . . . . 0.0 108.261 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -158.65 171.56 19.88 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.836 1.254 . . . . 0.0 110.474 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 93.58 0.41 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.202 0.601 . . . . 0.0 110.379 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.99 -172.48 40.81 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 -169.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.71 134.26 36.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.144 1.377 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -142.57 168.33 19.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.482 1.513 . . . . 0.0 111.31 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -127.13 150.52 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.086 1.754 . . . . 0.0 109.639 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.55 124.02 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.741 1.217 . . . . 0.0 108.7 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -144.6 156.96 44.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.759 0.823 . . . . 0.0 112.908 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -72.42 140.46 48.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 112.432 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -67.93 -7.43 28.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.413 . . . . 0.0 114.726 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.0 1.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.946 1.698 . . . . 0.0 114.317 -170.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mp 54.4 -142.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.736 1.215 . . . . 0.0 110.915 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.4 p -146.52 155.71 49.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.942 1.297 . . . . 0.0 112.144 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -68.16 -9.41 25.71 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.414 2.743 . . . . 0.0 113.657 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -62.72 -24.79 67.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.673 1.589 . . . . 0.0 112.851 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.99 14.99 27.46 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.188 1.375 . . . . 0.0 114.147 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -134.71 161.75 34.28 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.348 . . . . 0.0 111.996 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.75 164.93 11.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.341 1.456 . . . . 0.0 111.009 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.0 mt -133.43 128.54 35.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 109.712 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.05 48.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 112.051 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.98 130.59 47.48 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.242 0.617 . . . . 0.0 111.227 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -134.24 133.51 40.92 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.46 130.41 94.28 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.891 1.276 . . . . 0.0 111.437 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.15 -8.4 18.7 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.078 3.185 . . . . 0.0 114.412 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.29 -9.46 53.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.936 1.255 . . . . 0.0 115.625 173.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -155.3 176.23 12.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.942 1.371 . . . . 0.0 113.039 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -72.24 167.5 20.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.094 0.958 . . . . 0.0 111.494 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 55.39 34.46 22.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.64 1.576 . . . . 0.0 113.973 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 p -132.47 148.43 69.61 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 125.836 1.654 . . . . 0.0 110.67 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.97 156.36 52.31 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.92 2.414 . . . . 0.0 112.205 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.7 142.42 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 110.985 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -118.98 168.34 10.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.028 1.731 . . . . 0.0 109.801 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.02 149.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.013 -1.054 . . . . 0.0 113.414 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -147.71 164.03 24.56 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.845 1.658 . . . . 0.0 110.692 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.69 124.59 12.12 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.052 1.835 . . . . 0.0 111.469 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.79 128.33 36.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.003 0.921 . . . . 0.0 112.373 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -135.49 -16.7 1.8 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.932 1.693 . . . . 0.0 112.478 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 12.81 33.95 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.862 1.22 . . . . 0.0 114.639 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 159.13 15.1 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.061 1.344 . . . . 0.0 112.551 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -58.83 -23.66 60.92 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.496 1.118 . . . . 0.0 114.006 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.44 -10.13 58.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.741 1.216 . . . . 0.0 113.146 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -111.99 -17.45 12.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.824 1.65 . . . . 0.0 112.811 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.18 144.42 28.18 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.757 1.223 . . . . 0.0 111.444 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -134.37 174.21 10.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 110.825 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.37 154.47 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.111 1.365 . . . . 0.0 109.497 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -126.77 133.12 50.91 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.711 1.604 . . . . 0.0 108.032 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -136.79 126.43 25.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.821 1.248 . . . . 0.0 108.971 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 t -63.24 144.94 56.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.844 0.457 . . . . 0.0 111.473 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -120.98 -46.43 2.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.873 0.869 . . . . 0.0 111.348 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -151.8 104.68 3.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 111.738 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.6 p -63.6 -27.78 69.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.774 1.23 . . . . 0.0 113.238 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -67.06 -14.6 63.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.826 1.251 . . . . 0.0 112.662 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -123.93 4.26 8.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.674 1.59 . . . . 0.0 112.89 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.3 t30 47.99 35.51 5.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.328 1.851 . . . . 0.0 114.178 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -106.67 142.42 36.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.48 1.112 . . . . 0.0 112.569 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -142.72 167.11 22.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 110.039 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.1 p -110.42 154.35 23.72 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.628 1.171 . . . . 0.0 109.966 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -137.68 128.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.276 1.03 . . . . 0.0 109.816 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -140.61 148.44 53.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.254 1.422 . . . . 0.0 111.195 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.52 147.18 19.77 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.245 2.63 . . . . 0.0 111.326 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.71 -31.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.443 -0.786 . . . . 0.0 111.912 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.4 73.95 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.789 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -144.67 65.0 12.26 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.895 1.278 . . . . 0.0 112.794 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.5 -16.63 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 115.578 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -68.86 6.48 0.87 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.128 2.171 . . . . 0.0 114.682 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -129.33 158.19 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.091 1.756 . . . . 0.0 111.12 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -147.16 143.8 28.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.132 1.373 . . . . 0.0 110.128 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.65 129.6 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.826 -0.546 . . . . 0.0 109.972 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.31 176.62 21.62 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 125.406 1.479 . . . . 0.0 111.632 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.67 179.08 3.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.498 1.149 . . . . 0.0 110.449 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.06 22.2 1.76 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.045 -1.034 . . . . 0.0 114.091 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.87 -1.57 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.108 2.563 . . . . 0.0 117.619 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.39 26.12 21.1 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 127.178 2.323 . . . . 0.0 113.285 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 52.99 39.59 29.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.227 1.811 . . . . 0.0 114.629 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.96 150.41 65.11 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.845 1.658 . . . . 0.0 110.062 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -79.32 144.8 18.45 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.41 2.073 . . . . 0.0 109.635 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.4 t -135.78 139.94 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.693 1.997 . . . . 0.0 109.482 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.5 t -72.76 120.69 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.096 0.959 . . . . 0.0 109.982 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.24 162.8 53.25 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.246 1.019 . . . . 0.0 111.295 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.17 152.95 35.32 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 169.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 133.57 30.23 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.969 2.446 . . . . 0.0 111.86 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -147.89 -92.27 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.564 1.146 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -144.41 10.79 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.858 1.263 . . . . 0.0 113.03 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -67.27 123.16 19.54 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.696 -1.253 . . . . 0.0 110.978 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.63 157.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.61 0.764 . . . . 0.0 111.84 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -138.15 149.29 45.74 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.439 1.096 . . . . 0.0 110.333 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 m -87.83 134.24 33.73 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.263 1.425 . . . . 0.0 109.691 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.18 78.16 1.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.944 0.898 . . . . 0.0 110.019 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -75.03 124.52 27.13 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.415 -0.803 . . . . 0.0 111.875 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.03 147.45 23.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.362 1.465 . . . . 0.0 110.998 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -134.36 174.96 9.96 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.851 1.66 . . . . 0.0 111.951 174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.6 m -59.61 -6.47 1.14 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.76 30.18 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.062 -0.854 . . . . 0.0 115.189 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 -173.35 46.12 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.299 1.549 . . . . 0.0 114.858 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -125.96 159.34 32.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.385 1.474 . . . . 0.0 112.007 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -135.26 155.82 50.0 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.763 1.225 . . . . 0.0 109.952 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.23 112.23 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.145 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.07 159.39 39.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.463 1.105 . . . . 0.0 111.573 -169.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.15 166.03 10.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.358 0.599 . . . . 0.0 111.244 168.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.85 -33.28 35.31 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 115.087 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -90.72 -5.33 55.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.696 1.598 . . . . 0.0 113.57 -173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 56.98 16.29 2.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 127.584 2.354 . . . . 0.0 114.731 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.5 p -72.55 -19.15 61.56 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.73 -1.231 . . . . 0.0 112.797 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.04 172.39 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.331 1.852 . . . . 0.0 112.057 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.8 t -144.75 155.91 43.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.934 2.494 . . . . 0.0 110.314 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -75.87 130.62 38.82 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 111.847 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.9 m -140.63 171.22 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 113.427 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.85 174.5 5.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.721 2.008 . . . . 0.0 111.547 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -128.56 -31.52 2.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.009 1.724 . . . . 0.0 113.762 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -130.51 -7.5 4.16 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.641 1.576 . . . . 0.0 113.644 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.48 31.46 4.03 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.384 1.874 . . . . 0.0 114.756 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.4 p -146.52 152.07 38.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.421 1.488 . . . . 0.0 112.565 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.86 141.96 31.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.606 1.163 . . . . 0.0 113.915 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.52 -8.32 80.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.316 0.96 . . . . 0.0 114.343 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.18 169.31 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.853 1.327 . . . . 0.0 113.428 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -117.1 145.23 43.9 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.162 1.385 . . . . 0.0 109.63 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.19 169.0 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.73 0.776 . . . . 0.0 112.312 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -142.17 170.9 14.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.855 2.062 . . . . 0.0 111.235 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.99 128.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.839 1.256 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.13 -166.84 33.5 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.064 1.316 . . . . 0.0 111.923 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.23 158.64 5.15 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 118.049 0.925 . . . . 0.0 113.133 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -55.91 152.57 9.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.458 1.103 . . . . 0.0 112.539 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.53 150.43 47.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.827 1.651 . . . . 0.0 111.399 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -49.94 -39.95 42.01 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.752 1.621 . . . . 0.0 114.829 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -151.42 -27.21 0.2 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.1 p -72.73 1.61 8.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.285 1.434 . . . . 0.0 114.753 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.97 26.12 4.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.0 1.762 . . . . 0.0 113.894 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.4 150.81 51.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.279 1.432 . . . . 0.0 110.953 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.88 173.93 11.17 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -165.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.91 148.26 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.222 2.209 . . . . 0.0 107.664 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.0 mt -134.3 142.09 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.969 1.308 . . . . 0.0 109.006 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.82 149.33 36.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.568 1.147 . . . . 0.0 111.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.6 145.04 28.24 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 125.472 1.509 . . . . 0.0 114.511 -179.377 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.09 8.32 0.09 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.003 1.161 . . . . 0.0 116.003 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -142.82 10.78 1.8 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.501 1.52 . . . . 0.0 112.649 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -70.25 -14.51 62.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 113.907 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -148.49 162.46 39.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.471 1.909 . . . . 0.0 110.878 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -150.55 169.17 22.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 112.095 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -147.04 172.13 14.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.756 1.222 . . . . 0.0 111.665 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -60.01 159.94 8.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.998 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -145.69 159.91 42.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -59.9 153.94 19.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.888 1.275 . . . . 0.0 113.093 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.1 p -71.22 -0.48 9.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.78 -12.34 20.5 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.275 1.893 . . . . 0.0 115.868 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.1 -23.17 66.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.632 1.173 . . . . 0.0 113.431 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.1 p -65.97 158.39 76.09 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.393 1.077 . . . . 0.0 113.204 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.36 159.72 4.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.967 3.111 . . . . 0.0 116.143 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.69 9.4 2.86 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.504 1.522 . . . . 0.0 113.666 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.84 161.47 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.819 1.247 . . . . 0.0 113.389 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -156.02 169.72 23.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 109.996 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.7 mt -122.7 145.83 48.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.931 1.692 . . . . 0.0 111.256 170.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -157.65 173.56 16.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.906 2.082 . . . . 0.0 110.318 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.07 108.07 1.72 Allowed 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.885 -0.509 . . . . 0.0 110.686 171.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.45 -173.62 45.81 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.751 -0.593 . . . . 0.0 114.479 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -98.17 137.77 36.45 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 110.902 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -144.38 170.93 15.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.503 1.521 . . . . 0.0 112.174 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.2 148.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.557 1.943 . . . . 0.0 108.89 168.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.88 125.94 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.107 1.363 . . . . 0.0 107.986 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -144.64 155.52 43.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.879 0.847 . . . . 0.0 113.082 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.26 136.71 55.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.605 0.762 . . . . 0.0 110.62 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -66.14 -17.25 64.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.68 128.2 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 122.256 1.027 . . . . 0.0 112.345 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 169.46 3.45 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 111.275 168.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.1 t -125.81 147.9 60.41 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.499 1.12 . . . . 0.0 112.402 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.28 -18.74 5.49 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.423 3.416 . . . . 0.0 115.173 168.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -57.04 -21.65 32.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.316 1.446 . . . . 0.0 113.629 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.33 -3.01 40.09 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.758 1.647 . . . . 0.0 114.698 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -140.89 170.2 16.2 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.313 1.445 . . . . 0.0 112.507 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.68 151.36 42.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.952 1.301 . . . . 0.0 110.759 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.03 123.64 49.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.368 1.067 . . . . 0.0 109.835 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.48 151.56 37.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.873 1.269 . . . . 0.0 112.415 -169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 tp -58.21 119.65 7.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.952 1.301 . . . . 0.0 109.871 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.2 m -129.71 128.92 43.48 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.142 0.977 . . . . 0.0 110.567 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -62.4 130.17 93.05 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.407 1.483 . . . . 0.0 111.172 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.43 -7.52 17.9 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.081 2.521 . . . . 0.0 114.624 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.15 64.19 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.407 1.003 . . . . 0.0 115.079 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -154.3 170.76 20.53 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.656 1.228 . . . . 0.0 113.82 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -74.68 162.19 28.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.217 1.807 . . . . 0.0 112.953 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 48.18 35.13 5.0 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.97 2.108 . . . . 0.0 114.218 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -134.49 135.64 24.16 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 126.014 1.726 . . . . 0.0 109.731 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.69 139.31 67.68 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.942 3.095 . . . . 0.0 114.048 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.46 157.62 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.712 0.805 . . . . 0.0 110.515 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.83 163.34 29.31 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.0 1.32 . . . . 0.0 110.667 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.22 139.71 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 121.567 -0.708 . . . . 0.0 111.931 169.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -145.27 162.02 39.16 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.45 1.5 . . . . 0.0 110.569 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.91 130.33 12.9 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.655 2.904 . . . . 0.0 113.767 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -63.98 120.93 12.94 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.834 0.854 . . . . 0.0 111.749 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -134.98 -21.2 1.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.736 2.014 . . . . 0.0 112.201 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.89 28.04 61.52 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.84 0.733 . . . . 0.0 113.983 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -63.93 175.62 1.14 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.647 1.579 . . . . 0.0 113.259 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -56.67 -20.04 19.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 170.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.78 -1.23 46.72 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.185 1.394 . . . . 0.0 113.128 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -124.29 -13.24 7.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.295 1.438 . . . . 0.0 114.297 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.64 139.72 32.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.434 0.694 . . . . 0.0 109.814 168.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -132.78 174.71 10.02 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.396 1.479 . . . . 0.0 110.238 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.68 150.89 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.566 1.147 . . . . 0.0 110.51 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.45 135.47 51.09 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.114 1.766 . . . . 0.0 107.211 169.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -138.11 121.24 16.81 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.174 1.39 . . . . 0.0 109.058 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -61.72 145.25 52.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.312 0.645 . . . . 0.0 111.452 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -125.56 -45.12 1.8 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.606 0.763 . . . . 0.0 112.313 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -154.01 104.73 2.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.705 0.764 . . . . 0.0 111.583 169.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 p -64.73 -27.32 68.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.16 1.384 . . . . 0.0 113.204 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -65.87 -15.32 62.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.634 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -124.42 4.07 8.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.442 1.497 . . . . 0.0 112.982 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.75 35.89 7.07 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.64 1.976 . . . . 0.0 114.144 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 143.86 33.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.234 1.414 . . . . 0.0 112.632 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -141.1 172.61 12.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.009 2.124 . . . . 0.0 109.802 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -121.41 152.73 38.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.694 1.198 . . . . 0.0 109.729 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.05 129.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.543 1.137 . . . . 0.0 109.289 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -140.03 148.71 55.94 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.24 1.016 . . . . 0.0 111.393 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.7 144.0 21.75 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.209 2.606 . . . . 0.0 111.169 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.38 -29.38 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.496 -0.752 . . . . 0.0 111.993 175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.53 -23.77 77.35 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.118 0.866 . . . . 0.0 115.065 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 m -146.78 62.36 7.5 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.561 1.18 . . . . 0.0 113.459 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 -14.42 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.98 3.12 . . . . 0.0 115.568 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.39 -9.36 5.26 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.584 1.953 . . . . 0.0 115.077 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -144.03 162.64 35.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.355 1.462 . . . . 0.0 111.164 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -137.07 167.19 22.01 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.043 1.337 . . . . 0.0 111.361 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -78.12 132.83 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.677 -0.64 . . . . 0.0 109.883 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.28 174.51 25.28 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.026 1.774 . . . . 0.0 111.781 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.63 159.55 30.16 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.052 1.426 . . . . 0.0 111.062 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.77 21.53 7.06 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.255 0.931 . . . . 0.0 114.335 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.06 -0.21 0.05 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 128.204 2.602 . . . . 0.0 117.545 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.27 27.28 19.94 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.912 2.196 . . . . 0.0 113.385 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.8 37.93 21.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.501 1.92 . . . . 0.0 114.302 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.07 147.81 55.06 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.136 1.774 . . . . 0.0 110.043 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.82 149.03 20.32 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 110.376 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.62 159.02 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.989 1.716 . . . . 0.0 110.988 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.68 129.41 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 109.563 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.76 146.51 22.15 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.199 0.6 . . . . 0.0 111.558 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.64 154.92 18.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.048 2.499 . . . . 0.0 113.552 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.99 138.06 39.3 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.03 2.487 . . . . 0.0 112.983 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -149.31 -82.89 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.226 1.411 . . . . 0.0 109.438 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -149.09 11.55 0.82 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.624 1.169 . . . . 0.0 113.083 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -68.49 121.43 16.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.418 -1.426 . . . . 0.0 111.032 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.34 163.53 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.086 0.954 . . . . 0.0 112.635 -172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -139.72 153.57 47.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.567 1.547 . . . . 0.0 110.462 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -100.42 140.41 34.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.09 1.356 . . . . 0.0 109.823 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.26 119.92 36.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.906 0.483 . . . . 0.0 111.233 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -124.21 104.65 8.95 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.481 0.658 . . . . 0.0 112.174 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.4 tp -65.13 150.84 47.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.188 1.795 . . . . 0.0 112.406 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 p -133.38 -178.32 4.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.528 1.531 . . . . 0.0 112.07 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -62.61 -3.09 1.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.91 23.75 0.1 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.61 -172.34 43.6 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.383 1.592 . . . . 0.0 113.635 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.5 161.99 26.69 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.468 1.507 . . . . 0.0 112.065 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -133.29 155.31 49.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.631 1.172 . . . . 0.0 110.635 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.4 mt -135.87 118.75 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.973 1.309 . . . . 0.0 108.565 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -136.41 163.26 30.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.828 0.851 . . . . 0.0 112.509 -170.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.27 165.8 7.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.069 0.947 . . . . 0.0 111.915 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.67 67.49 Favored Glycine 0 CA--C 1.539 1.545 0 O-C-N 121.094 -1.004 . . . . 0.0 114.832 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -93.44 -7.02 45.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.209 1.403 . . . . 0.0 112.859 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.07 22.71 6.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.185 2.594 . . . . 0.0 114.412 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -73.86 -17.74 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.104 -0.997 . . . . 0.0 113.159 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.67 177.59 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.314 1.846 . . . . 0.0 111.615 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -144.39 155.35 43.73 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.391 1.876 . . . . 0.0 110.938 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.01 126.62 30.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.579 0.751 . . . . 0.0 110.732 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -144.85 169.96 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.185 1.394 . . . . 0.0 112.888 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.7 175.63 5.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.987 1.715 . . . . 0.0 110.481 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -121.14 -34.65 3.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.399 1.08 . . . . 0.0 112.452 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -128.99 -14.13 4.46 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.563 1.945 . . . . 0.0 111.908 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.63 28.5 12.09 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.131 1.772 . . . . 0.0 113.935 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -89.41 159.57 17.24 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 112.26 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.53 135.81 57.86 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.639 -0.663 . . . . 0.0 112.119 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.9 1.52 89.8 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.378 0.99 . . . . 0.0 114.823 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -69.0 135.54 51.07 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.116 1.458 . . . . 0.0 112.086 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -69.66 127.62 33.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.592 0.757 . . . . 0.0 109.695 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.12 150.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.714 -0.616 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -129.57 167.68 17.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.502 1.521 . . . . 0.0 112.124 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -131.5 134.69 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.883 1.273 . . . . 0.0 109.204 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.13 -158.26 22.97 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.086 0.851 . . . . 0.0 111.857 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.46 150.62 18.28 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.75 -0.853 . . . . 0.0 111.801 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.42 159.78 17.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.359 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.72 131.38 20.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.602 1.161 . . . . 0.0 111.469 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -57.34 -26.95 61.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.669 1.588 . . . . 0.0 115.207 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -128.37 -7.05 5.28 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.7 p -137.14 8.91 2.97 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.895 1.225 . . . . 0.0 114.233 -172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.83 34.74 2.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.717 1.627 . . . . 0.0 113.397 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -147.07 157.66 43.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.009 2.124 . . . . 0.0 110.872 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -137.19 177.44 7.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.027 0.918 . . . . 0.0 113.317 -167.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.38 141.84 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.851 2.061 . . . . 0.0 107.678 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.5 mt -132.82 138.21 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 108.647 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.55 146.9 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.894 1.278 . . . . 0.0 111.048 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -85.26 144.86 27.85 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.102 1.361 . . . . 0.0 110.698 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 125.542 1.537 . . . . 0.0 114.629 -179.624 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.07 179.85 48.23 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.098 0.856 . . . . 0.0 113.479 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -69.85 -10.39 58.29 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 114.485 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -146.55 162.53 38.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.133 1.773 . . . . 0.0 111.13 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -150.36 167.4 27.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.644 1.578 . . . . 0.0 111.802 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -146.75 161.72 40.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.351 1.061 . . . . 0.0 111.5 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -149.47 163.58 37.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.084 1.354 . . . . 0.0 111.43 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.92 157.79 45.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 111.799 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -149.94 171.67 16.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.118 1.367 . . . . 0.0 111.516 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -127.38 -10.56 5.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.747 1.219 . . . . 0.0 114.221 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -96.48 13.93 26.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.854 1.262 . . . . 0.0 112.663 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.86 13.33 0.13 Allowed Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.347 1.451 . . . . 0.0 115.167 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.68 25.48 1.32 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.665 1.586 . . . . 0.0 111.733 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 149.59 29.17 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.983 1.713 . . . . 0.0 110.648 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.03 165.87 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.005 3.137 . . . . 0.0 115.734 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.98 14.71 5.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.48 1.512 . . . . 0.0 113.625 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.69 163.41 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.314 1.846 . . . . 0.0 112.267 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.1 p -143.91 162.26 36.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.777 1.631 . . . . 0.0 111.746 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.029 1.732 . . . . 0.0 108.612 167.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 t -158.3 171.67 19.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.058 1.743 . . . . 0.0 109.211 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 108.68 1.31 Allowed 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.422 -0.799 . . . . 0.0 112.028 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.05 32.97 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.622 -0.674 . . . . 0.0 114.721 -172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -105.17 135.41 46.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.601 1.56 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -143.38 169.12 18.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.351 1.46 . . . . 0.0 111.958 -172.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 pt -125.6 147.57 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.263 1.825 . . . . 0.0 108.726 168.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.41 130.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 107.987 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -143.68 150.41 38.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.879 0.871 . . . . 0.0 111.895 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -78.26 142.07 38.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.664 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -60.24 -22.8 63.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.938 1.295 . . . . 0.0 113.936 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.98 -14.86 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.2 mt 52.48 -155.97 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.719 1.207 . . . . 0.0 111.478 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -134.63 142.98 44.64 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.04 -1.037 . . . . 0.0 111.868 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.46 -16.67 3.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.657 3.571 . . . . 0.0 115.485 169.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -62.29 -12.56 21.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.771 1.229 . . . . 0.0 113.985 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.89 14.74 57.52 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.347 1.451 . . . . 0.0 113.691 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.1 169.87 17.01 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.859 1.664 . . . . 0.0 111.779 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.16 146.84 49.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 111.761 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -108.86 84.83 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.369 1.468 . . . . 0.0 109.599 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.02 21.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.652 1.181 . . . . 0.0 113.153 -169.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.872 0.869 . . . . 0.0 111.324 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -133.14 131.41 40.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.969 1.308 . . . . 0.0 110.334 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -61.35 127.73 88.71 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.895 1.278 . . . . 0.0 110.203 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.04 -5.21 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.876 2.384 . . . . 0.0 114.793 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.04 -9.73 61.64 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.911 1.244 . . . . 0.0 114.456 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -157.78 -178.91 7.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.386 1.474 . . . . 0.0 113.323 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -92.75 166.13 12.6 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.657 1.583 . . . . 0.0 111.988 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 54.88 33.02 18.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.701 1.6 . . . . 0.0 113.069 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.9 m -135.44 137.95 27.48 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 126.579 1.951 . . . . 0.0 109.549 -171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.74 154.13 64.02 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.727 2.284 . . . . 0.0 113.405 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.92 142.37 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.943 0.897 . . . . 0.0 110.926 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 m -116.45 169.34 9.4 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.597 1.559 . . . . 0.0 109.822 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.02 151.2 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.995 -1.066 . . . . 0.0 113.806 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.9 m -147.74 163.32 27.97 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.31 1.844 . . . . 0.0 111.227 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.51 137.35 59.29 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.706 1.604 . . . . 0.0 110.3 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.47 126.54 27.73 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 0.0 112.225 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.47 -20.23 2.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.785 2.434 . . . . 0.0 111.673 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.96 22.54 61.09 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.201 0.905 . . . . 0.0 114.431 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -66.22 170.32 5.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.761 1.225 . . . . 0.0 113.11 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.4 p -57.96 -18.53 24.17 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.17 -2.58 42.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.831 1.252 . . . . 0.0 112.774 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -119.96 -14.38 8.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 114.105 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.28 143.37 30.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.539 0.735 . . . . 0.0 111.284 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -133.18 175.22 9.58 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.503 1.521 . . . . 0.0 110.456 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 pt -127.17 155.18 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 110.122 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -127.57 128.42 45.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.894 1.678 . . . . 0.0 107.701 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -137.99 132.19 31.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 122.095 0.95 . . . . 0.0 110.552 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -60.48 139.88 57.53 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.999 1.72 . . . . 0.0 112.216 -170.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -133.34 -38.16 0.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.84 154.43 41.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.656 0.782 . . . . 0.0 112.334 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.7 m -120.05 -7.6 9.88 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -105.0 -14.48 15.41 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.642 1.577 . . . . 0.0 113.197 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -118.02 0.4 11.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.762 2.025 . . . . 0.0 112.838 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 51.34 36.37 16.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.646 1.578 . . . . 0.0 113.921 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.6 p -101.12 143.99 30.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.535 1.16 . . . . 0.0 112.732 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -142.34 164.39 30.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.134 1.773 . . . . 0.0 110.01 -171.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.5 p -102.51 152.81 20.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.688 0.795 . . . . 0.0 110.397 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.54 129.21 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.664 1.186 . . . . 0.0 109.479 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -140.96 150.64 60.03 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.262 1.025 . . . . 0.0 111.43 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.52 146.61 27.57 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.051 2.501 . . . . 0.0 111.34 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.1 t -67.55 -25.81 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.266 -0.896 . . . . 0.0 112.227 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 -19.64 78.29 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.063 0.84 . . . . 0.0 115.168 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.7 p -153.76 61.25 3.37 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 118.672 1.236 . . . . 0.0 112.813 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.93 -5.16 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.969 3.112 . . . . 0.0 113.959 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.61 -11.0 30.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.046 1.739 . . . . 0.0 113.843 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -138.85 164.04 30.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.68 1.992 . . . . 0.0 110.695 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.43 164.6 29.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.159 0.984 . . . . 0.0 112.935 -169.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.89 132.11 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.621 -0.675 . . . . 0.0 110.456 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.48 179.32 20.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.231 1.872 . . . . 0.0 111.883 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 169.68 17.04 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.176 -1.191 . . . . 0.0 110.517 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.27 21.29 3.67 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.111 0.863 . . . . 0.0 114.385 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 -0.31 0.05 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.913 2.485 . . . . 0.0 117.404 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.88 25.44 22.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 127.033 2.254 . . . . 0.0 113.144 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 52.38 43.26 31.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.222 1.809 . . . . 0.0 114.382 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.41 149.83 58.88 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.053 1.741 . . . . 0.0 110.131 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.51 144.27 17.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.613 2.208 . . . . 0.0 110.16 169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.77 137.8 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.096 2.158 . . . . 0.0 109.308 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.24 126.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.748 -0.595 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.6 mt -138.85 158.6 69.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.468 1.507 . . . . 0.0 112.439 -170.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.69 155.09 2.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.432 3.421 . . . . 0.0 114.408 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.76 132.37 21.6 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.911 2.408 . . . . 0.0 111.925 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.27 -108.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.794 1.638 . . . . 0.0 109.198 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -149.01 21.03 0.98 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.487 1.515 . . . . 0.0 111.382 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -65.7 123.41 19.66 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.778 -1.201 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.96 160.11 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.752 0.821 . . . . 0.0 112.113 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -139.43 147.89 42.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.156 1.382 . . . . 0.0 109.705 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.3 m -83.87 135.17 34.6 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.054 0.942 . . . . 0.0 109.488 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.54 78.16 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.966 0.907 . . . . 0.0 109.877 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 m -73.38 132.35 42.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.726 . . . . 0.0 111.405 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 114' ' ' TYR . 57.2 tp -97.16 148.35 23.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.999 1.319 . . . . 0.0 111.935 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.6 p -131.11 174.61 9.85 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.503 1.521 . . . . 0.0 111.157 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -59.81 -8.58 2.22 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.12 23.16 0.27 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.24 46.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.035 1.418 . . . . 0.0 114.229 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CZ ' HD13 ' A' ' 109' ' ' LEU . 16.4 m-85 -124.91 165.55 17.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.476 1.511 . . . . 0.0 112.11 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -137.16 156.65 48.08 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.093 1.357 . . . . 0.0 110.332 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.0 mt -132.92 113.23 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.176 0.99 . . . . 0.0 108.644 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -135.77 162.23 33.35 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.59 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.87 167.79 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.383 0.673 . . . . 0.0 112.659 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.71 -6.45 4.96 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.691 1.836 . . . . 0.0 117.691 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 0.56 9.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.364 1.865 . . . . 0.0 112.403 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 28.77 8.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.23 1.812 . . . . 0.0 113.634 -175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -79.05 -21.24 47.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.202 -0.936 . . . . 0.0 112.69 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.98 168.62 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.064 1.746 . . . . 0.0 112.681 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.2 t -140.66 146.81 38.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.111 2.165 . . . . 0.0 110.948 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -71.93 144.01 49.1 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.746 0.818 . . . . 0.0 111.998 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -150.3 175.27 11.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.919 1.288 . . . . 0.0 114.242 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.14 169.3 14.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.045 2.138 . . . . 0.0 110.43 172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -118.94 -33.84 4.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -116.57 -6.57 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.67 1.188 . . . . 0.0 113.57 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.39 40.34 26.32 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.58 1.552 . . . . 0.0 114.571 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 p -139.42 163.84 31.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.587 1.555 . . . . 0.0 112.474 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.24 149.96 31.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.884 0.874 . . . . 0.0 112.976 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.56 57.2 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.61 1.1 . . . . 0.0 114.39 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.44 154.11 33.22 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.128 1.371 . . . . 0.0 112.075 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -111.89 135.68 52.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.66 1.184 . . . . 0.0 109.872 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.16 143.64 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -128.11 171.35 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.774 1.63 . . . . 0.0 111.331 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.9 137.97 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.508 1.523 . . . . 0.0 109.652 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.22 175.93 38.65 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.03 1.3 . . . . 0.0 111.67 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -40.74 80.32 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.475 1.138 . . . . 0.0 113.308 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -165.3 173.93 10.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.67 2.388 . . . . 0.0 109.731 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.51 153.73 42.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.622 1.169 . . . . 0.0 111.64 169.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -55.29 -40.01 70.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.192 1.397 . . . . 0.0 114.526 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -158.06 -24.4 0.08 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.265 1.426 . . . . 0.0 113.729 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -72.26 1.3 7.93 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.25 5.62 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.82 1.676 . . . . 0.0 113.267 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -130.36 147.93 52.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.523 1.929 . . . . 0.0 108.887 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -138.46 169.05 18.47 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.089 0.947 . . . . 0.0 112.79 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.2 t -142.72 143.72 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.52 1.528 . . . . 0.0 108.171 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.3 mt -135.89 140.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.833 1.253 . . . . 0.0 109.323 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.35 147.84 36.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.878 1.271 . . . . 0.0 111.172 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -86.24 145.5 26.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.908 1.283 . . . . 0.0 110.927 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.633 1.573 . . . . 0.0 114.465 -179.376 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.32 -9.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -144.93 171.69 14.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.511 1.524 . . . . 0.0 111.907 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -149.47 169.12 21.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.351 1.46 . . . . 0.0 111.76 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -150.43 171.89 16.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.089 1.356 . . . . 0.0 111.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -150.84 167.11 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.0 1.32 . . . . 0.0 112.084 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -147.4 -17.99 0.38 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -140.83 5.64 1.97 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.954 1.301 . . . . 0.0 113.872 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -150.11 168.65 23.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.58 1.552 . . . . 0.0 112.175 -173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.26 173.23 15.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.066 1.346 . . . . 0.0 110.512 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.2 m -135.18 6.19 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.453 1.901 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.11 18.42 1.74 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.994 1.283 . . . . 0.0 115.037 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -151.34 -25.83 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.643 1.177 . . . . 0.0 113.735 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.1 p -141.6 162.76 45.12 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.814 1.646 . . . . 0.0 112.117 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -50.09 157.7 2.75 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.553 3.502 . . . . 0.0 116.145 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.77 -14.55 1.41 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.71 163.34 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.263 1.425 . . . . 0.0 111.493 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -155.67 156.25 34.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.567 1.547 . . . . 0.0 109.525 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.85 159.37 34.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.067 0.936 . . . . 0.0 111.536 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.9 p -150.61 170.1 19.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.399 1.479 . . . . 0.0 110.876 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.87 107.41 2.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.825 0.45 . . . . 0.0 110.503 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.21 -174.0 46.65 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -95.75 135.91 36.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.053 1.341 . . . . 0.0 110.226 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -144.08 169.3 18.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.417 1.487 . . . . 0.0 111.611 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.67 149.54 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.476 1.91 . . . . 0.0 108.835 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.1 123.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.692 1.197 . . . . 0.0 108.319 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -142.37 155.77 45.17 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -63.68 135.37 56.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.237 1.015 . . . . 0.0 110.619 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -64.3 -21.82 66.74 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.1 t -105.59 119.66 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.799 1.24 . . . . 0.0 109.127 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 mt -56.48 148.98 18.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.8 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -70.16 163.19 63.89 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.51 -18.08 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.063 3.175 . . . . 0.0 115.417 168.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -69.61 -18.32 63.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.929 0.891 . . . . 0.0 113.118 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.32 22.05 28.07 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.461 1.505 . . . . 0.0 113.822 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -140.98 161.5 37.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.436 1.094 . . . . 0.0 112.332 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.76 145.34 49.98 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.912 1.285 . . . . 0.0 111.278 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -126.67 110.48 13.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.72 1.608 . . . . 0.0 108.751 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.15 151.79 30.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.459 1.104 . . . . 0.0 113.719 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.63 135.9 57.81 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.959 0.904 . . . . 0.0 111.08 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.3 m -139.47 141.01 37.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.93 1.292 . . . . 0.0 110.97 -171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.11 127.66 92.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.846 1.658 . . . . 0.0 111.015 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.76 -4.66 15.75 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.757 2.971 . . . . 0.0 114.683 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.8 45.39 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.184 1.373 . . . . 0.0 115.181 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -151.76 179.58 8.29 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.844 1.257 . . . . 0.0 112.672 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.11 163.13 23.37 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.139 1.375 . . . . 0.0 111.727 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 54.51 41.62 31.84 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.571 1.548 . . . . 0.0 113.743 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.6 p -137.26 150.83 70.23 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.43 1.892 . . . . 0.0 111.038 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.39 142.17 48.83 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.509 2.806 . . . . 0.0 112.327 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.44 145.85 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.315 1.046 . . . . 0.0 110.917 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 p -117.92 179.3 4.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.184 1.393 . . . . 0.0 112.434 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.56 151.55 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 m -151.48 162.82 25.63 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 127.054 2.142 . . . . 0.0 110.487 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.79 152.48 80.45 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.006 1.804 . . . . 0.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.21 126.37 27.1 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.594 0.711 . . . . 0.0 111.987 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -144.69 -23.28 0.52 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.166 2.186 . . . . 0.0 112.754 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.66 6.57 76.61 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -67.53 161.21 26.03 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.781 1.291 . . . . 0.0 113.02 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -58.88 -21.15 56.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.07 1.348 . . . . 0.0 114.457 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -20.62 60.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.134 0.973 . . . . 0.0 113.178 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -125.8 0.17 7.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 114.004 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.09 146.88 26.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.041 . . . . 0.0 109.592 167.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -136.22 174.5 10.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.818 1.247 . . . . 0.0 110.863 -174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.06 152.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.978 1.311 . . . . 0.0 109.474 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -122.01 135.05 54.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.91 1.684 . . . . 0.0 107.453 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -138.45 132.55 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.764 1.226 . . . . 0.0 109.629 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 t -64.9 145.5 56.21 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -126.67 -34.0 2.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.737 0.815 . . . . 0.0 112.4 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.17 160.17 43.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.041 0.936 . . . . 0.0 112.065 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.2 p -121.19 -23.2 5.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.372 1.869 . . . . 0.0 114.049 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.07 -17.54 22.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.419 1.488 . . . . 0.0 112.674 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -111.27 -2.48 15.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.68 1.592 . . . . 0.0 113.678 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.3 t30 54.53 38.49 29.85 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.508 1.523 . . . . 0.0 114.363 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 p -108.84 147.19 32.49 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 113.047 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -145.41 170.78 15.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.57 1.948 . . . . 0.0 110.186 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.0 p -122.35 150.44 42.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.506 1.122 . . . . 0.0 110.034 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.31 131.67 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.824 1.25 . . . . 0.0 109.488 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.8 m -142.04 147.82 46.0 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.12 0.968 . . . . 0.0 111.775 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 144.04 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.96 2.44 . . . . 0.0 111.323 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.38 -26.88 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.394 -0.816 . . . . 0.0 112.268 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.84 -29.78 70.77 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.305 -0.719 . . . . 0.0 114.501 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -146.23 60.17 6.04 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.174 1.389 . . . . 0.0 112.967 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 -3.76 12.33 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.801 3.001 . . . . 0.0 113.788 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -67.61 -0.83 4.27 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.659 1.584 . . . . 0.0 113.682 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.0 p -148.87 175.07 11.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.005 2.122 . . . . 0.0 111.038 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -138.12 167.3 22.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.11 0.964 . . . . 0.0 112.649 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 57.8 mt -70.46 129.76 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -141.36 -168.07 11.38 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.329 1.919 . . . . 0.0 111.395 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -135.24 170.09 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.817 0.847 . . . . 0.0 110.329 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.28 22.73 2.89 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.358 0.98 . . . . 0.0 113.118 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.78 0.57 0.11 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.422 2.289 . . . . 0.0 116.472 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.47 27.15 14.61 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.165 2.317 . . . . 0.0 114.115 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.67 26.88 13.5 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.366 1.866 . . . . 0.0 115.753 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.02 141.02 28.63 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.63 1.172 . . . . 0.0 110.401 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.08 146.38 18.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.387 2.058 . . . . 0.0 110.685 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.33 155.36 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.461 1.504 . . . . 0.0 111.912 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.26 124.51 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -142.47 145.34 34.32 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.755 0.822 . . . . 0.0 111.578 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -49.82 153.83 5.55 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.025 3.15 . . . . 0.0 115.087 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 125.13 10.97 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 111.248 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.83 -100.44 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.115 1.366 . . . . 0.0 109.786 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -153.26 24.35 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.763 1.625 . . . . 0.0 111.399 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -73.17 69.97 1.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.602 -1.311 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.31 160.45 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.72 1.608 . . . . 0.0 113.079 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -140.35 163.41 32.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 110.303 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.4 m -110.86 138.67 46.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.862 1.665 . . . . 0.0 110.007 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.78 132.9 56.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.554 0.342 . . . . 0.0 110.834 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 m -133.61 114.22 13.27 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.882 -0.511 . . . . 0.0 112.306 -172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.49 152.03 36.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.58 1.152 . . . . 0.0 112.392 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 p -132.3 -179.48 5.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.412 1.885 . . . . 0.0 111.226 169.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.3 p -61.27 -10.1 6.28 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.47 27.86 0.25 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.11 -178.78 44.13 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 118.909 1.355 . . . . 0.0 113.543 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -117.45 165.37 13.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.353 1.461 . . . . 0.0 112.53 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -138.04 159.3 42.39 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.0 1.72 . . . . 0.0 109.959 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.8 mt -136.54 125.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.494 1.118 . . . . 0.0 109.212 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.01 168.73 19.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 111.986 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -83.42 178.87 7.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.081 0.952 . . . . 0.0 112.168 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.11 -14.77 61.99 Favored Glycine 0 CA--C 1.541 1.7 0 O-C-N 120.79 -1.194 . . . . 0.0 115.205 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -87.93 -24.81 23.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.026 1.413 . . . . 0.0 112.299 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 51.11 21.1 0.97 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.194 2.597 . . . . 0.0 114.56 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p -78.54 -12.2 60.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.023 1.329 . . . . 0.0 112.292 170.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.57 170.81 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.914 2.085 . . . . 0.0 111.997 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t -142.84 148.44 37.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.852 2.461 . . . . 0.0 109.726 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.43 141.1 54.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.791 -0.568 . . . . 0.0 110.505 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.2 p -155.84 168.55 26.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.3 163.97 14.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.127 1.771 . . . . 0.0 110.977 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -113.97 -31.01 6.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.31 -5.85 6.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.317 1.047 . . . . 0.0 113.335 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.8 43.26 24.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.152 1.781 . . . . 0.0 114.577 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 p -130.03 160.61 33.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.583 1.553 . . . . 0.0 112.221 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.14 134.48 50.6 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.275 -0.891 . . . . 0.0 112.376 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.83 -10.99 57.54 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.109 1.337 . . . . 0.0 112.86 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.99 169.82 7.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.027 1.731 . . . . 0.0 113.411 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.17 129.14 56.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.13 1.772 . . . . 0.0 108.994 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.17 151.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.525 0.678 . . . . 0.0 110.476 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -136.73 176.58 8.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.43 1.892 . . . . 0.0 111.416 -171.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -137.22 134.34 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.791 1.636 . . . . 0.0 108.897 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.79 173.77 40.71 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.318 0.961 . . . . 0.0 111.833 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.01 73.42 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.51 175.3 7.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.269 2.228 . . . . 0.0 109.992 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.69 154.24 44.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 111.38 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.5 t -54.93 -38.55 67.82 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.908 1.283 . . . . 0.0 114.127 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.56 -28.68 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.685 1.594 . . . . 0.0 112.746 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 m -63.66 5.46 0.2 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.762 2.025 . . . . 0.0 116.215 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.98 4.02 27.21 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.993 1.758 . . . . 0.0 114.374 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 149.71 21.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.647 1.224 . . . . 0.0 110.057 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -136.29 168.5 19.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.787 1.235 . . . . 0.0 111.284 -172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.5 t -139.07 146.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.954 1.701 . . . . 0.0 107.576 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.3 mt -135.13 141.26 43.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 108.119 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -150.3 144.9 25.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 112.101 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.914 1.286 . . . . 0.0 110.846 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 125.542 1.537 . . . . 0.0 114.534 -179.269 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.518 0.199 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.56 175.87 46.72 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.229 0.919 . . . . 0.0 113.33 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -141.27 3.87 1.78 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.13 1.372 . . . . 0.0 113.796 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.94 -12.97 61.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.095 1.758 . . . . 0.0 114.142 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -148.32 165.26 31.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.117 2.167 . . . . 0.0 110.764 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -155.29 174.05 15.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.473 1.109 . . . . 0.0 111.495 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -139.06 -5.39 1.47 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.029 1.732 . . . . 0.0 114.261 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -140.1 19.18 2.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.232 1.813 . . . . 0.0 112.169 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -146.11 172.3 13.62 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.782 1.633 . . . . 0.0 111.153 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 53.3 23.72 3.39 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.624 1.97 . . . . 0.0 115.974 -169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 t -134.65 31.17 3.4 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.837 1.655 . . . . 0.0 110.452 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.52 26.78 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.972 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.71 -7.32 10.34 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -137.09 78.16 41.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 120.86 -1.15 . . . . 0.0 112.225 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.69 177.02 0.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.8 3.0 . . . . 0.0 114.33 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.3 -63.86 0.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 111.643 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 t -144.24 -63.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 125.889 1.676 . . . . 0.0 109.788 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -170.05 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.122 1.769 . . . . 0.0 111.022 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.49 140.76 39.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.431 1.092 . . . . 0.0 111.886 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 t -155.64 159.01 39.25 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.168 1.387 . . . . 0.0 110.401 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.41 121.62 11.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.375 1.07 . . . . 0.0 111.769 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.36 47.47 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.51 137.99 31.89 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.963 1.305 . . . . 0.0 110.037 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -140.17 169.46 17.65 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.234 1.414 . . . . 0.0 111.909 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 pt -127.22 151.58 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.601 1.96 . . . . 0.0 109.275 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.7 127.66 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 0.0 108.697 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -142.68 154.97 44.82 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.987 0.915 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -72.51 142.72 48.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.571 -0.706 . . . . 0.0 111.494 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -13.08 61.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.99 2.97 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.747 1.619 . . . . 0.0 111.917 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.7 mt 54.79 -136.98 1.23 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.679 1.591 . . . . 0.0 111.717 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -134.89 155.09 79.56 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 124.188 0.995 . . . . 0.0 112.712 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.69 -9.49 25.04 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.181 2.587 . . . . 0.0 113.505 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.57 -22.05 66.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.866 1.266 . . . . 0.0 113.171 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.18 15.51 21.45 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.38 1.467 . . . . 0.0 113.821 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.43 159.49 40.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.103 1.361 . . . . 0.0 111.939 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.42 164.88 20.01 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.229 1.412 . . . . 0.0 112.593 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -137.11 134.76 36.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.139 1.376 . . . . 0.0 110.758 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.64 150.34 51.58 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.369 1.468 . . . . 0.0 112.358 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.19 120.83 12.87 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.464 1.106 . . . . 0.0 110.263 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -129.02 128.7 44.16 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.91 0.862 . . . . 0.0 110.625 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -62.89 132.16 94.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.688 1.195 . . . . 0.0 110.738 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.91 -4.84 16.13 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.214 2.609 . . . . 0.0 114.115 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.11 -9.56 61.45 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.34 1.448 . . . . 0.0 114.387 175.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -159.49 -178.39 7.1 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.556 1.542 . . . . 0.0 113.158 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.58 169.56 8.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.551 1.541 . . . . 0.0 112.145 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 54.38 37.87 28.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.07 1.748 . . . . 0.0 112.312 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.4 m -142.74 141.9 21.35 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.784 2.034 . . . . 0.0 109.822 -168.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.81 148.24 82.21 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.001 2.467 . . . . 0.0 112.446 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 t -68.35 163.85 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.424 1.09 . . . . 0.0 110.759 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -133.61 165.47 24.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.067 0.947 . . . . 0.0 110.719 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.73 143.5 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.157 -0.964 . . . . 0.0 112.033 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.0 m -145.42 164.83 24.22 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 109.846 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -51.74 139.82 48.14 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.624 2.216 . . . . 0.0 113.417 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.88 123.41 19.33 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.212 0.53 . . . . 0.0 111.022 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -135.05 -23.8 1.49 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.143 1.777 . . . . 0.0 112.146 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.99 18.46 69.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.62 -0.675 . . . . 0.0 114.436 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.7 t -59.72 167.82 1.95 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.329 1.452 . . . . 0.0 112.115 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.5 p -59.36 -22.18 60.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.623 1.169 . . . . 0.0 113.59 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.27 -9.51 58.69 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 113.43 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.97 -5.44 7.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.777 1.631 . . . . 0.0 113.434 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.79 138.03 31.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.341 1.056 . . . . 0.0 110.288 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -132.24 174.13 10.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.659 1.583 . . . . 0.0 110.386 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -128.55 153.22 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.992 1.317 . . . . 0.0 110.097 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.98 130.55 52.76 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.794 1.637 . . . . 0.0 108.022 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -136.62 129.38 30.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 109.581 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -64.59 145.86 55.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.982 0.513 . . . . 0.0 112.283 -171.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -125.34 -43.55 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.304 1.042 . . . . 0.0 111.15 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -151.18 102.45 2.94 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.059 0.933 . . . . 0.0 112.256 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.0 p -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.927 1.691 . . . . 0.0 114.063 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.83 -8.21 56.33 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.362 1.065 . . . . 0.0 113.115 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t -128.33 6.05 5.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.051 1.34 . . . . 0.0 113.266 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 51.38 32.69 8.85 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.078 1.751 . . . . 0.0 114.245 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.64 137.52 42.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.13 0.972 . . . . 0.0 113.096 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -139.44 155.86 47.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.518 1.927 . . . . 0.0 109.78 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.0 p -91.59 154.51 19.0 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.6 mt -133.75 128.33 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.908 . . . . 0.0 109.65 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.6 m -140.04 151.85 66.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.608 1.163 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.57 149.24 30.26 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.125 2.55 . . . . 0.0 110.984 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.92 -29.08 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.495 -0.753 . . . . 0.0 112.11 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.65 -19.89 67.29 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.0 m -145.57 58.0 4.61 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.683 1.193 . . . . 0.0 112.809 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.81 -6.97 18.19 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.604 2.869 . . . . 0.0 114.273 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -67.83 -2.31 7.01 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.324 1.45 . . . . 0.0 114.006 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 t -141.06 168.02 20.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 111.227 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -147.11 165.5 29.78 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.182 -0.949 . . . . 0.0 113.487 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -78.14 131.23 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.301 0.64 . . . . 0.0 110.881 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.6 -177.29 14.87 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.507 2.003 . . . . 0.0 111.853 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -111.63 108.49 17.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.498 1.119 . . . . 0.0 110.185 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.12 147.24 42.49 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.19 -1.79 3.62 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.62 20.61 48.78 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.989 2.233 . . . . 0.0 114.166 171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.04 45.7 17.49 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.527 1.931 . . . . 0.0 114.186 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.51 152.66 69.37 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.534 1.533 . . . . 0.0 110.636 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.47 144.83 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.925 1.75 . . . . 0.0 110.452 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.57 157.55 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.402 1.481 . . . . 0.0 111.291 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.31 129.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.861 0.864 . . . . 0.0 108.781 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.8 tp -148.79 143.51 17.25 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.79 0.836 . . . . 0.0 111.821 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.64 151.32 5.18 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 124.177 3.251 . . . . 0.0 114.455 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.51 140.17 42.95 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.636 2.224 . . . . 0.0 113.945 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -150.54 -87.72 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.221 1.808 . . . . 0.0 108.468 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -157.11 22.31 0.31 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.128 1.771 . . . . 0.0 112.485 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -66.9 121.4 15.42 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.162 -1.586 . . . . 0.0 110.732 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.8 164.87 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.836 0.854 . . . . 0.0 111.971 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -141.9 152.03 43.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.015 1.326 . . . . 0.0 110.119 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -93.81 133.84 36.77 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.936 1.294 . . . . 0.0 109.757 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.42 85.86 2.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.614 1.165 . . . . 0.0 111.608 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 m -116.28 126.73 53.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.619 0.768 . . . . 0.0 112.832 -168.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.52 138.65 36.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.968 0.907 . . . . 0.0 111.409 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.9 p -130.08 176.41 8.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.888 1.675 . . . . 0.0 110.639 170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.74 -4.04 0.39 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -127.6 -7.38 4.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.263 1.411 . . . . 0.0 115.718 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.31 30.05 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.181 1.99 . . . . 0.0 114.018 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -70.94 160.17 33.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.578 1.18 . . . . 0.0 111.758 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.04 151.05 52.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.01 1.724 . . . . 0.0 109.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.06 104.58 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.77 160.41 37.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.821 0.848 . . . . 0.0 112.819 -168.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.0 159.93 10.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.128 0.971 . . . . 0.0 112.349 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.6 -8.75 21.97 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.305 1.431 . . . . 0.0 116.01 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.49 4.25 18.69 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.303 1.551 . . . . 0.0 112.755 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 53.0 21.78 2.18 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.519 2.328 . . . . 0.0 114.763 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p -66.96 -23.62 65.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.882 1.273 . . . . 0.0 113.796 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 m -145.48 178.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.831 2.052 . . . . 0.0 111.435 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -147.22 153.63 40.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.586 1.954 . . . . 0.0 111.009 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -69.48 134.9 49.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 0.0 111.15 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.8 p -144.55 175.02 10.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.5 mt -130.18 159.45 36.8 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.236 1.814 . . . . 0.0 110.919 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -124.76 -23.7 4.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.414 1.485 . . . . 0.0 113.918 -174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -113.6 -15.13 12.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.32 1.448 . . . . 0.0 112.075 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.05 33.51 12.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.167 1.787 . . . . 0.0 114.204 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -140.69 163.86 31.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.315 1.446 . . . . 0.0 112.126 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.32 149.96 40.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.548 0.739 . . . . 0.0 112.699 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.94 -6.62 83.52 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.133 1.349 . . . . 0.0 114.416 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.92 140.93 57.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.337 1.568 . . . . 0.0 111.601 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -78.72 11.33 2.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.576 1.55 . . . . 0.0 113.937 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 t 59.61 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 127.277 2.231 . . . . 0.0 112.164 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.4 t -148.43 167.0 26.44 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.112 -1.618 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -138.09 135.24 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.715 1.606 . . . . 0.0 108.998 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.07 -163.22 27.13 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.263 0.935 . . . . 0.0 112.687 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.32 160.51 5.12 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.769 -0.842 . . . . 0.0 112.863 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.41 154.77 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.351 1.06 . . . . 0.0 112.96 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.64 159.87 41.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.974 1.71 . . . . 0.0 112.095 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -92.02 -25.79 18.66 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -137.23 -1.26 2.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.9 p -133.5 9.26 3.98 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.657 1.183 . . . . 0.0 114.152 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.26 31.33 1.95 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.255 1.407 . . . . 0.0 114.032 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -133.09 145.97 51.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.011 1.725 . . . . 0.0 109.867 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -133.44 174.24 10.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.756 1.222 . . . . 0.0 111.815 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.59 143.15 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.167 1.787 . . . . 0.0 107.833 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.56 142.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.913 1.285 . . . . 0.0 108.473 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -149.86 146.78 27.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.008 0.523 . . . . 0.0 112.273 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -83.84 142.7 30.43 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.89 1.276 . . . . 0.0 110.855 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.585 1.554 . . . . 0.0 114.782 -177.838 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 175.45 40.49 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.968 0.794 . . . . 0.0 113.845 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -140.22 -1.31 1.55 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.021 1.328 . . . . 0.0 114.004 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -149.78 166.89 28.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.339 1.456 . . . . 0.0 111.357 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -63.19 159.71 17.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.783 1.233 . . . . 0.0 112.523 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -147.54 168.4 22.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.322 1.449 . . . . 0.0 111.043 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.49 144.13 43.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.371 0.668 . . . . 0.0 111.776 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -150.49 161.42 42.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.165 1.386 . . . . 0.0 110.903 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.447 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 32.7 t60 57.19 -170.86 0.09 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.021 1.728 . . . . 0.0 113.705 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 2.0 t60 -148.1 174.72 11.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.898 1.279 . . . . 0.0 111.626 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -138.71 11.32 2.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.897 1.679 . . . . 0.0 112.947 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.07 0.6 6.11 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.099 1.333 . . . . 0.0 115.759 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -144.4 -4.23 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.944 1.297 . . . . 0.0 113.818 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -146.05 159.42 46.26 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.123 1.769 . . . . 0.0 112.346 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.0 161.25 5.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.209 3.273 . . . . 0.0 115.405 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.32 10.17 5.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.254 1.422 . . . . 0.0 113.621 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -60.79 158.52 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.481 1.512 . . . . 0.0 114.403 -170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 t -132.33 8.91 4.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.415 1.086 . . . . 0.0 113.369 173.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.9 mt -55.17 152.26 8.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.834 1.253 . . . . 0.0 112.139 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -150.15 173.04 14.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.77 112.4 8.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.753 0.821 . . . . 0.0 111.15 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.2 -170.45 43.46 Favored Glycine 0 N--CA 1.474 1.191 0 O-C-N 121.644 -0.66 . . . . 0.0 114.673 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.02 136.57 33.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.886 1.274 . . . . 0.0 110.137 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -143.61 170.34 16.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.231 1.412 . . . . 0.0 111.359 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 pt -126.55 148.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.221 1.809 . . . . 0.0 109.149 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.21 123.53 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.77 1.228 . . . . 0.0 108.601 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -140.84 155.12 46.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.977 0.911 . . . . 0.0 112.416 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -88.92 138.97 30.93 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.948 -0.47 . . . . 0.0 111.1 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttt-85 -67.06 -12.69 60.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 113.728 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.46 -23.35 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp 50.29 -153.39 0.15 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.795 1.238 . . . . 0.0 111.539 -173.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -148.18 152.72 40.12 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 120.457 -1.402 . . . . 0.0 112.313 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.93 -12.55 34.7 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.186 2.591 . . . . 0.0 114.239 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -72.26 -8.92 57.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.52 25.64 17.83 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.413 1.006 . . . . 0.0 113.865 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.54 -178.77 5.21 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.932 1.693 . . . . 0.0 111.253 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.94 163.23 20.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.263 1.425 . . . . 0.0 111.777 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.51 139.01 51.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.407 1.083 . . . . 0.0 110.289 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.42 158.55 34.07 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.743 1.617 . . . . 0.0 111.442 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.1 132.16 49.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.619 0.368 . . . . 0.0 110.833 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -135.65 128.88 31.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.166 0.986 . . . . 0.0 110.802 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.76 125.07 86.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.839 1.255 . . . . 0.0 111.163 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.7 -10.19 16.1 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.962 3.108 . . . . 0.0 116.392 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.71 -8.26 68.38 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.862 1.22 . . . . 0.0 114.252 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -148.13 173.84 12.56 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.069 1.748 . . . . 0.0 111.62 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -93.39 167.09 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.43 1.492 . . . . 0.0 112.343 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 56.9 44.73 22.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.932 1.693 . . . . 0.0 112.602 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.5 p -138.65 144.43 42.05 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 126.809 2.044 . . . . 0.0 111.17 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.73 140.54 93.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.547 2.832 . . . . 0.0 113.18 170.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.06 146.05 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.761 0.824 . . . . 0.0 110.458 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -118.69 166.48 12.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.052 1.341 . . . . 0.0 109.827 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.99 142.2 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.445 -0.784 . . . . 0.0 112.553 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -148.57 164.8 20.06 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 126.111 1.764 . . . . 0.0 110.689 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.85 157.25 3.88 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.507 2.805 . . . . 0.0 113.822 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 tp -120.51 133.03 55.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.352 1.061 . . . . 0.0 112.001 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -137.45 0.07 2.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.446 1.898 . . . . 0.0 113.081 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.27 5.63 63.54 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.007 1.289 . . . . 0.0 115.312 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.6 t -62.41 152.38 34.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.554 1.677 . . . . 0.0 112.597 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -58.82 -19.09 38.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.33 1.852 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.82 -13.0 54.83 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.044 0.838 . . . . 0.0 112.38 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -117.18 -11.82 10.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.622 1.569 . . . . 0.0 113.493 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.8 145.02 28.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.389 1.076 . . . . 0.0 111.657 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -134.98 175.6 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.241 1.417 . . . . 0.0 111.438 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.47 154.39 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.989 1.316 . . . . 0.0 109.848 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.37 132.13 53.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.909 1.683 . . . . 0.0 107.969 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -139.65 130.02 25.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.888 1.275 . . . . 0.0 109.632 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -63.81 149.26 47.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.318 0.647 . . . . 0.0 111.972 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -129.86 -40.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.224 1.01 . . . . 0.0 111.97 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.07 152.29 29.38 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.296 1.038 . . . . 0.0 112.404 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.5 p -106.73 -25.25 11.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.481 1.513 . . . . 0.0 114.042 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -63.94 -24.95 67.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.971 1.308 . . . . 0.0 113.224 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -123.99 7.97 8.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.866 1.667 . . . . 0.0 113.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.84 39.84 26.58 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.39 1.476 . . . . 0.0 113.337 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -105.27 140.55 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.162 1.785 . . . . 0.0 113.009 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -136.04 169.78 17.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.246 1.818 . . . . 0.0 110.428 -169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.5 p -117.46 151.03 37.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.795 1.238 . . . . 0.0 109.61 169.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -137.98 132.86 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 109.229 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 m -140.82 147.35 48.02 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.778 0.831 . . . . 0.0 111.606 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -76.77 142.85 23.09 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 111.17 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.47 -27.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.459 -0.776 . . . . 0.0 112.186 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.11 -27.74 73.53 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.756 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.0 m -144.1 64.41 12.59 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.777 1.231 . . . . 0.0 112.969 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.18 -16.01 25.83 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.929 3.086 . . . . 0.0 114.824 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.2 0.4 2.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.858 2.063 . . . . 0.0 115.002 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.0 m -149.53 165.8 31.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.474 1.909 . . . . 0.0 110.883 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.375 1.07 . . . . 0.0 113.156 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -66.52 127.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.807 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.39 -171.1 12.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.453 1.502 . . . . 0.0 112.126 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -123.93 178.03 5.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.122 0.969 . . . . 0.0 109.754 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.3 19.19 2.28 Favored Glycine 0 N--CA 1.47 0.931 0 O-C-N 121.263 -0.898 . . . . 0.0 113.491 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.72 2.1 0.15 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.069 2.148 . . . . 0.0 116.165 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.77 27.69 19.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 127.293 2.377 . . . . 0.0 113.665 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.91 28.69 15.0 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.941 1.696 . . . . 0.0 115.296 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.81 137.08 16.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 109.825 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.61 152.81 33.79 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.124 1.883 . . . . 0.0 110.688 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.96 -178.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.285 2.234 . . . . 0.0 110.705 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.18 131.27 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.944 -1.097 . . . . 0.0 109.616 171.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -139.6 159.77 64.07 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.418 1.487 . . . . 0.0 112.668 -169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 161.83 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.737 3.625 . . . . 0.0 115.643 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.5 127.02 24.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.454 3.436 . . . . 0.0 114.513 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -163.48 -152.17 0.2 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.458 2.303 . . . . 0.0 108.693 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -118.93 27.3 8.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.32 1.848 . . . . 0.0 111.807 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -61.53 120.41 10.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.872 -1.143 . . . . 0.0 109.317 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 m -127.96 159.98 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.742 1.217 . . . . 0.0 112.208 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.06 146.17 36.81 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.015 1.326 . . . . 0.0 110.486 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -94.1 137.24 33.51 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.051 1.34 . . . . 0.0 109.853 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.07 126.51 50.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.633 0.773 . . . . 0.0 109.982 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.2 m -135.54 140.57 44.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.314 0.646 . . . . 0.0 111.606 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.2 tp -111.05 136.27 50.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.741 1.216 . . . . 0.0 110.823 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.8 p -128.82 -178.3 4.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.591 1.557 . . . . 0.0 111.402 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.8 p -62.09 -7.4 3.96 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.85 -21.76 2.85 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.605 1.098 . . . . 0.0 115.711 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -178.89 41.76 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 119.199 1.5 . . . . 0.0 114.111 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -73.77 163.85 27.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.645 1.212 . . . . 0.0 111.444 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -141.31 154.61 45.8 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.869 2.068 . . . . 0.0 109.382 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -135.79 119.7 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.95 1.3 . . . . 0.0 108.294 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -138.1 162.91 32.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.352 1.061 . . . . 0.0 111.16 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -73.86 172.71 11.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.837 0.827 . . . . 0.0 112.819 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.48 -13.32 60.46 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 120.991 -1.068 . . . . 0.0 115.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -104.54 -5.28 21.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.426 1.89 . . . . 0.0 114.003 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 54.42 15.63 1.05 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.163 2.585 . . . . 0.0 116.245 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.5 p -72.66 -15.66 61.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.61 1.095 . . . . 0.0 113.221 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.19 172.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.29 2.236 . . . . 0.0 111.124 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -142.58 154.25 44.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.269 1.828 . . . . 0.0 111.399 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.88 140.02 45.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.802 0.841 . . . . 0.0 111.691 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.2 p -148.74 170.12 18.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -124.58 167.27 14.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.696 1.999 . . . . 0.0 110.83 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -135.17 -27.25 1.24 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -118.78 -27.51 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.161 1.785 . . . . 0.0 111.975 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.33 37.08 26.78 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.567 1.547 . . . . 0.0 114.879 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.8 p -141.86 172.16 13.07 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.123 1.769 . . . . 0.0 112.177 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.66 143.57 46.17 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.844 -1.16 . . . . 0.0 112.788 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 -0.73 89.4 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 124.349 0.976 . . . . 0.0 114.82 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.16 151.12 46.9 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.196 1.798 . . . . 0.0 113.705 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -122.17 127.07 49.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.964 1.305 . . . . 0.0 109.817 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.14 145.56 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -131.74 170.19 15.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.906 1.683 . . . . 0.0 111.059 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -136.1 138.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.492 1.517 . . . . 0.0 109.184 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.79 -159.58 24.13 Favored Glycine 0 CA--C 1.528 0.89 0 O-C-N 121.846 -0.534 . . . . 0.0 113.011 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.51 160.52 4.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.408 0.623 . . . . 0.0 112.493 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -60.15 156.81 14.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.976 0.894 . . . . 0.0 112.856 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.78 167.92 20.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.645 1.978 . . . . 0.0 111.277 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.88 -22.05 12.6 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -129.41 -16.48 3.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.2 p -128.15 0.88 5.83 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.19 0.66 31.3 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.981 1.277 . . . . 0.0 114.42 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -86.83 143.64 27.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.625 1.17 . . . . 0.0 110.02 170.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -131.79 167.96 18.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.974 1.31 . . . . 0.0 110.796 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.1 t -142.52 144.26 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.949 1.3 . . . . 0.0 108.556 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.88 141.31 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.068 1.347 . . . . 0.0 108.947 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.36 146.9 35.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.788 1.235 . . . . 0.0 111.157 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -84.42 144.51 28.72 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.733 1.213 . . . . 0.0 110.785 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.289 1.436 . . . . 0.0 114.574 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.56 -7.19 0.1 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -60.22 -21.51 61.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.43 1.492 . . . . 0.0 114.63 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.18 170.19 20.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.651 1.98 . . . . 0.0 111.157 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -149.54 166.94 27.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.734 1.214 . . . . 0.0 111.497 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -141.15 6.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.446 1.498 . . . . 0.0 114.125 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -140.59 177.17 8.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.406 1.482 . . . . 0.0 111.0 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.5 t60 60.69 -8.7 0.07 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.683 2.393 . . . . 0.0 116.611 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -133.59 -0.49 3.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.516 1.926 . . . . 0.0 113.515 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -146.7 -28.76 0.39 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.122 1.369 . . . . 0.0 113.942 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 m -128.94 12.8 6.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.376 1.471 . . . . 0.0 113.396 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.65 30.32 0.76 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.342 . . . . 0.0 114.083 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -134.13 9.44 3.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.201 1.4 . . . . 0.0 113.186 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -154.47 144.6 15.68 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.726 1.611 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.03 159.64 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.845 3.03 . . . . 0.0 116.012 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.21 2.92 1.52 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.85 1.26 . . . . 0.0 114.396 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -56.54 157.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.759 1.223 . . . . 0.0 114.03 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -129.25 12.29 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.165 1.386 . . . . 0.0 112.524 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -54.86 154.69 4.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -149.7 167.16 27.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.493 1.117 . . . . 0.0 111.117 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.1 115.42 7.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.673 0.789 . . . . 0.0 111.147 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.28 46.01 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -91.45 136.72 32.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.843 1.257 . . . . 0.0 110.45 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -143.22 170.79 15.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.393 . . . . 0.0 111.506 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.69 150.59 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 0.0 109.168 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.74 128.45 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.944 1.298 . . . . 0.0 108.219 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -144.18 156.28 44.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.096 0.958 . . . . 0.0 111.456 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -69.34 155.75 39.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.949 0.88 . . . . 0.0 112.356 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -76.98 -5.75 49.87 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -123.48 107.8 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.551 1.54 . . . . 0.0 109.487 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 31' ' ' LEU . 2.7 mm? -57.06 160.0 3.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.754 1.622 . . . . 0.0 112.33 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -57.88 164.31 3.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.726 1.21 . . . . 0.0 113.662 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.63 -8.99 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.584 3.523 . . . . 0.0 116.616 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -119.56 -2.43 10.5 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.62 32.79 5.84 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.189 0.9 . . . . 0.0 115.157 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -128.82 155.66 44.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.621 1.211 . . . . 0.0 112.029 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.86 144.31 56.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.457 -0.777 . . . . 0.0 111.557 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -120.78 110.79 16.77 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.538 1.535 . . . . 0.0 108.511 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.03 151.17 29.64 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.104 1.361 . . . . 0.0 113.634 -168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.14 122.97 14.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 110.048 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -132.55 130.03 39.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.926 0.89 . . . . 0.0 110.724 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -62.36 131.59 93.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.86 1.664 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.72 -5.66 17.41 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.604 2.869 . . . . 0.0 114.719 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -9.54 55.41 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.011 1.291 . . . . 0.0 115.213 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -152.64 177.98 10.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.131 1.373 . . . . 0.0 112.599 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -79.81 166.51 21.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 112.007 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 59.18 29.71 19.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.922 1.689 . . . . 0.0 114.105 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.3 p -129.29 153.59 80.51 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.973 . . . . 0.0 110.929 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.75 144.52 48.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.067 2.511 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.17 153.0 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.313 0.645 . . . . 0.0 110.342 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.6 m -126.18 164.49 20.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.119 1.368 . . . . 0.0 110.594 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.0 137.58 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.051 0.94 . . . . 0.0 111.055 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 m -150.32 161.83 29.51 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.023 1.329 . . . . 0.0 111.345 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.28 132.68 34.78 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.366 2.711 . . . . 0.0 113.063 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.3 tp -67.64 126.75 30.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.216 0.531 . . . . 0.0 111.446 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -133.44 -15.12 2.5 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.061 1.744 . . . . 0.0 112.433 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.97 14.43 60.77 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 170.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -59.77 165.39 3.12 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.322 1.449 . . . . 0.0 112.469 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -58.52 -25.26 62.23 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -76.73 -9.45 58.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.6 1.56 . . . . 0.0 113.165 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -120.92 -15.21 8.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.778 1.631 . . . . 0.0 113.351 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.054 0.942 . . . . 0.0 109.815 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -134.15 175.27 9.64 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.969 1.307 . . . . 0.0 110.264 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.87 155.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.825 1.25 . . . . 0.0 110.063 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -121.83 133.01 54.89 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.734 1.614 . . . . 0.0 108.022 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -137.46 131.81 32.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.946 1.298 . . . . 0.0 109.949 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -64.36 144.27 57.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 0.0 111.435 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -130.02 -34.5 1.68 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.747 0.819 . . . . 0.0 112.685 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.78 153.99 36.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.861 0.864 . . . . 0.0 112.48 174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.6 m -115.07 -8.4 12.44 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -105.55 -11.93 16.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.52 1.528 . . . . 0.0 113.411 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -119.71 0.98 11.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.268 1.827 . . . . 0.0 113.27 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.7 t30 50.48 38.79 19.32 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.747 1.619 . . . . 0.0 113.941 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 p -102.99 144.58 31.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.188 1.395 . . . . 0.0 112.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -139.31 171.94 13.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.792 2.037 . . . . 0.0 109.628 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.1 p -121.26 150.49 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 110.013 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.65 132.22 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 109.215 -168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.0 m -140.26 144.82 38.87 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.347 0.659 . . . . 0.0 111.972 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.58 140.86 21.68 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.058 2.505 . . . . 0.0 111.07 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.55 -26.45 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.473 -0.767 . . . . 0.0 111.942 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.25 -26.06 74.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.363 0.982 . . . . 0.0 115.009 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.2 m -143.35 64.29 13.71 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.732 1.213 . . . . 0.0 113.129 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.67 -14.35 16.99 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.998 3.132 . . . . 0.0 115.48 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.08 1.11 2.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.12 1.768 . . . . 0.0 114.444 170.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.9 p -147.36 167.44 24.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.78 1.632 . . . . 0.0 112.744 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -144.45 160.65 40.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.625 1.57 . . . . 0.0 111.585 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.86 129.41 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.357 0.663 . . . . 0.0 109.932 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.77 -168.34 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.442 1.972 . . . . 0.0 111.733 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.461 ' O ' ' H82' ' A' ' 154' ' ' NAG . 8.5 t90 -133.48 171.98 13.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.411 1.084 . . . . 0.0 110.048 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.82 21.52 2.33 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.186 0.898 . . . . 0.0 113.342 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.79 3.55 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.22 2.208 . . . . 0.0 116.135 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.73 29.52 12.34 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 127.125 2.297 . . . . 0.0 113.792 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m120 58.11 22.89 9.52 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.078 1.751 . . . . 0.0 115.408 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.63 134.8 16.39 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.649 1.18 . . . . 0.0 110.214 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.66 154.89 44.57 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.213 1.942 . . . . 0.0 110.645 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.39 179.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.855 2.062 . . . . 0.0 110.291 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 t -122.26 130.69 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -143.14 159.72 54.86 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.591 1.557 . . . . 0.0 111.394 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.0 154.72 54.74 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.573 2.182 . . . . 0.0 112.167 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.77 134.74 38.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.288 2.659 . . . . 0.0 112.676 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -148.3 -86.59 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 109.876 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -147.98 10.54 0.91 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.422 1.089 . . . . 0.0 113.523 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.424 ' CE1' ' H83' ' A' ' 154' ' ' NAG . 20.5 m-85 -66.65 129.73 40.83 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.32 -1.487 . . . . 0.0 110.741 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.84 160.08 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.837 . . . . 0.0 112.376 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -140.65 145.53 36.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.232 1.413 . . . . 0.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 m -91.62 141.3 28.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.42 1.088 . . . . 0.0 109.858 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -117.83 135.47 54.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.432 0.693 . . . . 0.0 109.822 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 m -137.77 132.89 33.39 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.792 0.724 . . . . 0.0 111.846 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.4 tp -87.92 149.32 24.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.579 1.152 . . . . 0.0 112.085 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -126.77 178.09 6.16 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.621 1.568 . . . . 0.0 111.536 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -59.5 -8.46 1.88 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.97 29.44 0.2 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.058 0.844 . . . . 0.0 115.108 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.08 -172.35 44.48 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 118.946 1.373 . . . . 0.0 113.807 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -127.24 163.25 24.31 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.791 1.636 . . . . 0.0 112.095 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -130.12 155.84 45.53 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.088 1.755 . . . . 0.0 110.725 170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mt -136.23 122.25 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.291 1.437 . . . . 0.0 108.364 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -137.79 164.25 29.36 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.783 0.833 . . . . 0.0 112.126 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -61.61 165.89 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.241 1.016 . . . . 0.0 111.856 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.06 -1.34 25.71 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -122.51 -2.29 8.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.595 1.958 . . . . 0.0 112.246 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.46 21.89 5.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.352 2.661 . . . . 0.0 114.55 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p -72.1 -19.96 61.72 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.031 -1.043 . . . . 0.0 113.096 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.17 177.97 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.687 1.995 . . . . 0.0 111.145 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.2 t -143.09 151.2 40.49 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.184 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -69.15 134.21 49.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.167 0.587 . . . . 0.0 111.082 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -146.06 178.74 7.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.317 1.447 . . . . 0.0 112.498 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.57 139.52 45.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.249 1.419 . . . . 0.0 110.403 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.76 -31.78 72.95 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -137.61 -4.47 1.82 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.6 1.96 . . . . 0.0 113.749 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.59 38.99 23.94 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.674 1.59 . . . . 0.0 115.072 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.0 p -126.46 167.15 15.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.028 0.931 . . . . 0.0 113.033 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.0 146.73 41.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.549 1.14 . . . . 0.0 114.038 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.96 -6.84 61.24 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.222 1.392 . . . . 0.0 114.395 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -72.98 144.91 47.06 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.375 1.088 . . . . 0.0 112.192 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.67 136.12 43.77 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.635 -0.665 . . . . 0.0 110.407 170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.84 149.87 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.52 -0.737 . . . . 0.0 110.142 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -135.13 167.05 21.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.691 1.197 . . . . 0.0 111.871 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.2 mt -140.82 127.73 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.235 1.814 . . . . 0.0 109.027 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.68 -161.54 21.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.478 0.561 . . . . 0.0 113.296 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.22 160.17 6.75 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.683 0.754 . . . . 0.0 112.989 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.14 149.17 45.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.616 1.166 . . . . 0.0 113.114 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.76 149.09 32.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.425 1.09 . . . . 0.0 113.092 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -85.47 -27.21 25.83 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -131.51 -4.56 3.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.8 p -130.23 9.15 5.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.227 1.411 . . . . 0.0 113.374 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.89 38.47 1.42 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.26 1.886 . . . . 0.0 112.776 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -135.2 143.16 46.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.316 1.847 . . . . 0.0 109.638 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -135.87 169.45 17.56 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.845 0.858 . . . . 0.0 111.998 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.27 146.75 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.607 1.963 . . . . 0.0 107.799 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 38.9 mt -132.0 141.62 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.991 1.316 . . . . 0.0 108.749 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -139.81 147.02 40.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 0.0 110.576 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -88.87 143.14 27.08 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.644 1.178 . . . . 0.0 110.526 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 125.173 1.389 . . . . 0.0 114.701 -177.168 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . 0.461 ' H82' ' O ' ' A' ' 89' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.26 -14.06 0.08 OUTLIER Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -146.32 173.07 12.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.163 1.785 . . . . 0.0 111.305 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -146.79 155.37 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.283 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -155.25 171.62 19.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 111.828 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -146.56 163.62 35.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.742 1.217 . . . . 0.0 111.246 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -135.13 0.16 2.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.282 1.433 . . . . 0.0 113.818 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -128.98 14.31 6.3 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.667 1.187 . . . . 0.0 113.257 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -64.1 156.76 27.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.859 0.863 . . . . 0.0 112.341 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -152.31 175.12 13.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.743 1.217 . . . . 0.0 111.959 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.8 m -127.87 4.61 6.0 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.072 1.349 . . . . 0.0 114.407 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.35 3.17 0.86 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.886 1.708 . . . . 0.0 114.904 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -138.57 2.99 2.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.009 1.724 . . . . 0.0 112.953 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.7 t -154.59 147.06 17.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.099 1.76 . . . . 0.0 110.44 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.78 159.1 5.33 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.694 2.929 . . . . 0.0 116.224 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.56 6.99 1.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.83 1.252 . . . . 0.0 113.898 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.89 175.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.089 1.756 . . . . 0.0 111.813 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.94 -179.29 6.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.22 1.808 . . . . 0.0 109.86 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.02 152.36 45.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.047 2.139 . . . . 0.0 111.688 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.6 p -154.6 176.62 12.18 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.645 1.978 . . . . 0.0 110.735 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 118.83 10.69 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.498 -0.751 . . . . 0.0 111.689 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.49 43.25 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.534 HD21 ' CG2' ' A' ' 80' ' ' VAL . 3.4 t-20 -89.46 137.24 32.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.028 1.331 . . . . 0.0 110.751 173.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -141.68 167.34 22.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.394 1.478 . . . . 0.0 111.686 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.06 150.46 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.49 1.916 . . . . 0.0 109.364 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.2 128.7 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.772 1.229 . . . . 0.0 108.676 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -141.54 158.49 43.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.106 0.962 . . . . 0.0 112.704 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -72.98 145.18 46.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.532 -0.73 . . . . 0.0 112.073 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -69.87 -2.24 11.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.69 -6.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.242 1.817 . . . . 0.0 113.849 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.1 mt 50.08 -127.02 2.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.076 1.351 . . . . 0.0 111.692 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.4 p -149.62 158.49 37.61 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-N 119.657 1.117 . . . . 0.0 112.86 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.28 -6.35 18.66 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.191 2.594 . . . . 0.0 113.591 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -73.0 -8.06 54.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.192 1.397 . . . . 0.0 113.409 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.59 61.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.492 1.044 . . . . 0.0 113.966 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -142.26 155.72 45.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.153 1.381 . . . . 0.0 111.555 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -68.1 159.01 31.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.851 1.26 . . . . 0.0 112.524 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.77 138.71 50.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.327 1.451 . . . . 0.0 110.314 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.3 154.09 51.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.545 1.138 . . . . 0.0 112.771 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.72 120.38 11.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.136 1.374 . . . . 0.0 110.43 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.5 m -129.02 129.29 45.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.803 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -59.45 130.3 87.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.986 1.315 . . . . 0.0 110.204 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.53 -1.86 10.9 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.987 2.458 . . . . 0.0 114.428 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.01 -7.84 67.42 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.953 1.264 . . . . 0.0 114.293 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -155.98 170.71 21.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.711 1.604 . . . . 0.0 112.941 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -88.13 171.01 10.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.925 1.69 . . . . 0.0 112.204 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 52.6 31.7 10.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.08 1.752 . . . . 0.0 113.368 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 m -138.93 142.09 32.43 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.847 2.059 . . . . 0.0 109.224 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.96 148.84 71.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.812 2.341 . . . . 0.0 113.214 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.3 155.33 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.217 1.007 . . . . 0.0 110.952 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -133.32 167.06 21.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.306 1.442 . . . . 0.0 110.337 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.74 145.84 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.075 -1.015 . . . . 0.0 112.28 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.0 m -148.19 164.01 24.04 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.581 1.552 . . . . 0.0 110.242 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 136.27 32.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.141 2.561 . . . . 0.0 113.345 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 tp -66.29 125.6 26.11 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.483 0.659 . . . . 0.0 111.475 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.49 -22.2 1.72 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.03 2.132 . . . . 0.0 111.829 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.72 25.87 64.08 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.644 -0.66 . . . . 0.0 113.838 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -63.86 174.02 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.294 1.438 . . . . 0.0 112.828 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 p -56.91 -18.89 14.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -96.54 -0.42 48.88 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 112.718 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -125.15 -12.86 6.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.381 1.472 . . . . 0.0 114.027 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.68 28.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.892 0.877 . . . . 0.0 109.915 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -138.31 171.26 14.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.346 1.458 . . . . 0.0 109.455 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.5 pt -121.76 153.79 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.201 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -123.82 133.82 53.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.124 1.77 . . . . 0.0 107.672 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -138.87 136.22 35.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.795 1.238 . . . . 0.0 109.73 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -64.49 144.7 57.0 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.898 0.479 . . . . 0.0 111.625 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.2 -39.36 1.18 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.15 0.98 . . . . 0.0 112.308 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -153.47 158.92 42.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.123 0.969 . . . . 0.0 111.94 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -115.89 -24.65 8.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 113.02 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -66.21 -20.57 66.16 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.818 1.247 . . . . 0.0 113.011 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 t -127.76 4.96 6.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.385 1.874 . . . . 0.0 113.658 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 t30 48.49 36.57 7.55 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.798 1.639 . . . . 0.0 114.176 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -97.9 144.52 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 112.915 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -137.84 160.84 38.18 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.297 1.839 . . . . 0.0 109.329 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.6 p -99.15 152.38 19.94 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.42 130.28 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -140.62 145.76 41.77 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.89 145.88 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.2 2.6 . . . . 0.0 111.7 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 23' ' ' ASN . 79.5 t -62.55 -27.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.55 -0.719 . . . . 0.0 112.162 173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.63 -10.21 83.6 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.004 1.288 . . . . 0.0 115.255 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.6 t -151.21 60.07 3.67 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.907 1.353 . . . . 0.0 112.811 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.58 -18.54 33.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.954 3.103 . . . . 0.0 115.06 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.06 -1.81 3.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 114.459 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.9 m -147.71 170.93 16.5 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.879 2.072 . . . . 0.0 111.091 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.3 163.43 33.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.846 1.258 . . . . 0.0 112.465 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.63 131.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.576 -0.703 . . . . 0.0 110.031 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.29 -177.71 15.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.427 1.965 . . . . 0.0 111.949 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -120.48 103.63 9.33 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.494 -1.003 . . . . 0.0 111.129 -169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.78 152.42 52.31 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.924 0.736 . . . . 0.0 112.362 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.95 -3.27 4.94 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 114.664 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.44 21.74 43.91 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.037 2.256 . . . . 0.0 113.808 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.85 43.41 27.63 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.16 1.784 . . . . 0.0 114.699 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.09 152.19 60.87 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 125.773 1.629 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.59 146.34 24.08 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.354 2.036 . . . . 0.0 110.029 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -137.55 174.42 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.316 2.246 . . . . 0.0 110.001 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.41 129.55 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 121.492 -0.755 . . . . 0.0 110.025 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -142.53 159.14 58.68 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.396 1.479 . . . . 0.0 112.313 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.02 158.28 2.34 Favored 'Trans proline' 0 CA--C 1.548 1.211 0 C-N-CA 124.512 3.475 . . . . 0.0 114.611 170.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.37 119.15 6.12 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.791 2.994 . . . . 0.0 112.234 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -151.81 28.71 0.61 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.968 1.707 . . . . 0.0 111.528 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 56.91 31.13 19.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.556 1.543 . . . . 0.0 114.248 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -61.36 139.18 58.23 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.633 -1.292 . . . . 0.0 109.175 168.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.22 161.29 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.592 -0.693 . . . . 0.0 112.194 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -141.05 143.87 34.63 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.892 1.277 . . . . 0.0 109.58 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -84.69 138.53 32.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.777 0.831 . . . . 0.0 109.56 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.39 120.48 38.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.122 0.569 . . . . 0.0 110.429 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -132.19 128.85 38.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.996 0.518 . . . . 0.0 111.328 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.13 158.04 33.99 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -131.87 179.49 6.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.491 1.916 . . . . 0.0 111.565 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 57.5 p -58.53 -10.93 2.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.99 26.67 0.16 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.37 0.987 . . . . 0.0 115.1 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.95 -159.75 24.27 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.309 1.055 . . . . 0.0 113.307 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -133.71 162.75 31.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.341 1.857 . . . . 0.0 112.796 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -122.9 157.54 32.33 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.032 1.733 . . . . 0.0 110.393 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.7 mt -135.16 112.75 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.122 1.369 . . . . 0.0 108.008 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.65 158.47 44.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.725 0.81 . . . . 0.0 111.923 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.73 161.78 7.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.226 0.61 . . . . 0.0 112.197 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.4 0.96 0.5 Allowed Glycine 0 CA--C 1.547 2.071 0 N-CA-C 117.858 1.903 . . . . 0.0 117.858 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -2.02 7.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.502 1.921 . . . . 0.0 112.678 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.96 21.67 3.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.276 2.231 . . . . 0.0 114.343 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 p -70.95 -20.47 62.45 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.932 -1.105 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.0 m -143.72 175.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 111.588 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -144.32 155.43 43.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.225 1.81 . . . . 0.0 111.163 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -71.68 123.2 22.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.841 0.856 . . . . 0.0 111.569 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -141.64 173.09 11.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.154 0.982 . . . . 0.0 113.328 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -133.47 169.69 16.6 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.033 2.533 . . . . 0.0 110.121 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -128.78 -19.2 3.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -118.29 -14.85 9.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 111.906 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.68 38.38 26.01 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.745 2.018 . . . . 0.0 114.268 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -139.26 164.15 30.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.275 1.43 . . . . 0.0 113.12 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.26 151.3 19.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 113.485 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 -9.81 40.13 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.959 1.266 . . . . 0.0 114.337 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -68.59 132.41 46.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.439 1.12 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.16 131.44 42.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.467 0.707 . . . . 0.0 109.912 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.77 148.49 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.935 0.894 . . . . 0.0 110.069 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.6 t -134.13 173.5 11.52 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.764 1.226 . . . . 0.0 111.889 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.5 mt -135.21 140.8 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.892 1.277 . . . . 0.0 109.705 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.53 -161.86 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.276 0.941 . . . . 0.0 112.197 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.77 156.56 6.37 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.027 -0.69 . . . . 0.0 112.36 169.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.72 159.66 13.12 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.275 1.036 . . . . 0.0 113.556 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.39 176.86 9.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.946 1.698 . . . . 0.0 110.62 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.3 t -113.5 -28.64 7.45 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -126.63 -3.09 6.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.049 1.339 . . . . 0.0 113.537 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 76.5 p -136.48 5.94 2.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 114.084 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.41 32.35 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.012 1.292 . . . . 0.0 113.735 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -140.31 154.77 46.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.424 1.89 . . . . 0.0 110.211 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -136.88 178.61 6.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -168.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -142.95 145.76 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 126.919 2.088 . . . . 0.0 107.041 172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.43 141.28 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.232 1.013 . . . . 0.0 109.085 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -141.3 153.19 45.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.694 1.197 . . . . 0.0 111.777 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.72 142.09 29.16 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.679 1.192 . . . . 0.0 111.041 -171.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 126.281 1.832 . . . . 0.0 114.052 -176.65 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.7 -24.05 0.1 OUTLIER Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.831 0.729 . . . . 0.0 114.791 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -147.29 142.88 27.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.456 1.502 . . . . 0.0 110.87 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -148.9 -2.53 0.47 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.152 1.381 . . . . 0.0 113.669 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -70.89 164.02 26.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.791 1.636 . . . . 0.0 113.435 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -131.77 1.76 4.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.994 1.317 . . . . 0.0 113.088 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -134.81 11.17 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.19 1.796 . . . . 0.0 112.637 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.33 164.46 13.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.43 1.492 . . . . 0.0 112.446 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -150.25 179.45 8.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.517 1.127 . . . . 0.0 111.861 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -139.7 177.32 8.03 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.095 1.358 . . . . 0.0 112.392 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 m -141.2 8.23 2.03 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.11 4.34 2.88 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.283 1.421 . . . . 0.0 115.157 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.79 -7.79 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.731 1.612 . . . . 0.0 113.383 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.8 p -150.58 163.16 25.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.389 1.876 . . . . 0.0 112.287 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.73 161.41 2.16 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.463 3.442 . . . . 0.0 115.78 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.72 2.99 5.46 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.601 1.16 . . . . 0.0 114.105 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.47 159.67 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.619 1.168 . . . . 0.0 112.614 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -128.66 8.29 5.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.223 1.009 . . . . 0.0 112.69 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.86 152.45 5.54 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.436 1.094 . . . . 0.0 111.237 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -150.08 170.79 18.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.461 1.104 . . . . 0.0 110.676 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.04 108.34 4.02 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.641 -0.662 . . . . 0.0 110.41 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.48 46.43 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.34 138.65 32.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.084 1.354 . . . . 0.0 110.474 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.34 172.76 12.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.333 1.453 . . . . 0.0 111.923 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.79 148.56 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.681 1.993 . . . . 0.0 108.747 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.93 125.01 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.554 1.142 . . . . 0.0 108.619 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.16 154.08 44.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.901 0.88 . . . . 0.0 112.148 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.79 144.18 52.74 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.765 -0.585 . . . . 0.0 110.932 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -66.21 -15.6 63.31 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.17 116.04 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.995 1.318 . . . . 0.0 109.773 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.5 162.98 7.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.549 1.539 . . . . 0.0 112.273 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.9 p -59.08 160.87 10.44 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.925 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.79 -2.12 7.12 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.257 2.638 . . . . 0.0 113.712 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -101.33 -12.33 18.73 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.074 1.75 . . . . 0.0 113.034 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.61 26.9 6.61 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.515 1.055 . . . . 0.0 115.174 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -133.11 151.66 51.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.995 1.397 . . . . 0.0 112.378 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.19 150.54 48.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.679 0.791 . . . . 0.0 111.55 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.26 122.49 37.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.533 1.533 . . . . 0.0 109.233 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.38 154.05 42.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 113.411 -168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.05 126.23 26.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.431 0.692 . . . . 0.0 110.752 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -132.45 134.88 45.61 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.335 1.454 . . . . 0.0 110.01 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.63 131.43 92.74 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.414 1.086 . . . . 0.0 110.902 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.7 -10.38 23.38 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.517 2.811 . . . . 0.0 114.815 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.75 -10.01 34.84 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.383 1.468 . . . . 0.0 114.877 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -152.1 174.71 13.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.924 1.289 . . . . 0.0 112.584 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -74.37 164.57 26.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.234 1.014 . . . . 0.0 112.149 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 55.12 38.25 30.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.618 1.567 . . . . 0.0 114.183 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -133.08 151.66 78.26 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 125.198 1.399 . . . . 0.0 111.748 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.06 143.44 83.49 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.411 2.74 . . . . 0.0 113.444 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.0 145.25 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.574 0.75 . . . . 0.0 110.716 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -111.76 167.7 10.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.923 1.289 . . . . 0.0 110.41 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -132.32 138.83 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.525 1.53 . . . . 0.0 109.699 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 m -151.7 165.4 17.51 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.456 1.502 . . . . 0.0 110.891 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.74 135.42 22.31 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.446 2.764 . . . . 0.0 112.976 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.04 124.85 23.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.493 0.663 . . . . 0.0 111.286 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.97 -23.38 1.76 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.677 1.991 . . . . 0.0 111.8 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.91 63.3 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.904 0.764 . . . . 0.0 113.83 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.0 p -64.47 173.78 1.97 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.351 1.46 . . . . 0.0 112.936 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.0 m -57.0 -18.65 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.597 1.159 . . . . 0.0 113.933 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.4 -0.24 46.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.478 . . . . 0.0 112.855 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -125.09 -8.83 7.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.522 1.529 . . . . 0.0 113.877 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.39 140.73 33.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.802 0.841 . . . . 0.0 110.939 170.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -133.5 174.86 9.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.737 1.615 . . . . 0.0 110.282 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.92 153.43 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.338 1.055 . . . . 0.0 110.63 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.03 135.73 53.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.555 1.942 . . . . 0.0 107.657 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -137.79 130.99 30.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.122 1.369 . . . . 0.0 109.508 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.7 t -66.3 146.42 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.208 0.603 . . . . 0.0 111.496 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -128.13 -34.02 2.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.769 0.827 . . . . 0.0 112.774 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.44 155.21 39.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.781 0.833 . . . . 0.0 112.629 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -118.19 -7.82 10.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -107.92 -12.28 15.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.774 1.629 . . . . 0.0 113.412 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -120.07 2.2 10.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.218 1.807 . . . . 0.0 113.135 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 50.59 42.29 26.69 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.833 1.653 . . . . 0.0 113.691 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -105.8 144.89 31.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.144 1.378 . . . . 0.0 112.802 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -142.76 169.61 17.25 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.562 1.945 . . . . 0.0 110.079 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.8 p -119.8 154.1 34.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.096 0.959 . . . . 0.0 110.66 169.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -137.23 132.94 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.854 1.262 . . . . 0.0 109.002 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.2 p -145.65 152.83 49.96 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.581 0.752 . . . . 0.0 112.85 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 142.66 17.51 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.813 2.342 . . . . 0.0 111.029 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.87 -26.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.476 -0.765 . . . . 0.0 111.934 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.31 -16.95 79.97 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.402 1.001 . . . . 0.0 115.405 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 m -148.3 66.11 9.09 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-N 119.254 1.527 . . . . 0.0 112.913 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.73 -15.41 20.93 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.809 3.006 . . . . 0.0 115.0 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.31 -1.71 5.02 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.556 1.943 . . . . 0.0 114.825 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -142.0 176.32 9.04 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.394 1.877 . . . . 0.0 111.232 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -152.46 151.69 31.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.787 2.035 . . . . 0.0 110.263 -168.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.2 130.83 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.787 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.4 175.75 23.98 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.12 1.343 . . . . 0.0 112.236 173.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.56 167.86 17.55 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.42 -1.047 . . . . 0.0 110.664 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.57 19.54 4.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.212 0.911 . . . . 0.0 114.525 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.76 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.659 2.384 . . . . 0.0 117.25 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.1 25.05 19.68 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 127.319 2.39 . . . . 0.0 112.998 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 52.89 38.44 26.88 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.537 1.935 . . . . 0.0 114.614 -176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.68 152.35 74.33 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.601 1.56 . . . . 0.0 110.254 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.49 144.27 19.98 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.532 2.155 . . . . 0.0 110.74 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.7 t -137.06 138.86 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.491 2.316 . . . . 0.0 108.617 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.56 123.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.861 -0.524 . . . . 0.0 110.629 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -141.15 161.13 54.97 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.524 1.53 . . . . 0.0 111.609 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.21 152.87 14.02 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.183 2.589 . . . . 0.0 113.868 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.23 118.28 5.45 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.594 2.863 . . . . 0.0 112.063 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -148.67 35.1 0.77 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.567 1.547 . . . . 0.0 110.729 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . 0.273 13.2 p30 39.14 52.32 2.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.805 2.042 . . . . 0.0 114.37 -172.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.57 60.3 0.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.357 1.463 . . . . 0.0 111.333 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.73 154.39 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -133.72 154.9 50.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.547 1.539 . . . . 0.0 110.135 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -99.24 136.94 38.47 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.182 1.393 . . . . 0.0 109.529 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.52 140.86 49.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 0.0 110.06 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 m -137.83 131.3 30.9 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.621 0.646 . . . . 0.0 111.889 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.04 147.16 23.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.0 1.32 . . . . 0.0 110.923 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.0 p -134.37 172.0 13.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.204 1.802 . . . . 0.0 111.571 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 m -59.42 -3.96 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.26 27.41 0.21 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.252 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.76 -176.33 46.98 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.588 1.694 . . . . 0.0 114.587 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -120.11 164.52 16.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.735 1.614 . . . . 0.0 112.243 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -135.16 156.25 49.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.891 1.677 . . . . 0.0 110.755 172.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.59 122.56 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.257 1.423 . . . . 0.0 108.872 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.88 162.77 34.67 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.415 1.086 . . . . 0.0 112.481 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.88 156.57 23.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.435 1.094 . . . . 0.0 112.665 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.07 -2.41 2.0 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -120.25 -0.67 10.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.753 . . . . 0.0 112.936 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.38 66.62 1.13 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.505 1.922 . . . . 0.0 112.204 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.3 p -128.86 -19.3 3.66 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 114.021 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.9 m -146.41 175.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.893 2.077 . . . . 0.0 111.038 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.2 t -144.35 154.06 42.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.966 1.306 . . . . 0.0 111.206 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -69.62 137.42 52.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.9 0.48 . . . . 0.0 110.929 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.3 p -147.48 169.56 19.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.27 169.76 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.275 2.23 . . . . 0.0 111.178 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -139.28 -24.81 0.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -121.61 -25.77 5.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.708 2.003 . . . . 0.0 111.44 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.79 42.18 29.77 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.657 1.583 . . . . 0.0 114.173 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -139.72 178.07 7.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.539 1.936 . . . . 0.0 111.912 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.77 147.22 52.28 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.711 -1.243 . . . . 0.0 112.387 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.06 9.6 83.98 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 123.591 0.615 . . . . 0.0 114.524 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.52 159.61 15.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.093 2.157 . . . . 0.0 113.061 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.97 114.27 16.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.318 1.047 . . . . 0.0 109.531 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.42 145.84 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.713 0.805 . . . . 0.0 111.344 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 t -135.83 178.96 6.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 110.913 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.1 mt -137.49 134.42 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.829 1.251 . . . . 0.0 109.656 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.28 -162.02 25.86 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.831 0.729 . . . . 0.0 112.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.28 159.95 5.59 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.578 0.704 . . . . 0.0 112.824 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 155.83 17.2 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.695 1.198 . . . . 0.0 113.135 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.58 153.63 40.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.236 1.415 . . . . 0.0 112.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 t -87.94 -22.46 24.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -138.25 -3.19 1.77 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -130.75 9.87 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.995 1.318 . . . . 0.0 113.59 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.11 35.35 1.37 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.728 1.156 . . . . 0.0 113.605 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -141.72 147.74 37.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.525 1.93 . . . . 0.0 109.043 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -132.08 174.97 9.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.135 0.969 . . . . 0.0 112.706 -166.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.2 t -140.26 143.74 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.33 1.852 . . . . 0.0 107.554 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.1 mt -129.7 138.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.606 1.162 . . . . 0.0 108.527 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -140.26 152.14 45.69 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 0.0 111.449 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -95.18 141.0 29.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.902 1.281 . . . . 0.0 110.624 -171.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 125.31 1.444 . . . . 0.0 114.64 -176.391 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.62 47.04 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.359 0.981 . . . . 0.0 113.084 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -152.38 172.15 16.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.203 1.401 . . . . 0.0 112.171 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -143.81 139.03 29.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.327 1.451 . . . . 0.0 110.51 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.3 -32.89 0.12 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.938 1.295 . . . . 0.0 113.046 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -142.8 -1.79 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.949 1.3 . . . . 0.0 114.149 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -65.51 161.19 20.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.013 1.725 . . . . 0.0 113.045 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -150.04 168.82 22.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.588 1.155 . . . . 0.0 112.566 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -142.52 13.0 1.94 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 112.654 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.27 172.25 16.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.279 1.432 . . . . 0.0 112.03 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.5 m -134.13 9.46 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.012 1.325 . . . . 0.0 113.904 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.82 82.1 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.783 1.182 . . . . 0.0 114.505 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -153.13 169.39 23.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.56 1.944 . . . . 0.0 110.898 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -149.32 153.1 37.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.572 1.549 . . . . 0.0 111.287 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.88 168.11 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.017 3.145 . . . . 0.0 115.146 169.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.64 -36.5 35.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.607 1.563 . . . . 0.0 114.802 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.6 t -142.9 -58.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.35 1.86 . . . . 0.0 109.514 169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -169.44 18.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.319 1.447 . . . . 0.0 111.545 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -52.73 145.23 12.55 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.448 1.099 . . . . 0.0 111.702 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 t -151.74 165.09 35.5 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.791 1.236 . . . . 0.0 110.85 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.31 122.88 18.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 111.208 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.6 -174.74 46.24 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.95 135.63 33.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.038 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -141.68 169.48 17.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.259 1.423 . . . . 0.0 111.544 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -128.01 149.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.31 1.844 . . . . 0.0 108.883 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 127.18 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.712 1.205 . . . . 0.0 108.342 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -142.36 150.28 40.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.936 0.894 . . . . 0.0 112.237 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -76.94 148.18 36.51 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.893 -0.504 . . . . 0.0 111.895 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -65.31 3.23 0.68 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.109 1.764 . . . . 0.0 115.344 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.06 -3.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.111 1.764 . . . . 0.0 114.068 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt 54.7 -152.64 0.33 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.425 1.09 . . . . 0.0 111.575 -172.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -132.07 155.96 80.7 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 124.97 1.308 . . . . 0.0 111.698 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.33 -10.99 30.54 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.06 2.507 . . . . 0.0 113.756 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -63.35 -27.04 69.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.454 1.101 . . . . 0.0 112.932 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.17 20.22 9.94 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.146 1.355 . . . . 0.0 113.821 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.05 160.71 39.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.714 1.605 . . . . 0.0 111.003 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -54.48 149.31 10.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.788 1.235 . . . . 0.0 111.79 172.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 tp -117.92 101.52 8.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.113 1.365 . . . . 0.0 109.004 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.75 155.46 19.67 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -167.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.14 132.86 55.1 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.749 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 m -132.96 128.43 36.41 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.277 1.431 . . . . 0.0 109.823 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -63.36 131.85 94.94 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.822 1.249 . . . . 0.0 111.494 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.96 -10.3 22.88 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.044 2.496 . . . . 0.0 114.964 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.17 -7.89 72.63 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.222 0.915 . . . . 0.0 114.944 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -153.81 168.0 27.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.864 1.266 . . . . 0.0 113.735 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.09 165.94 24.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.051 1.74 . . . . 0.0 112.488 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 51.44 30.9 6.67 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.293 1.837 . . . . 0.0 114.054 170.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.8 m -136.35 138.39 26.85 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 126.534 1.934 . . . . 0.0 108.654 -169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.37 151.6 65.69 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.562 2.175 . . . . 0.0 113.417 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.41 148.62 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.562 0.745 . . . . 0.0 109.715 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 m -128.15 164.05 23.33 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.735 1.214 . . . . 0.0 109.788 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.98 146.39 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 t -152.5 152.7 29.45 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.148 1.779 . . . . 0.0 109.932 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.39 135.07 59.79 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.849 2.366 . . . . 0.0 112.46 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.52 126.54 28.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.433 0.693 . . . . 0.0 111.611 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -132.42 -15.8 2.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.152 1.781 . . . . 0.0 112.139 171.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.63 55.12 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.873 0.749 . . . . 0.0 114.527 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -59.68 161.73 5.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.558 1.543 . . . . 0.0 112.402 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 m -59.05 -23.25 61.85 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -81.62 -10.91 59.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.775 1.63 . . . . 0.0 113.196 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -114.4 -13.48 12.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.89 1.676 . . . . 0.0 113.394 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.46 140.95 31.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.244 1.017 . . . . 0.0 110.778 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -132.79 174.59 10.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.198 1.399 . . . . 0.0 110.759 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.7 153.39 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.287 1.435 . . . . 0.0 109.918 170.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.47 133.6 55.39 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.711 1.605 . . . . 0.0 107.888 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -135.21 130.46 35.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.17 142.96 57.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.368 0.667 . . . . 0.0 111.727 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -123.82 -33.27 3.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.282 169.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.19 165.94 28.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.031 0.932 . . . . 0.0 112.257 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 p -126.84 -20.5 4.23 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.611 1.964 . . . . 0.0 114.222 -173.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -99.64 -6.83 26.6 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.695 1.998 . . . . 0.0 113.665 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -121.66 0.31 9.84 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.746 1.618 . . . . 0.0 113.625 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 t30 49.65 38.71 15.76 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.741 1.616 . . . . 0.0 113.611 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -104.21 144.69 31.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.564 1.546 . . . . 0.0 112.771 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -143.53 170.47 15.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.652 1.981 . . . . 0.0 110.106 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.0 p -122.26 155.51 35.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.562 1.145 . . . . 0.0 110.06 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.56 131.88 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.407 1.083 . . . . 0.0 110.34 -168.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -138.81 153.05 71.69 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.039 1.336 . . . . 0.0 111.238 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.73 151.25 31.81 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.182 2.588 . . . . 0.0 110.904 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.34 -29.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.379 -0.826 . . . . 0.0 112.016 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.31 -25.09 69.22 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.08 0.792 . . . . 0.0 115.08 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -143.25 58.9 7.06 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.012 1.325 . . . . 0.0 112.886 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -69.31 -4.35 13.54 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.765 2.977 . . . . 0.0 114.237 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -66.59 -11.07 51.56 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.086 1.354 . . . . 0.0 113.869 169.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.5 m -135.81 166.16 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.235 1.814 . . . . 0.0 111.411 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.62 160.02 43.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.7 mt -75.72 135.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.371 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.22 174.66 26.93 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.468 1.509 . . . . 0.0 112.826 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.76 157.1 35.79 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.354 -1.086 . . . . 0.0 110.338 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 20.08 7.29 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.995 0.807 . . . . 0.0 114.137 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.85 0.35 0.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.921 2.489 . . . . 0.0 117.093 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.07 24.29 26.87 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 127.169 2.319 . . . . 0.0 113.322 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 52.96 40.08 30.43 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.266 1.826 . . . . 0.0 114.509 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.6 m -138.53 149.08 61.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.729 1.612 . . . . 0.0 110.255 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.73 137.77 10.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.938 2.425 . . . . 0.0 110.186 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.47 154.42 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.407 1.883 . . . . 0.0 111.459 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.44 128.42 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.451 0.7 . . . . 0.0 110.157 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -140.8 162.73 47.14 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.336 1.055 . . . . 0.0 112.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.74 160.31 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 124.545 3.497 . . . . 0.0 114.126 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.31 103.55 1.1 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.525 2.817 . . . . 0.0 112.818 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -148.58 160.52 43.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.017 2.527 . . . . 0.0 107.091 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -65.82 38.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 129.005 2.922 . . . . 0.0 115.731 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.07 55.75 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.742 2.017 . . . . 0.0 113.062 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.99 158.06 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.728 1.611 . . . . 0.0 113.915 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.25 150.47 50.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.734 1.614 . . . . 0.0 109.575 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 121' ' ' ARG . 11.4 m -93.66 138.97 31.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.775 0.83 . . . . 0.0 109.487 174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.63 138.66 44.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 m -140.58 142.21 35.13 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.7 -0.625 . . . . 0.0 110.527 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 110' ' ' THR . 2.6 tm? -117.3 144.58 44.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.269 1.028 . . . . 0.0 110.753 175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.449 ' H ' HD22 ' A' ' 109' ' ' LEU . 54.2 p -136.1 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.133 1.773 . . . . 0.0 111.661 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.9 p -60.23 -6.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.0 -9.09 2.53 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.044 -1.42 . . . . 0.0 116.505 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.29 38.48 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 120.395 2.098 . . . . 0.0 114.727 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.67 161.59 23.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.588 1.185 . . . . 0.0 112.271 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -135.63 157.99 45.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.943 2.097 . . . . 0.0 109.94 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.33 112.31 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.075 1.35 . . . . 0.0 107.531 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.57 163.75 22.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.057 0.943 . . . . 0.0 112.244 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -62.32 157.07 20.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.214 1.007 . . . . 0.0 111.976 168.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.59 4.05 2.36 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.961 1.743 . . . . 0.0 116.06 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 6.12 5.21 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.243 2.217 . . . . 0.0 113.659 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER 51.05 62.63 2.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.556 1.942 . . . . 0.0 113.883 177.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.1 p -122.53 -17.82 6.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.636 1.174 . . . . 0.0 113.925 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.21 167.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.446 1.498 . . . . 0.0 111.96 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.0 t -134.13 151.21 51.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.779 2.031 . . . . 0.0 110.543 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -69.69 136.23 50.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.311 0.644 . . . . 0.0 111.291 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.2 p -147.08 175.62 10.56 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.695 1.598 . . . . 0.0 113.19 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.81 170.24 11.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.859 2.064 . . . . 0.0 110.482 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -114.01 -28.36 7.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.588 1.155 . . . . 0.0 113.141 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -128.14 -8.37 5.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.855 2.062 . . . . 0.0 112.052 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.53 42.77 20.35 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.884 1.673 . . . . 0.0 114.509 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -138.12 163.41 31.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.847 1.259 . . . . 0.0 112.241 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.65 22.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.79 0.836 . . . . 0.0 113.013 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.79 8.72 87.47 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.54 0.591 . . . . 0.0 114.277 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -103.49 143.77 32.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.009 1.324 . . . . 0.0 111.588 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -79.35 140.13 37.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.378 1.071 . . . . 0.0 111.437 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.67 147.73 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.397 1.079 . . . . 0.0 110.633 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -130.87 174.89 9.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.359 1.863 . . . . 0.0 111.185 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.63 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.498 1.519 . . . . 0.0 109.44 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.98 -163.42 27.39 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.358 0.98 . . . . 0.0 112.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.4 161.41 5.74 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.548 -0.972 . . . . 0.0 112.859 170.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 150.3 16.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.4 1.08 . . . . 0.0 112.148 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.45 152.02 41.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.919 1.688 . . . . 0.0 111.31 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -50.03 -39.57 42.03 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -149.97 -32.7 0.19 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.958 1.303 . . . . 0.0 113.202 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 p -67.85 1.94 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.692 . . . . 0.0 115.081 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.81 25.25 3.25 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.755 2.121 . . . . 0.0 113.468 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.02 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.222 1.809 . . . . 0.0 110.337 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -140.18 174.83 10.12 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.174 0.988 . . . . 0.0 113.602 -166.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 t -140.36 144.75 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.671 1.988 . . . . 0.0 107.804 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.54 141.26 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.808 1.243 . . . . 0.0 109.087 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -142.56 152.57 42.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.7 1.2 . . . . 0.0 111.764 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -95.0 141.34 28.77 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.857 1.263 . . . . 0.0 110.737 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 125.325 1.45 . . . . 0.0 114.62 -176.459 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 118.69 -0.672 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.25 10.93 0.55 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.555 1.07 . . . . 0.0 114.697 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -146.56 1.94 0.82 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.585 1.954 . . . . 0.0 113.163 -172.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -71.61 -8.13 52.15 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.574 1.949 . . . . 0.0 114.041 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -146.59 165.96 27.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -151.48 160.61 43.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.726 1.611 . . . . 0.0 111.251 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.47 -13.69 62.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -148.38 150.93 34.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.565 1.546 . . . . 0.0 111.377 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -146.34 158.12 43.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.647 1.579 . . . . 0.0 111.126 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -149.29 -30.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m 60.28 13.9 4.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.178 1.791 . . . . 0.0 115.785 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.53 19.66 0.31 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.856 1.217 . . . . 0.0 114.646 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.92 -28.58 63.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.226 1.013 . . . . 0.0 112.969 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 t -63.59 122.97 79.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.914 1.285 . . . . 0.0 111.525 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.24 163.31 3.51 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.16 3.24 . . . . 0.0 115.975 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.17 -7.16 2.05 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.531 1.532 . . . . 0.0 113.731 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.69 172.15 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.928 2.491 . . . . 0.0 109.87 -177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 p -137.02 152.6 50.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.576 1.15 . . . . 0.0 113.235 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.26 145.83 52.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.872 2.069 . . . . 0.0 108.671 168.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -156.54 172.72 18.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.791 1.636 . . . . 0.0 109.712 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 112.76 3.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.206 -0.934 . . . . 0.0 111.846 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.1 -169.16 42.0 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.767 0.699 . . . . 0.0 114.264 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -97.84 138.59 34.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.46 1.504 . . . . 0.0 110.773 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -144.55 172.24 13.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.502 1.521 . . . . 0.0 112.39 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.79 151.1 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 127.002 2.121 . . . . 0.0 108.543 168.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.1 126.66 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.697 1.199 . . . . 0.0 108.159 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.91 155.8 43.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.696 0.76 . . . . 0.0 112.96 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -64.69 136.33 56.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.591 0.756 . . . . 0.0 110.25 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -63.49 -16.82 61.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.48 117.29 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 126.415 1.886 . . . . 0.0 108.8 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.2 mt -56.76 153.38 10.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.692 1.197 . . . . 0.0 111.823 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -65.91 158.56 75.03 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 121.595 -0.691 . . . . 0.0 112.709 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.67 -21.56 19.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.986 3.124 . . . . 0.0 115.186 169.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -66.08 -24.97 66.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.9 1.28 . . . . 0.0 112.98 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.94 26.9 9.27 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.595 1.569 . . . . 0.0 113.399 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -135.75 157.9 45.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.45 1.1 . . . . 0.0 112.479 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.38 142.54 57.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.259 1.024 . . . . 0.0 110.8 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.9 tp -133.32 114.8 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.219 1.408 . . . . 0.0 108.989 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.68 157.36 37.51 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -166.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.05 131.67 48.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.303 1.841 . . . . 0.0 111.317 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -133.71 134.01 42.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.719 1.208 . . . . 0.0 111.696 -170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.82 128.39 92.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.534 1.133 . . . . 0.0 110.511 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.21 -1.81 11.14 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.341 2.694 . . . . 0.0 114.586 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.69 -10.12 60.67 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.293 1.425 . . . . 0.0 114.853 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -153.32 176.08 12.39 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.448 1.499 . . . . 0.0 112.211 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -81.46 168.35 18.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.308 1.043 . . . . 0.0 111.936 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 56.69 36.03 27.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.438 1.495 . . . . 0.0 113.615 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -135.89 154.0 77.47 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.333 1.853 . . . . 0.0 111.056 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.19 143.77 40.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.347 2.698 . . . . 0.0 112.525 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -69.87 135.69 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.246 0.618 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -114.91 178.68 4.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.801 1.241 . . . . 0.0 113.039 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.55 139.51 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.827 -169.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -149.55 161.44 31.69 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 124.442 1.097 . . . . 0.0 113.085 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.24 126.18 21.67 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.476 2.784 . . . . 0.0 112.387 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -63.69 128.9 37.87 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -137.03 -14.87 1.54 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.813 1.645 . . . . 0.0 112.662 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.03 14.28 46.34 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.546 1.069 . . . . 0.0 114.664 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.27 160.6 8.23 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.399 1.48 . . . . 0.0 113.137 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -60.84 -19.83 60.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -85.9 -7.32 58.77 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.839 1.256 . . . . 0.0 113.175 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.82 -13.18 11.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.608 1.563 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.08 148.14 22.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.628 1.171 . . . . 0.0 111.447 174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -139.0 176.79 8.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.603 1.561 . . . . 0.0 110.956 -170.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.63 152.46 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.169 1.387 . . . . 0.0 110.487 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.91 134.64 54.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.282 1.833 . . . . 0.0 107.843 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -138.41 128.14 25.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.639 1.576 . . . . 0.0 109.174 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -65.79 149.11 50.69 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.776 0.431 . . . . 0.0 112.013 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -121.89 -50.73 2.04 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 0.0 111.275 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.97 105.45 2.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.822 0.82 . . . . 0.0 112.082 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.36 -28.45 70.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.822 1.249 . . . . 0.0 113.089 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -66.4 -14.17 61.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.841 1.256 . . . . 0.0 112.836 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -123.25 4.27 9.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.757 1.623 . . . . 0.0 112.768 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 49.22 30.56 3.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.312 1.845 . . . . 0.0 114.053 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 p -101.38 144.7 29.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.89 1.329 . . . . 0.0 112.761 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -142.94 173.26 11.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.954 2.102 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 p -121.59 152.98 38.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.786 1.234 . . . . 0.0 109.293 168.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.3 mt -136.1 133.16 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.412 1.085 . . . . 0.0 109.165 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 148.17 53.0 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.724 0.81 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.72 145.03 28.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.916 2.411 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.08 -22.64 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.97 -19.99 58.44 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.309 0.956 . . . . 0.0 114.75 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -141.56 58.11 8.12 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.829 1.252 . . . . 0.0 112.397 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -68.9 -5.38 15.5 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.551 2.834 . . . . 0.0 113.83 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -65.68 -7.62 16.36 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.101 1.36 . . . . 0.0 113.733 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -146.1 166.97 24.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.382 2.273 . . . . 0.0 110.991 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.98 161.94 36.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.57 1.148 . . . . 0.0 113.001 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 mt -67.08 131.34 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.567 -0.708 . . . . 0.0 109.949 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.85 -171.26 12.45 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.393 1.949 . . . . 0.0 111.369 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -121.74 174.69 6.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.936 0.894 . . . . 0.0 109.774 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.09 20.61 2.3 Favored Glycine 0 N--CA 1.47 0.944 0 O-C-N 121.417 -0.802 . . . . 0.0 113.247 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.46 1.72 0.18 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.456 2.302 . . . . 0.0 116.457 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.78 28.17 17.15 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.403 2.43 . . . . 0.0 113.689 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.5 27.87 14.68 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.19 1.796 . . . . 0.0 115.524 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.15 138.89 19.91 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 125.087 1.355 . . . . 0.0 110.305 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.64 153.0 38.47 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.366 2.044 . . . . 0.0 110.613 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 -179.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.125 2.17 . . . . 0.0 110.294 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.24 131.29 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.147 -0.971 . . . . 0.0 109.659 171.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -141.19 157.9 65.55 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.623 1.569 . . . . 0.0 111.974 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.46 154.0 9.41 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.786 2.99 . . . . 0.0 113.764 169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.26 135.81 30.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.233 2.622 . . . . 0.0 112.254 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -148.59 -86.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.29 1.436 . . . . 0.0 108.893 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.12 13.12 0.5 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.727 1.211 . . . . 0.0 112.703 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.6 127.82 33.45 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.188 -1.57 . . . . 0.0 111.028 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.99 162.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.044 0.938 . . . . 0.0 112.507 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -140.43 145.56 37.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 109.953 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 m -92.31 134.28 35.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.682 1.193 . . . . 0.0 109.625 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.84 74.99 1.17 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.285 1.041 . . . . 0.0 109.555 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 m -71.53 121.09 18.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.157 0.983 . . . . 0.0 111.736 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.67 148.08 49.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.182 0.993 . . . . 0.0 111.356 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -140.23 168.82 18.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.245 1.418 . . . . 0.0 110.958 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 m -57.97 -3.88 0.27 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 -168.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.0 32.94 0.23 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.758 1.17 . . . . 0.0 114.01 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.69 39.89 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 118.559 1.18 . . . . 0.0 113.637 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -116.63 166.04 12.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.315 1.446 . . . . 0.0 112.541 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -134.71 159.43 41.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.592 1.957 . . . . 0.0 109.092 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.78 117.42 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.45 160.59 37.98 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.257 1.023 . . . . 0.0 110.819 -170.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.43 177.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.677 0.751 . . . . 0.0 112.411 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.7 8.6 3.17 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 120.549 -1.345 . . . . 0.0 115.811 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.42 -15.47 5.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.767 1.627 . . . . 0.0 113.47 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 17.1 7.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p -75.01 -16.48 60.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.108 0.963 . . . . 0.0 113.159 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.4 m -144.23 171.98 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 127.355 2.262 . . . . 0.0 110.954 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 t -144.13 155.84 44.1 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.945 1.698 . . . . 0.0 111.298 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -72.56 130.78 41.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 111.324 173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.4 m -141.73 167.69 21.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.91 1.284 . . . . 0.0 112.73 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.53 175.09 5.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.515 2.326 . . . . 0.0 110.857 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.03 -31.43 1.91 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 114.025 -173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -130.54 -21.04 2.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.871 2.068 . . . . 0.0 112.542 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.22 42.95 32.11 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.464 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.5 p -137.09 172.09 13.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.419 1.887 . . . . 0.0 112.08 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.08 131.6 50.38 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.032 -1.042 . . . . 0.0 112.384 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.32 0.79 62.91 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 123.977 0.799 . . . . 0.0 114.012 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.35 158.8 6.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 113.98 172.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.56 142.21 49.86 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.967 1.307 . . . . 0.0 110.346 169.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.99 148.39 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.216 0.532 . . . . 0.0 110.513 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 t -130.39 164.77 23.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.95 1.7 . . . . 0.0 110.82 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.37 131.55 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.919 1.288 . . . . 0.0 109.886 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 173.0 -153.6 18.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.826 1.203 . . . . 0.0 110.966 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.7 143.42 41.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 117.578 0.689 . . . . 0.0 111.208 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.24 167.71 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.854 0.862 . . . . 0.0 112.921 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.71 139.79 29.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.351 1.06 . . . . 0.0 112.508 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.6 t -60.02 -31.38 69.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -169.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -128.56 -5.79 5.25 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 p -131.54 9.84 4.72 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.108 1.363 . . . . 0.0 113.5 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.28 45.61 0.92 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.139 1.828 . . . . 0.0 111.542 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -140.84 144.18 35.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.466 2.307 . . . . 0.0 109.359 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.9 166.47 23.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.386 1.089 . . . . 0.0 112.872 -169.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.7 t -139.62 147.81 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.594 1.958 . . . . 0.0 107.399 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.8 mt -141.51 136.99 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -150.79 144.74 25.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.069 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -83.79 143.26 30.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.12 . . . . 0.0 111.472 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 125.694 1.598 . . . . 0.0 114.609 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.405 0.145 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 175.57 47.53 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.108 0.861 . . . . 0.0 113.345 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -137.55 -3.22 1.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.922 1.289 . . . . 0.0 114.12 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -138.16 -3.18 1.79 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.188 1.795 . . . . 0.0 113.8 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.91 168.18 26.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.106 1.762 . . . . 0.0 110.516 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.64 9.88 7.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.08 1.752 . . . . 0.0 112.702 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 28.2 t-80 -147.54 -169.71 3.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.794 2.038 . . . . 0.0 110.227 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 33.4 p80 -122.82 -0.89 8.98 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.76 1.624 . . . . 0.0 113.42 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 23.6 t-80 -143.38 -160.63 1.13 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.164 2.186 . . . . 0.0 109.747 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 66.1 t60 -67.97 6.03 0.79 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.136 2.174 . . . . 0.0 114.766 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m 54.95 26.38 7.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.76 1.624 . . . . 0.0 114.195 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.31 20.78 1.07 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.279 1.419 . . . . 0.0 114.332 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.95 -11.59 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.95 1.7 . . . . 0.0 114.405 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -135.61 159.83 69.99 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.89 2.076 . . . . 0.0 112.749 -174.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.46 158.71 7.26 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.041 3.16 . . . . 0.0 116.142 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.9 12.55 1.44 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.729 1.611 . . . . 0.0 113.165 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -68.81 166.91 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.683 1.593 . . . . 0.0 113.709 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -142.51 172.09 13.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.791 1.636 . . . . 0.0 110.525 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -119.71 158.33 26.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.98 2.112 . . . . 0.0 111.496 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -151.9 170.04 20.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.058 1.743 . . . . 0.0 110.796 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.36 114.96 4.16 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.659 -0.65 . . . . 0.0 111.667 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.16 -170.47 43.61 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.705 0.642 . . . . 0.0 114.705 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.86 136.83 33.74 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.079 1.351 . . . . 0.0 110.532 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -143.42 171.32 14.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.392 1.477 . . . . 0.0 111.998 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 pt -128.65 149.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.412 1.885 . . . . 0.0 109.074 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.41 129.41 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.79 1.236 . . . . 0.0 108.674 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -144.76 152.76 40.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -74.41 138.86 43.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -57.73 -30.7 65.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.648 1.179 . . . . 0.0 114.169 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.74 3.63 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.3 mt 57.1 -156.18 0.31 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.391 1.076 . . . . 0.0 111.169 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -129.44 143.59 49.51 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.572 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.09 -16.51 4.63 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.443 3.429 . . . . 0.0 115.631 169.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -61.72 -14.48 32.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.706 1.202 . . . . 0.0 114.027 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.73 13.12 51.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.397 1.475 . . . . 0.0 114.003 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.62 169.43 17.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.091 1.756 . . . . 0.0 111.324 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -56.88 149.98 17.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 112.121 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.16 84.17 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.255 1.422 . . . . 0.0 109.348 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 146.0 24.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.028 1.331 . . . . 0.0 114.046 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.26 126.46 27.41 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.552 1.141 . . . . 0.0 110.308 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 m -132.15 127.99 37.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.255 -171.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -62.8 135.48 95.94 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.743 1.617 . . . . 0.0 110.82 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.13 -7.25 19.61 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.242 2.628 . . . . 0.0 114.464 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 -5.59 62.64 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.729 1.156 . . . . 0.0 114.542 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -152.46 167.93 27.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.046 1.338 . . . . 0.0 113.63 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.6 167.02 22.19 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.072 1.749 . . . . 0.0 112.516 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 48.49 36.96 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.793 2.037 . . . . 0.0 114.319 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 m -137.54 139.04 26.06 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 111.022 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.23 146.38 50.24 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.177 3.251 . . . . 0.0 114.914 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.74 159.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.139 0.976 . . . . 0.0 110.975 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -133.62 165.05 25.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.45 1.5 . . . . 0.0 110.747 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.89 141.47 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.246 -0.909 . . . . 0.0 112.643 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -151.19 166.49 14.99 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.715 1.606 . . . . 0.0 111.617 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.62 137.5 58.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.182 2.588 . . . . 0.0 112.582 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.42 125.82 27.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.664 0.745 . . . . 0.0 112.041 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.69 -17.0 5.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.529 2.332 . . . . 0.0 111.299 169.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.44 25.78 62.65 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.435 -0.79 . . . . 0.0 114.567 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.6 p -65.44 173.82 2.47 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.757 1.223 . . . . 0.0 112.968 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -58.35 -19.54 36.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -92.16 -2.38 56.6 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.987 1.315 . . . . 0.0 112.823 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -125.32 -15.8 6.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.062 1.345 . . . . 0.0 114.248 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 140.62 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.628 0.771 . . . . 0.0 109.561 168.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -132.13 175.11 9.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.176 1.39 . . . . 0.0 110.377 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.3 pt -124.7 154.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.175 1.39 . . . . 0.0 109.969 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -124.77 128.43 48.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.89 1.676 . . . . 0.0 107.975 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -134.87 130.26 35.69 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.811 1.244 . . . . 0.0 109.998 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -64.36 147.11 53.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.182 0.593 . . . . 0.0 112.443 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.53 -37.69 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 112.213 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.45 146.47 26.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.064 0.847 . . . . 0.0 113.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -106.29 -10.15 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.69 -18.34 15.88 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.14 1.376 . . . . 0.0 113.221 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.0 m -114.73 2.66 14.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.256 1.822 . . . . 0.0 113.259 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.3 t30 51.22 37.37 18.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 114.064 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.8 p -101.46 145.65 28.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.865 1.317 . . . . 0.0 112.661 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -143.49 169.94 16.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.693 1.997 . . . . 0.0 109.338 -171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.1 p -113.05 151.82 30.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.56 1.144 . . . . 0.0 109.644 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.8 mt -136.32 128.83 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.405 1.082 . . . . 0.0 109.514 -169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 m -140.93 151.06 61.49 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.677 0.791 . . . . 0.0 111.746 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.79 142.76 20.43 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.07 2.513 . . . . 0.0 110.894 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.27 -28.6 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.35 -0.844 . . . . 0.0 112.122 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.58 -13.05 83.01 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.843 -0.976 . . . . 0.0 115.248 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -152.56 57.51 2.14 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.289 1.544 . . . . 0.0 113.238 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.79 -1.92 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.602 2.868 . . . . 0.0 114.154 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.11 -7.94 20.68 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 112.934 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 t -144.88 164.23 31.7 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.529 2.332 . . . . 0.0 110.112 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -140.06 169.01 18.48 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.994 0.918 . . . . 0.0 112.252 -173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -74.87 125.7 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.341 -0.85 . . . . 0.0 109.095 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -134.83 -171.87 12.6 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.58 2.038 . . . . 0.0 111.019 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -123.37 173.87 7.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.303 1.041 . . . . 0.0 109.537 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.66 22.19 1.83 Allowed Glycine 0 N--CA 1.469 0.897 0 O-C-N 121.501 -0.749 . . . . 0.0 113.229 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.65 4.56 0.26 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 127.081 2.152 . . . . 0.0 116.559 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.65 28.48 14.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 127.344 2.402 . . . . 0.0 113.492 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.99 30.27 13.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.267 1.827 . . . . 0.0 115.069 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.68 140.55 22.44 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 125.349 1.46 . . . . 0.0 110.068 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.71 151.67 28.56 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.397 2.065 . . . . 0.0 110.282 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.07 153.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.342 1.457 . . . . 0.0 111.192 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.3 124.75 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.05 135.56 10.34 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.628 0.649 . . . . 0.0 111.92 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -50.74 153.37 8.27 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.971 3.114 . . . . 0.0 114.853 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.91 133.95 30.7 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.134 2.556 . . . . 0.0 112.883 -172.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -145.99 -83.84 0.13 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.749 1.62 . . . . 0.0 108.371 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.57 13.82 0.42 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.499 1.12 . . . . 0.0 112.974 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.71 129.27 39.32 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.372 -1.455 . . . . 0.0 110.77 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.63 161.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.94 0.896 . . . . 0.0 112.285 -173.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -139.87 148.87 42.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.422 1.489 . . . . 0.0 110.109 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -92.35 138.04 31.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.45 1.1 . . . . 0.0 109.757 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.8 74.85 0.91 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.662 1.185 . . . . 0.0 110.192 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -81.47 131.8 35.29 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.095 0.958 . . . . 0.0 112.011 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.44 142.34 32.97 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.323 1.049 . . . . 0.0 110.307 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 70.1 p -139.94 175.38 9.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.596 1.558 . . . . 0.0 111.463 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 p -61.53 -6.27 2.31 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.54 6.81 3.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.772 1.177 . . . . 0.0 115.781 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.42 -175.05 34.18 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.536 1.668 . . . . 0.0 114.549 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -84.65 160.43 20.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.815 1.293 . . . . 0.0 111.127 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -138.66 151.6 47.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.871 1.669 . . . . 0.0 107.583 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.59 122.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -140.97 161.77 37.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.107 0.963 . . . . 0.0 111.69 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.35 165.54 3.54 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.9 5.04 4.95 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -130.1 2.44 4.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.867 2.067 . . . . 0.0 112.111 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.41 23.48 4.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.127 2.571 . . . . 0.0 115.01 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -71.72 -22.41 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.593 -1.317 . . . . 0.0 113.558 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.5 178.45 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 127.051 2.14 . . . . 0.0 111.365 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.4 t -147.0 153.09 39.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.766 1.626 . . . . 0.0 111.823 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -69.42 133.25 47.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.846 0.858 . . . . 0.0 111.307 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.6 p -150.08 174.57 12.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.867 1.267 . . . . 0.0 113.669 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.08 167.92 16.08 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.531 1.932 . . . . 0.0 110.675 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -119.42 -27.62 5.54 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.589 1.156 . . . . 0.0 113.011 -170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -124.99 -6.67 7.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.256 1.822 . . . . 0.0 111.805 171.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.69 43.55 27.84 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.066 1.746 . . . . 0.0 113.939 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 p -138.0 161.8 35.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.444 1.497 . . . . 0.0 112.945 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.26 148.11 23.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.055 . . . . 0.0 113.656 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.4 -10.61 58.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.33 1.443 . . . . 0.0 114.461 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.5 134.83 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.483 1.142 . . . . 0.0 112.15 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.32 123.22 20.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.385 0.674 . . . . 0.0 109.238 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.79 149.94 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.727 -0.608 . . . . 0.0 111.11 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.4 m -128.06 173.66 9.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.794 1.637 . . . . 0.0 111.823 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.65 135.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.301 1.44 . . . . 0.0 109.09 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.8 -161.57 24.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.129 0.871 . . . . 0.0 112.798 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.06 157.57 7.86 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 121.779 -0.836 . . . . 0.0 112.975 171.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.24 151.89 26.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.213 1.405 . . . . 0.0 113.03 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.17 159.71 44.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.129 1.372 . . . . 0.0 112.601 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.2 t -101.93 -22.96 14.2 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -133.2 6.34 3.87 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.018 1.327 . . . . 0.0 113.5 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -142.13 -5.99 0.97 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.643 -1.286 . . . . 0.0 114.046 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.22 37.79 1.46 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.724 1.63 . . . . 0.0 113.001 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -132.96 150.22 52.18 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.426 1.89 . . . . 0.0 108.1 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -134.67 172.11 13.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.198 0.999 . . . . 0.0 112.524 -166.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.74 143.86 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.251 1.82 . . . . 0.0 107.606 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.9 mt -133.77 140.24 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.652 1.181 . . . . 0.0 109.11 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -140.68 147.76 39.75 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.807 1.243 . . . . 0.0 110.806 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.5 143.22 26.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.749 1.22 . . . . 0.0 110.529 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.489 1.504 0 C-N-CA 125.333 1.453 . . . . 0.0 114.705 -177.289 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.94 -29.1 0.02 OUTLIER Glycine 0 N--CA 1.476 1.359 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -128.56 5.41 5.62 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.226 1.41 . . . . 0.0 112.78 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -75.3 179.57 5.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.121 2.568 . . . . 0.0 112.801 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -132.45 19.59 4.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.133 1.373 . . . . 0.0 112.75 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -130.2 12.82 5.61 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.311 1.444 . . . . 0.0 113.702 -169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -128.41 5.15 5.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.216 1.807 . . . . 0.0 113.527 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -145.58 168.76 19.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.192 1.797 . . . . 0.0 111.386 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -149.13 166.24 29.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.429 1.092 . . . . 0.0 111.93 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -137.25 -7.13 1.78 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.214 1.806 . . . . 0.0 114.414 -173.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 m 49.69 27.58 2.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 -26.19 1.36 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.9 1.714 . . . . 0.0 115.141 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.8 134.42 12.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.692 1.597 . . . . 0.0 111.395 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.1 p -148.36 160.38 36.87 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.925 1.69 . . . . 0.0 112.151 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.97 157.91 7.35 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.136 3.224 . . . . 0.0 115.724 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 4.15 2.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.958 1.303 . . . . 0.0 114.206 -175.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 m -140.3 165.07 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.467 1.507 . . . . 0.0 111.811 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -147.81 153.77 39.6 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.25 1.42 . . . . 0.0 109.576 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.8 mt -72.29 149.48 44.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.887 0.851 . . . . 0.0 111.85 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -155.53 171.3 20.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.032 1.733 . . . . 0.0 110.269 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.77 109.97 2.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.085 0.954 . . . . 0.0 111.377 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.46 -168.83 41.68 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.549 -0.72 . . . . 0.0 114.643 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.07 135.47 39.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.09 1.356 . . . . 0.0 110.262 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.7 169.85 16.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.412 1.485 . . . . 0.0 111.662 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 pt -129.49 150.77 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.443 1.897 . . . . 0.0 109.055 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -131.87 129.7 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.372 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -143.2 152.56 41.88 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.973 0.909 . . . . 0.0 111.396 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -73.26 153.09 40.75 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.947 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -73.13 -15.67 61.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.6 -27.22 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.355 1.462 . . . . 0.0 112.93 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.3 mt 57.25 -161.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.705 1.602 . . . . 0.0 111.874 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 p -148.22 155.13 43.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.31 -1.07 9.09 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.878 3.052 . . . . 0.0 113.938 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.37 -20.49 63.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.558 1.143 . . . . 0.0 112.868 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.35 13.7 56.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.805 1.193 . . . . 0.0 113.639 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.53 159.98 41.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.224 1.81 . . . . 0.0 110.187 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -57.46 153.37 12.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.143 0.977 . . . . 0.0 111.191 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.4 111.22 17.88 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.149 1.38 . . . . 0.0 108.13 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.02 158.34 28.01 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.9 120.84 9.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.825 2.05 . . . . 0.0 110.725 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.5 m -133.79 133.46 41.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.185 0.994 . . . . 0.0 110.675 -170.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -62.66 132.65 94.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.112 1.365 . . . . 0.0 111.24 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.18 -4.45 15.43 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.79 2.993 . . . . 0.0 114.579 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 -9.6 60.86 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.225 1.393 . . . . 0.0 114.857 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -154.95 -179.4 8.02 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.125 1.37 . . . . 0.0 112.888 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.29 164.55 19.99 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.575 1.55 . . . . 0.0 111.681 169.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 58.27 36.07 25.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.815 1.646 . . . . 0.0 113.476 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 p -133.73 148.11 67.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 126.581 1.952 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.33 146.98 70.89 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.854 2.369 . . . . 0.0 111.677 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -67.75 143.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.891 -0.506 . . . . 0.0 110.474 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -121.96 170.75 9.5 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.548 1.139 . . . . 0.0 110.487 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.83 150.11 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.133 -0.979 . . . . 0.0 112.44 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.4 t -152.44 152.98 30.07 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.598 1.559 . . . . 0.0 109.999 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.08 135.58 52.13 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.738 2.292 . . . . 0.0 111.946 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 57' ' ' GLY . 3.2 tm? -69.69 126.7 30.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.313 1.054 . . . . 0.0 111.615 -173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -131.55 -7.41 3.68 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.932 2.493 . . . . 0.0 111.29 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 55' ' ' LEU . . . 68.39 27.36 73.81 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.565 1.078 . . . . 0.0 114.298 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.7 p -66.26 171.8 4.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.778 1.231 . . . . 0.0 113.036 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.1 m -56.88 -23.21 42.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 113.619 171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.17 0.61 55.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.649 1.58 . . . . 0.0 112.88 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.12 -15.08 6.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.876 1.67 . . . . 0.0 113.9 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 138.5 35.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.062 0.945 . . . . 0.0 109.97 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -130.79 174.16 10.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.329 1.452 . . . . 0.0 110.435 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.95 152.95 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.605 1.162 . . . . 0.0 109.82 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.08 130.11 52.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.957 1.703 . . . . 0.0 107.972 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -138.43 128.78 25.99 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.78 1.232 . . . . 0.0 109.261 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -63.21 149.27 45.83 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.707 0.803 . . . . 0.0 112.223 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -124.5 -33.39 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.288 1.035 . . . . 0.0 112.351 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -151.42 149.13 28.93 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 112.888 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -109.34 -10.26 14.93 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.49 1.516 . . . . 0.0 114.992 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -102.24 -12.98 17.59 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.424 1.49 . . . . 0.0 113.176 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.8 t -114.25 -2.19 13.41 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.484 1.913 . . . . 0.0 113.065 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 50.91 38.27 19.64 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.657 1.583 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -104.88 141.73 36.0 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.462 1.505 . . . . 0.0 112.523 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -137.5 167.71 21.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.458 1.903 . . . . 0.0 109.899 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.1 p -113.44 152.25 30.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.931 1.292 . . . . 0.0 109.989 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.8 mt -136.66 130.31 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.416 1.086 . . . . 0.0 109.379 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 p -148.57 153.72 40.24 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 123.672 0.789 . . . . 0.0 112.227 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.06 147.53 26.66 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.922 2.415 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.97 -29.8 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 121.376 -0.828 . . . . 0.0 111.951 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.26 -25.72 70.1 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.004 -0.887 . . . . 0.0 115.047 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.9 m -143.26 59.18 7.37 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.675 1.19 . . . . 0.0 113.232 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.1 -5.06 13.82 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.979 3.12 . . . . 0.0 113.546 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.78 5.92 1.72 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.859 2.064 . . . . 0.0 113.635 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -147.84 175.95 10.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.075 2.15 . . . . 0.0 110.453 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -147.53 164.64 32.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.515 0.726 . . . . 0.0 112.486 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.2 mt -77.05 129.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.61 169.77 22.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.643 1.592 . . . . 0.0 110.749 171.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -79.72 -176.03 5.16 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.267 -1.137 . . . . 0.0 109.694 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.42 154.27 25.18 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.051 -1.031 . . . . 0.0 112.102 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.91 -0.02 5.02 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.622 1.569 . . . . 0.0 115.191 -171.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.64 14.68 60.42 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 126.751 2.119 . . . . 0.0 113.936 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 59.1 41.98 19.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.682 1.993 . . . . 0.0 114.109 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.8 m -141.09 154.56 68.18 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.635 1.574 . . . . 0.0 111.07 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.4 140.87 17.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.636 2.224 . . . . 0.0 110.715 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.05 139.4 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.738 2.015 . . . . 0.0 109.385 -172.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.53 123.13 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.644 -0.66 . . . . 0.0 109.578 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.7 mt -136.09 157.24 76.13 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.598 1.159 . . . . 0.0 112.252 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.97 153.83 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.791 2.994 . . . . 0.0 113.487 169.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.8 132.64 29.11 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.128 2.552 . . . . 0.0 111.744 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -140.33 -54.6 0.52 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.819 1.248 . . . . 0.0 110.772 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 p30 136.75 26.5 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 1 C-N-CA 132.814 4.445 . . . . 0.0 112.168 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -54.48 142.91 25.74 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.761 -1.212 . . . . 0.0 109.628 168.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.07 163.49 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -137.21 141.26 42.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.807 1.643 . . . . 0.0 109.344 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -86.57 139.22 31.04 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.88 140.56 49.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.87 0.468 . . . . 0.0 110.144 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 m -137.58 104.36 5.31 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.9 -0.5 . . . . 0.0 111.95 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.1 tp -65.14 148.58 51.42 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.375 1.07 . . . . 0.0 111.544 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.5 p -137.09 176.16 8.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.971 1.709 . . . . 0.0 110.752 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.9 m -61.1 -11.46 8.79 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.16 26.34 0.55 Allowed Glycine 0 CA--C 1.538 1.471 0 CA-C-N 119.35 0.977 . . . . 0.0 115.272 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.91 -173.5 45.11 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.534 1.167 . . . . 0.0 113.783 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.61 165.08 16.25 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.578 1.551 . . . . 0.0 112.028 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -135.09 158.34 44.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.713 1.205 . . . . 0.0 110.575 170.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.7 mt -135.54 119.94 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.381 1.473 . . . . 0.0 107.655 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -134.57 154.88 51.26 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.106 0.962 . . . . 0.0 111.567 -172.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.62 156.05 27.88 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.097 -0.377 . . . . 0.0 111.593 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.36 -19.14 8.02 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 115.669 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -84.36 -13.46 52.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.88 1.84 . . . . 0.0 114.767 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.14 19.68 1.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.668 1.987 . . . . 0.0 115.05 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p -82.13 -17.03 47.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.542 1.137 . . . . 0.0 112.975 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.93 160.23 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.215 1.806 . . . . 0.0 112.163 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 t -127.99 153.47 46.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.657 2.383 . . . . 0.0 110.235 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -69.05 138.78 54.69 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.932 -0.48 . . . . 0.0 110.591 170.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.8 p -144.81 175.5 10.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.905 1.682 . . . . 0.0 113.142 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.53 172.72 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.973 2.109 . . . . 0.0 111.065 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -127.34 -32.06 2.48 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -119.56 -18.51 8.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.027 1.731 . . . . 0.0 111.925 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.9 34.76 17.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.238 1.815 . . . . 0.0 113.462 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.3 p -147.68 158.08 43.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.374 1.47 . . . . 0.0 111.569 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 132.78 47.36 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.357 0.663 . . . . 0.0 111.892 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.24 8.94 28.5 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.604 -174.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -111.99 165.94 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.931 1.365 . . . . 0.0 114.062 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -109.76 152.42 25.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 0.0 111.381 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.36 147.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.979 0.912 . . . . 0.0 110.441 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 m -133.28 171.48 13.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.252 1.821 . . . . 0.0 111.476 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -135.81 140.16 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.751 1.22 . . . . 0.0 109.263 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.32 -165.72 32.46 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.157 0.884 . . . . 0.0 112.921 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.71 162.88 3.64 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.971 -0.723 . . . . 0.0 112.835 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.16 154.04 6.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.679 1.192 . . . . 0.0 113.518 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.04 157.14 45.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.204 1.401 . . . . 0.0 112.279 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -59.79 -39.81 86.21 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.159 1.384 . . . . 0.0 113.829 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -152.54 -27.61 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.7 p -67.98 4.33 1.24 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.24 23.03 3.19 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.571 1.558 . . . . 0.0 113.878 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 145.36 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.293 1.437 . . . . 0.0 109.055 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -134.6 173.5 11.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.089 0.947 . . . . 0.0 112.805 -167.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 20.0 t -143.27 143.65 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 107.846 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.8 140.59 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.852 1.261 . . . . 0.0 108.645 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -141.91 152.32 43.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.703 1.201 . . . . 0.0 111.637 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -96.01 141.89 28.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.686 1.194 . . . . 0.0 110.664 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.381 1.472 . . . . 0.0 114.565 -176.187 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.43 19.23 0.07 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -156.8 171.72 19.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.634 1.574 . . . . 0.0 111.706 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -137.54 0.65 2.29 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.827 1.251 . . . . 0.0 113.757 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.34 -5.31 31.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.537 1.935 . . . . 0.0 114.94 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -57.22 151.1 16.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.325 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -144.25 151.19 39.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.545 1.138 . . . . 0.0 111.934 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -154.96 166.19 34.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.787 1.635 . . . . 0.0 110.942 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -139.12 171.68 13.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 112.592 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -137.96 173.25 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.944 1.298 . . . . 0.0 111.509 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 m 60.19 8.74 1.62 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.887 2.075 . . . . 0.0 115.247 -172.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.48 27.9 0.18 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.636 1.589 . . . . 0.0 113.775 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.63 -24.94 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.129 0.965 . . . . 0.0 112.722 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -150.05 146.36 20.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.425 1.89 . . . . 0.0 109.807 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.93 160.11 4.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.086 3.19 . . . . 0.0 115.349 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -34.12 73.54 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.331 1.052 . . . . 0.0 113.241 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.4 -57.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.676 1.99 . . . . 0.0 109.65 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 t -167.1 2.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 113.041 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.0 mt -53.16 134.58 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.927 -1.108 . . . . 0.0 111.15 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -152.91 172.3 16.99 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.766 1.226 . . . . 0.0 110.674 -168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.16 106.68 3.37 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.531 -0.731 . . . . 0.0 110.474 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.19 -169.37 41.94 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.641 -0.662 . . . . 0.0 114.75 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -95.19 134.78 37.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.889 1.276 . . . . 0.0 110.349 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -142.55 169.4 17.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.673 1.589 . . . . 0.0 111.523 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.52 149.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.067 1.747 . . . . 0.0 109.211 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.39 127.19 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.13 1.372 . . . . 0.0 108.081 -174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -141.67 152.15 43.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.879 0.871 . . . . 0.0 112.572 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.87 135.8 48.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.486 . . . . 0.0 110.697 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -20.8 66.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.708 1.203 . . . . 0.0 114.018 -172.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.18 -6.17 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 mt 54.18 -144.52 0.66 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.916 1.286 . . . . 0.0 110.525 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p -147.56 160.2 39.38 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 119.806 1.185 . . . . 0.0 113.665 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -54.17 -18.67 14.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.456 . . . . 0.0 115.809 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -61.78 -21.07 64.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.286 1.434 . . . . 0.0 113.234 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.83 16.09 62.07 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.97 1.271 . . . . 0.0 113.274 -172.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.39 164.34 28.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.522 1.529 . . . . 0.0 112.252 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -59.7 141.16 55.7 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.448 1.499 . . . . 0.0 111.772 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.0 tp -111.08 84.19 1.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.658 1.583 . . . . 0.0 109.812 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.37 156.69 18.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.486 1.514 . . . . 0.0 114.756 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -77.12 139.09 39.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.13 0.972 . . . . 0.0 111.935 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -134.35 132.93 40.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.305 1.442 . . . . 0.0 110.799 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -63.64 129.6 93.82 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.474 1.51 . . . . 0.0 111.611 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.31 -7.79 20.08 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.857 3.038 . . . . 0.0 114.652 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.81 -9.3 60.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.778 1.18 . . . . 0.0 115.722 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.87 175.81 12.51 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.031 1.416 . . . . 0.0 113.09 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -71.1 167.95 18.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.164 0.986 . . . . 0.0 111.692 169.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 54.33 35.41 22.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.576 1.55 . . . . 0.0 114.146 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -135.36 149.47 69.78 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.142 1.777 . . . . 0.0 110.473 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.66 152.12 42.18 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.042 2.495 . . . . 0.0 112.615 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.36 134.07 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.34 0.656 . . . . 0.0 109.865 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 52' ' ' VAL . 8.3 m -104.88 172.2 6.91 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.392 1.077 . . . . 0.0 110.364 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 20.5 t -134.64 139.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 110.829 -173.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -151.27 163.92 22.01 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.429 1.492 . . . . 0.0 111.864 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 138.76 47.83 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.324 1.35 . . . . 0.0 109.676 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.08 130.58 45.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.674 -0.641 . . . . 0.0 111.673 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -134.4 -21.99 1.76 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.667 1.987 . . . . 0.0 112.03 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.86 14.08 47.64 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.315 0.959 . . . . 0.0 114.886 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t -59.0 156.89 10.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.024 1.33 . . . . 0.0 112.619 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.9 p -59.89 -21.9 61.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.614 1.165 . . . . 0.0 113.145 169.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.3 -12.18 59.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.622 1.169 . . . . 0.0 113.241 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -115.57 -15.57 11.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.328 1.451 . . . . 0.0 113.455 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.99 32.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.137 0.975 . . . . 0.0 110.996 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.18 175.16 9.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.569 1.548 . . . . 0.0 110.332 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.3 pt -125.48 154.82 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.527 1.131 . . . . 0.0 110.005 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.67 135.66 51.46 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.779 2.032 . . . . 0.0 107.435 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -135.32 139.52 44.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 0.0 110.925 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -72.9 55.32 0.39 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.406 2.682 . . . . 0.0 113.592 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.67 -44.11 69.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.386 1.474 . . . . 0.0 113.167 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -146.64 165.37 29.75 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.295 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.6 p -123.49 -23.61 4.76 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.063 1.745 . . . . 0.0 113.215 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -62.92 -26.78 68.97 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.4 m -125.64 12.03 7.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.142 1.777 . . . . 0.0 113.918 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.4 t30 52.1 37.73 22.34 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.259 1.424 . . . . 0.0 113.753 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.8 142.67 34.31 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.054 1.742 . . . . 0.0 113.483 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -138.12 161.29 37.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.907 1.683 . . . . 0.0 110.17 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.9 p -105.4 149.94 25.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.386 0.674 . . . . 0.0 109.973 169.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.08 125.81 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.421 1.088 . . . . 0.0 109.313 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.4 m -140.45 148.09 52.18 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.503 1.121 . . . . 0.0 110.987 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.0 143.63 16.33 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.048 2.499 . . . . 0.0 111.545 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.0 -30.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.39 -0.819 . . . . 0.0 111.867 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.58 -26.18 74.55 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.222 -0.766 . . . . 0.0 114.752 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -146.69 65.9 10.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.704 1.201 . . . . 0.0 112.822 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.41 -15.86 16.46 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.164 3.243 . . . . 0.0 115.595 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -68.88 5.31 1.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.98 2.112 . . . . 0.0 114.705 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 m -133.8 160.85 36.36 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 111.707 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -147.05 144.45 29.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.275 1.83 . . . . 0.0 109.814 -172.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.18 129.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.747 -0.596 . . . . 0.0 110.079 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.73 174.12 24.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.545 1.545 . . . . 0.0 112.366 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.09 153.42 42.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.2 -1.177 . . . . 0.0 110.837 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.32 20.18 10.51 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.916 0.769 . . . . 0.0 114.722 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.66 -3.83 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 128.336 2.654 . . . . 0.0 117.578 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.53 25.82 24.61 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 127.054 2.264 . . . . 0.0 113.142 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.86 43.43 30.15 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.391 1.876 . . . . 0.0 114.035 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.64 149.62 63.07 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 126.382 1.873 . . . . 0.0 110.025 172.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.26 140.97 11.25 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.896 2.398 . . . . 0.0 110.173 169.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.08 155.86 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.913 1.685 . . . . 0.0 111.909 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.57 124.82 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.552 1.141 . . . . 0.0 110.371 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.52 163.71 43.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.945 1.298 . . . . 0.0 111.072 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.45 157.02 57.07 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.179 1.919 . . . . 0.0 111.247 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.84 116.28 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.316 2.678 . . . . 0.0 112.228 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -152.92 57.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.833 1.653 . . . . 0.0 109.895 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 58.79 19.42 6.91 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.7 118.82 13.97 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.946 -1.096 . . . . 0.0 109.943 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.83 157.44 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -140.76 156.7 46.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.308 1.443 . . . . 0.0 110.038 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.9 m -108.44 131.81 54.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.794 1.237 . . . . 0.0 109.923 -173.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.71 112.1 21.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.481 0.712 . . . . 0.0 111.417 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.7 m -130.19 129.93 44.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.206 0.602 . . . . 0.0 112.192 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -86.27 137.67 32.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.583 0.753 . . . . 0.0 111.525 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 77.5 p -132.38 175.12 9.56 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.641 1.577 . . . . 0.0 110.961 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.01 -4.82 0.53 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -173.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.0 -5.76 4.69 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.126 -1.374 . . . . 0.0 115.743 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.88 179.42 33.71 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.001 1.901 . . . . 0.0 114.267 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.91 160.71 30.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.4 1.095 . . . . 0.0 111.576 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -134.6 150.95 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.028 1.731 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.4 mt -135.21 110.37 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.734 1.214 . . . . 0.0 108.419 -173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -133.76 162.77 31.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -66.48 165.88 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.819 1.247 . . . . 0.0 112.965 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.14 -8.03 27.74 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -0.94 13.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.388 1.875 . . . . 0.0 112.175 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 54.55 21.36 3.32 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.672 2.389 . . . . 0.0 115.009 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.4 p -73.49 -19.69 60.87 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.337 -0.852 . . . . 0.0 113.236 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.37 176.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.941 1.696 . . . . 0.0 111.967 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -144.72 152.94 41.16 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.864 2.065 . . . . 0.0 111.081 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -69.24 137.53 53.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.328 0.651 . . . . 0.0 110.884 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.2 p -151.72 174.68 13.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.087 1.355 . . . . 0.0 113.466 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 99.2 mt -135.91 174.36 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.338 2.655 . . . . 0.0 110.083 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -129.94 -22.73 2.86 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -117.87 -15.91 9.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.882 1.673 . . . . 0.0 111.845 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.29 40.81 29.86 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.535 1.934 . . . . 0.0 114.141 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -141.64 165.84 26.37 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.951 1.3 . . . . 0.0 113.258 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.42 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.0 0.92 . . . . 0.0 113.228 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.8 -7.83 64.68 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.176 1.37 . . . . 0.0 113.962 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.19 163.28 28.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.778 1.631 . . . . 0.0 112.812 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -120.69 135.55 55.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.333 1.453 . . . . 0.0 109.475 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.63 145.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 111.478 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.0 m -124.16 167.46 14.23 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.422 1.889 . . . . 0.0 111.351 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.79 135.86 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.899 1.28 . . . . 0.0 109.123 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -177.82 -162.43 27.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.058 0.837 . . . . 0.0 112.687 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.91 158.9 6.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 170.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.96 160.48 14.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.342 1.057 . . . . 0.0 113.52 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.9 170.41 18.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.345 1.458 . . . . 0.0 112.299 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 t -105.22 -27.08 11.77 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -131.35 0.97 4.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.095 1.358 . . . . 0.0 113.881 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p -140.66 4.74 1.96 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -172.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.49 34.41 1.27 Allowed Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.794 1.187 . . . . 0.0 113.582 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -134.68 152.96 52.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.671 1.988 . . . . 0.0 109.138 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -137.76 169.75 17.24 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.7 0.8 . . . . 0.0 112.211 -167.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.94 144.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.177 1.791 . . . . 0.0 107.688 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.09 139.88 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.628 1.171 . . . . 0.0 109.044 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.43 148.12 35.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.892 1.277 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -86.25 145.17 27.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.989 1.316 . . . . 0.0 110.824 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 125.489 1.516 . . . . 0.0 114.647 -179.287 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.24 14.99 0.07 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -141.57 4.63 1.76 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.687 1.195 . . . . 0.0 113.771 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -142.5 9.45 1.81 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.157 1.383 . . . . 0.0 113.473 -171.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -139.1 7.29 2.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.768 1.227 . . . . 0.0 113.752 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -0.83 2.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.446 1.498 . . . . 0.0 113.983 -174.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -155.66 174.08 15.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.339 1.855 . . . . 0.0 110.666 -176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -58.28 154.15 13.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.872 1.269 . . . . 0.0 112.823 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -148.58 166.5 28.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.506 1.122 . . . . 0.0 113.001 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.58 147.81 27.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.817 1.647 . . . . 0.0 110.582 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -149.53 18.98 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.24 -27.87 4.42 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.515 2.007 . . . . 0.0 110.51 -169.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -153.23 172.95 16.19 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.537 1.935 . . . . 0.0 110.233 169.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.9 p -146.1 164.42 25.18 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.145 1.778 . . . . 0.0 112.152 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.14 159.83 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.264 3.31 . . . . 0.0 115.44 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.87 61.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.065 1.346 . . . . 0.0 114.279 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.31 -60.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 108.848 169.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -168.33 16.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.213 1.805 . . . . 0.0 110.793 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.79 148.82 23.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.817 1.247 . . . . 0.0 111.223 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -151.93 166.63 30.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.67 1.188 . . . . 0.0 110.429 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 117.35 5.92 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.586 -0.696 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.48 178.34 47.82 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.032 0.773 . . . . 0.0 115.032 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.85 138.9 31.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.009 1.324 . . . . 0.0 109.621 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.96 167.15 23.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.197 1.399 . . . . 0.0 111.237 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.6 146.51 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.902 1.681 . . . . 0.0 108.413 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.1 127.79 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 107.604 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -144.12 155.32 43.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -62.26 132.17 51.82 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.283 1.033 . . . . 0.0 110.752 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -60.41 -16.33 34.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.0 12.72 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 126.223 1.809 . . . . 0.0 111.754 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.8 mt 58.79 -154.74 0.36 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.059 1.344 . . . . 0.0 112.219 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -137.62 163.22 50.0 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.244 1.417 . . . . 0.0 112.902 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.84 -20.01 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.19 3.26 . . . . 0.0 115.741 170.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -65.2 -17.79 64.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.577 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.52 63.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.038 1.304 . . . . 0.0 113.791 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -137.09 167.74 20.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.644 1.578 . . . . 0.0 111.925 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.74 146.63 10.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.984 1.313 . . . . 0.0 111.653 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -119.71 84.23 2.17 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.854 1.662 . . . . 0.0 109.215 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.91 148.48 22.18 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.71 134.53 57.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.703 0.801 . . . . 0.0 111.41 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.9 m -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.92 1.688 . . . . 0.0 109.894 -172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -111.13 121.03 41.69 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.837 1.655 . . . . 0.0 110.77 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.72 -15.56 13.0 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 116.645 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.56 61.2 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.035 -0.869 . . . . 0.0 115.253 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -146.27 178.88 7.9 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.686 1.243 . . . . 0.0 113.486 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -82.76 155.31 24.32 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.791 1.237 . . . . 0.0 112.258 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 53.66 46.91 24.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.711 1.605 . . . . 0.0 113.089 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -129.3 146.17 59.79 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.236 1.414 . . . . 0.0 111.107 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.2 150.32 71.49 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.626 2.218 . . . . 0.0 111.73 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 p -117.4 174.43 6.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.254 1.022 . . . . 0.0 111.756 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.56 139.12 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.563 0.745 . . . . 0.0 110.942 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -152.93 160.7 30.65 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.047 1.339 . . . . 0.0 111.855 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -45.38 133.77 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.536 2.824 . . . . 0.0 113.29 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -66.22 127.19 31.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.945 0.898 . . . . 0.0 111.761 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -128.2 -17.76 4.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.339 2.256 . . . . 0.0 111.284 169.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.81 72.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.116 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.5 p -66.54 170.43 6.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.774 1.63 . . . . 0.0 113.208 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -60.23 -20.39 58.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.2 5.72 49.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.445 1.498 . . . . 0.0 113.211 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -122.94 -12.27 8.01 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.72 141.15 32.63 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.531 -0.731 . . . . 0.0 110.969 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -131.8 173.41 11.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 110.364 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 pt -127.38 152.85 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 110.845 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.8 131.32 56.85 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.842 2.057 . . . . 0.0 106.965 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -135.21 130.25 34.97 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.787 1.235 . . . . 0.0 108.969 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -65.43 149.23 50.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.694 0.283 . . . . 0.0 111.571 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -127.04 -44.75 1.6 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.766 0.827 . . . . 0.0 111.425 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.98 98.06 2.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.453 1.121 . . . . 0.0 112.649 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -64.37 -19.83 65.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.625 1.57 . . . . 0.0 113.425 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -71.46 -14.01 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.286 170.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -127.54 4.67 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.379 1.471 . . . . 0.0 113.21 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.78 32.84 12.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.826 1.65 . . . . 0.0 113.828 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -106.44 139.53 40.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.57 1.176 . . . . 0.0 113.289 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -141.8 159.81 41.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 109.951 -169.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -99.31 148.7 23.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.735 0.814 . . . . 0.0 109.353 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mt -131.19 132.16 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.065 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.1 p -147.16 154.64 46.42 Favored Pre-proline 0 N--CA 1.473 0.725 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.92 146.2 23.07 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 110.618 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.15 -24.07 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.67 -26.57 74.31 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.884 -0.953 . . . . 0.0 115.134 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 m -147.71 66.36 9.73 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 118.951 1.375 . . . . 0.0 113.722 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.81 -17.1 28.25 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.677 2.918 . . . . 0.0 114.713 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.45 2.79 2.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.855 2.062 . . . . 0.0 114.706 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.9 m -143.35 174.24 10.91 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.474 2.31 . . . . 0.0 109.745 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.34 161.37 40.17 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.213 -0.93 . . . . 0.0 112.32 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.2 mt -77.44 132.76 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 122.835 0.454 . . . . 0.0 110.063 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.84 176.51 22.42 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.479 1.99 . . . . 0.0 111.776 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.96 163.43 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.184 -1.186 . . . . 0.0 110.848 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.7 21.68 5.31 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.198 0.904 . . . . 0.0 114.461 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.32 -1.75 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.048 2.539 . . . . 0.0 117.704 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.66 25.43 22.87 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.071 2.272 . . . . 0.0 113.092 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.07 40.63 31.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.389 1.875 . . . . 0.0 114.332 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 151.29 71.49 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 110.506 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.67 141.39 13.7 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.157 2.571 . . . . 0.0 110.92 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.2 t -137.6 139.28 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 127.081 2.152 . . . . 0.0 109.336 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.14 124.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.926 -0.484 . . . . 0.0 110.086 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.9 mt -139.37 162.81 49.61 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.976 1.71 . . . . 0.0 111.701 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.38 157.36 6.94 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.16 3.24 . . . . 0.0 114.142 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.22 117.34 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.538 2.825 . . . . 0.0 112.465 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -151.38 43.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.15 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 45.72 35.5 2.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.818 2.047 . . . . 0.0 115.047 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -66.57 123.74 20.89 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.684 -1.26 . . . . 0.0 109.767 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.27 156.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -171.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -140.44 157.46 45.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.422 1.489 . . . . 0.0 110.095 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.4 m -104.24 132.64 50.28 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.972 1.309 . . . . 0.0 109.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.07 78.35 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.888 0.851 . . . . 0.0 110.268 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 m -82.16 139.62 34.23 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.674 0.79 . . . . 0.0 111.719 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.3 tp -98.9 150.8 21.54 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.146 1.378 . . . . 0.0 112.038 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 178.71 5.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.404 1.481 . . . . 0.0 111.221 169.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.9 p -60.53 -8.92 3.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.48 32.97 0.22 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.153 0.888 . . . . 0.0 115.025 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.8 47.2 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.817 1.308 . . . . 0.0 113.792 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.59 162.84 23.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.677 1.591 . . . . 0.0 112.259 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.15 157.41 44.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.393 1.477 . . . . 0.0 110.403 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.3 mt -135.56 118.63 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 108.884 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -146.64 164.94 31.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.85 169.96 17.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.8 1.24 . . . . 0.0 112.908 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.13 -16.09 59.48 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -88.91 -18.39 27.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.568 1.684 . . . . 0.0 112.153 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 53.2 22.66 2.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.104 2.162 . . . . 0.0 114.756 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 p -80.14 -17.56 52.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.338 1.055 . . . . 0.0 113.125 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.35 172.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.327 2.251 . . . . 0.0 110.787 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 t -141.57 157.89 44.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.99 1.716 . . . . 0.0 111.026 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 130.7 43.19 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.768 0.827 . . . . 0.0 111.059 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -144.24 168.72 19.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.838 1.255 . . . . 0.0 112.87 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.81 177.16 4.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.362 2.265 . . . . 0.0 110.225 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -123.05 -34.39 3.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -133.44 -13.18 2.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.021 1.728 . . . . 0.0 112.731 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.58 31.34 16.99 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.399 1.48 . . . . 0.0 113.599 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -91.58 164.54 13.73 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.709 1.603 . . . . 0.0 111.937 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.88 143.3 57.75 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.53 -0.731 . . . . 0.0 112.654 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.95 5.75 58.65 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.946 1.26 . . . . 0.0 115.421 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -70.28 135.53 49.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.387 1.593 . . . . 0.0 112.11 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -69.37 131.85 45.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.853 0.861 . . . . 0.0 111.206 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.75 152.17 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.848 0.859 . . . . 0.0 110.094 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.2 t -133.41 170.44 15.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.08 1.752 . . . . 0.0 111.321 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.29 129.69 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 109.104 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.11 -164.81 30.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.768 0.699 . . . . 0.0 113.155 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.17 158.34 9.08 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.986 -0.714 . . . . 0.0 112.856 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.36 144.31 36.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.547 1.139 . . . . 0.0 112.554 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.9 130.52 31.78 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 111.999 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 t -58.29 -31.49 67.53 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.631 1.572 . . . . 0.0 114.971 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -131.91 -3.42 3.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.2 p -133.86 8.23 3.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.04 27.43 3.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.154 1.359 . . . . 0.0 113.677 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -135.91 147.83 48.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.561 1.944 . . . . 0.0 110.703 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -134.8 170.93 15.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.093 0.957 . . . . 0.0 112.618 -168.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.96 146.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.772 2.029 . . . . 0.0 107.589 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.4 141.5 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.366 1.066 . . . . 0.0 108.756 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -140.61 146.71 38.32 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.89 0.876 . . . . 0.0 110.457 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -88.44 134.38 33.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.279 1.032 . . . . 0.0 110.405 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.964 2.106 . . . . 0.0 112.153 -174.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.438 0.161 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.63 178.38 47.21 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.127 0.87 . . . . 0.0 113.506 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.66 0.45 2.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.048 1.339 . . . . 0.0 113.91 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -67.51 -19.54 65.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.849 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.82 2.65 2.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.903 1.681 . . . . 0.0 113.497 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -148.14 164.45 33.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.81 1.644 . . . . 0.0 111.84 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.59 166.07 29.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.579 1.151 . . . . 0.0 112.237 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -150.03 151.31 33.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.395 1.478 . . . . 0.0 110.848 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -161.53 -45.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.074 2.149 . . . . 0.0 110.574 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -151.9 -13.17 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.347 1.859 . . . . 0.0 113.216 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.7 p -62.99 -2.05 1.11 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.82 18.63 3.37 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.791 2.139 . . . . 0.0 114.075 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.93 157.62 30.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.381 1.072 . . . . 0.0 112.796 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -153.02 150.08 23.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.757 1.223 . . . . 0.0 111.356 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.17 159.05 4.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.819 3.013 . . . . 0.0 114.984 169.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.49 14.2 2.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 m -60.9 161.28 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 171.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -57.25 146.4 28.6 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.025 0.916 . . . . 0.0 110.553 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.1 mt -77.86 161.61 27.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.494 1.518 . . . . 0.0 112.361 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -149.88 173.54 13.67 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.251 1.82 . . . . 0.0 110.148 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.62 102.55 1.19 Allowed 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.886 -0.509 . . . . 0.0 110.285 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.05 -177.47 47.61 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -93.9 138.2 32.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.298 1.439 . . . . 0.0 110.814 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -144.49 172.59 12.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.333 1.453 . . . . 0.0 111.805 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.0 pt -128.33 147.77 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.442 1.897 . . . . 0.0 108.977 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.37 130.58 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.903 1.281 . . . . 0.0 108.593 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.71 151.74 41.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.019 0.927 . . . . 0.0 112.514 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.31 148.39 32.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.821 -0.55 . . . . 0.0 111.318 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -59.07 -15.49 14.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.474 1.51 . . . . 0.0 115.011 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -66.92 -20.82 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.99 -165.46 0.06 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.697 1.199 . . . . 0.0 111.232 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -123.1 137.66 28.58 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 120.201 -1.562 . . . . 0.0 112.325 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -52.07 -19.06 8.09 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.585 3.523 . . . . 0.0 115.675 170.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -63.79 -19.65 65.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.553 1.541 . . . . 0.0 113.442 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.51 16.15 23.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.34 1.924 . . . . 0.0 113.625 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.88 177.69 7.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.381 1.872 . . . . 0.0 111.256 -171.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.85 157.91 29.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.235 1.014 . . . . 0.0 111.566 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.1 tp -120.08 84.05 2.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.847 1.659 . . . . 0.0 108.787 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 156.5 19.58 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -69.82 133.76 47.77 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.565 1.546 . . . . 0.0 111.025 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 m -131.9 129.13 39.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.361 1.065 . . . . 0.0 111.286 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.72 129.07 87.31 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.786 1.234 . . . . 0.0 110.394 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.43 -2.23 11.42 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.097 2.531 . . . . 0.0 114.588 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.51 -8.09 68.81 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.698 1.142 . . . . 0.0 114.203 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -154.58 171.65 19.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.646 1.578 . . . . 0.0 112.856 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -88.17 171.68 10.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.621 1.568 . . . . 0.0 112.021 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 53.41 31.54 12.25 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.962 1.705 . . . . 0.0 113.333 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -140.02 142.07 29.18 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.565 1.946 . . . . 0.0 110.05 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 148.51 77.04 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.31 2.673 . . . . 0.0 113.719 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.81 140.49 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.647 0.779 . . . . 0.0 111.447 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -105.56 167.96 9.41 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.75 1.22 . . . . 0.0 110.885 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.08 132.19 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.088 1.755 . . . . 0.0 109.959 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -150.27 160.54 32.98 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.86 1.264 . . . . 0.0 112.06 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 136.6 35.09 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.507 2.805 . . . . 0.0 112.762 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -64.55 130.54 44.05 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.694 0.759 . . . . 0.0 111.677 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -131.33 -21.04 2.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.405 2.282 . . . . 0.0 111.496 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.68 18.88 55.81 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.966 0.793 . . . . 0.0 114.657 172.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -65.77 167.0 9.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.499 1.12 . . . . 0.0 112.469 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.6 p -59.82 -24.49 64.21 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.27 -13.32 60.42 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.409 1.083 . . . . 0.0 113.074 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -116.89 -14.44 10.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.53 143.05 31.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.81 0.844 . . . . 0.0 110.512 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -134.22 172.55 12.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.327 1.451 . . . . 0.0 110.155 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 pt -124.84 151.9 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.442 1.097 . . . . 0.0 110.497 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.44 133.57 54.44 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.193 1.797 . . . . 0.0 107.601 171.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -137.86 123.62 19.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.179 1.392 . . . . 0.0 109.331 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.3 t -61.56 148.37 42.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.691 0.796 . . . . 0.0 112.205 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -128.24 -39.18 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.214 1.006 . . . . 0.0 112.09 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.36 167.06 28.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.952 0.901 . . . . 0.0 111.581 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.7 p -124.15 -21.91 4.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.015 2.126 . . . . 0.0 112.775 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -69.36 -22.77 63.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.625 1.57 . . . . 0.0 112.523 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.7 p -128.21 2.19 5.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.812 1.645 . . . . 0.0 114.507 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.08 43.23 29.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.931 1.292 . . . . 0.0 113.802 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -104.43 141.59 36.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 122.913 1.34 . . . . 0.0 112.944 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -140.63 173.2 11.73 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.188 1.795 . . . . 0.0 109.414 -174.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.9 p -118.68 154.47 32.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.136 0.975 . . . . 0.0 110.279 168.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.6 mt -135.83 132.88 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.564 1.146 . . . . 0.0 109.019 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -140.5 145.99 43.16 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.17 140.08 17.42 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.001 2.467 . . . . 0.0 111.235 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.88 -28.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.442 -0.786 . . . . 0.0 111.639 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.43 -14.11 82.28 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.826 1.203 . . . . 0.0 115.205 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -151.28 64.22 6.0 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.347 1.573 . . . . 0.0 113.082 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.15 -14.49 19.52 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.463 3.442 . . . . 0.0 115.95 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -67.53 -3.12 7.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 113.958 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.5 p -136.92 174.22 10.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.433 1.493 . . . . 0.0 113.486 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -148.81 145.54 27.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.117 2.167 . . . . 0.0 110.129 -168.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.13 126.5 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.435 -0.791 . . . . 0.0 109.552 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.7 -167.64 11.93 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.573 1.559 . . . . 0.0 112.567 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.536 ' O ' ' H82' ' A' ' 154' ' ' NAG . 8.2 t90 -136.12 172.58 12.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.531 1.532 . . . . 0.0 108.677 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.47 23.41 2.52 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.777 0.703 . . . . 0.0 113.209 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.99 4.74 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.088 2.155 . . . . 0.0 116.382 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.79 31.09 9.14 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.34 2.4 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.5 m120 58.35 23.2 10.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.936 1.694 . . . . 0.0 115.546 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.18 138.4 17.76 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 124.873 1.269 . . . . 0.0 110.202 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.56 157.72 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.19 1.927 . . . . 0.0 110.629 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.93 -179.67 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.943 2.097 . . . . 0.0 110.303 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.32 129.28 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.41 -0.806 . . . . 0.0 109.887 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.01 164.03 31.94 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.511 1.524 . . . . 0.0 111.094 -170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.86 152.67 16.88 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.74 2.294 . . . . 0.0 112.65 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.86 123.77 12.13 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.161 2.574 . . . . 0.0 111.896 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -149.88 39.42 0.78 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.48 1.512 . . . . 0.0 110.615 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 47.87 40.45 12.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.655 1.582 . . . . 0.0 113.551 -173.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CE1' ' H83' ' A' ' 154' ' ' NAG . 36.9 m-85 -70.81 70.34 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.105 -0.997 . . . . 0.0 110.497 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.89 153.79 8.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.589 0.755 . . . . 0.0 112.068 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -136.98 154.3 50.46 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.455 1.502 . . . . 0.0 109.711 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 m -93.29 134.86 35.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.748 1.219 . . . . 0.0 109.614 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.63 76.16 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.798 0.809 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.0 m -78.43 100.71 6.94 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.607 -0.683 . . . . 0.0 111.58 -174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.5 tp -63.67 149.16 47.21 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.335 1.454 . . . . 0.0 111.717 171.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 p -131.68 179.46 6.04 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.269 1.428 . . . . 0.0 111.314 171.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.6 p -61.87 -8.47 5.02 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.04 23.28 0.21 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.596 0.999 . . . . 0.0 115.596 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.9 -170.13 41.1 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.054 1.427 . . . . 0.0 113.735 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -130.14 163.78 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.723 1.609 . . . . 0.0 112.29 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -135.88 155.1 50.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.786 1.234 . . . . 0.0 109.696 169.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -135.29 114.27 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.044 0.937 . . . . 0.0 109.393 -173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -139.07 165.38 27.28 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.152 0.981 . . . . 0.0 112.727 -169.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.72 166.42 22.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.615 1.166 . . . . 0.0 111.868 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.31 -11.77 28.61 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.78 -6.83 13.27 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.895 2.078 . . . . 0.0 111.889 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.84 27.58 2.39 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.129 2.571 . . . . 0.0 114.002 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p -70.06 -18.28 63.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.983 0.913 . . . . 0.0 112.501 171.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.51 174.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.425 1.89 . . . . 0.0 111.557 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -143.25 152.7 42.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.16 1.784 . . . . 0.0 110.813 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -71.05 131.32 43.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.259 0.624 . . . . 0.0 110.805 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -143.98 167.18 22.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.558 1.143 . . . . 0.0 113.167 -176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.2 mt -129.62 168.83 15.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.448 1.899 . . . . 0.0 111.169 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -136.07 -22.82 1.36 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -171.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -113.42 -22.52 10.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.296 1.438 . . . . 0.0 111.729 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.96 38.36 28.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.709 2.004 . . . . 0.0 114.617 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.0 p -142.92 169.83 16.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.704 1.202 . . . . 0.0 113.643 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.44 36.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.776 1.23 . . . . 0.0 113.686 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.93 4.59 77.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.194 0.902 . . . . 0.0 114.869 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -68.97 163.29 24.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.757 1.223 . . . . 0.0 111.875 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -125.24 139.97 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.71 1.204 . . . . 0.0 109.206 174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 146.4 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.801 0.44 . . . . 0.0 111.117 -176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 t -122.18 161.27 23.49 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.052 1.341 . . . . 0.0 110.75 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -135.55 122.49 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.406 1.482 . . . . 0.0 109.012 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.94 -162.64 24.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.096 0.855 . . . . 0.0 112.107 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.01 157.66 4.39 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.49 160.69 8.5 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.761 1.224 . . . . 0.0 113.921 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.22 155.76 43.45 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.207 1.403 . . . . 0.0 112.266 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -86.86 -21.95 26.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.27 -19.3 2.49 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.2 p -130.05 1.71 4.76 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.47 24.53 22.12 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.573 1.559 . . . . 0.0 113.15 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -137.02 159.35 42.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.858 2.063 . . . . 0.0 109.863 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -138.85 172.3 13.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.896 0.855 . . . . 0.0 111.832 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.82 146.67 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 108.147 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.04 141.69 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.761 1.224 . . . . 0.0 109.092 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.78 147.2 40.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.205 1.402 . . . . 0.0 110.61 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.24 143.37 26.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.711 1.204 . . . . 0.0 110.586 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 125.206 1.402 . . . . 0.0 114.697 -177.317 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . 0.536 ' H82' ' O ' ' A' ' 89' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.59 179.14 45.93 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.36 0.981 . . . . 0.0 113.13 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -131.82 -2.97 3.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.66 1.184 . . . . 0.0 113.907 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.93 153.02 40.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.701 . . . . 0.0 110.938 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -135.77 -0.22 2.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.777 1.231 . . . . 0.0 113.594 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -158.34 170.37 22.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.65 1.98 . . . . 0.0 110.856 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -139.31 24.08 2.51 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 112.043 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.49 -0.59 4.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.156 1.382 . . . . 0.0 114.276 -168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -146.49 159.25 43.65 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.469 1.907 . . . . 0.0 109.52 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t60 61.07 -23.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.975 2.51 . . . . 0.0 116.766 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -133.79 10.8 3.98 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.161 2.584 . . . . 0.0 112.026 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.78 0.7 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.726 1.631 . . . . 0.0 114.438 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.1 152.69 32.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.132 1.773 . . . . 0.0 110.471 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 t -156.44 147.29 16.36 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.228 1.011 . . . . 0.0 111.99 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.81 163.78 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.536 3.491 . . . . 0.0 115.73 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.15 -8.22 20.64 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.61 163.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.607 1.163 . . . . 0.0 112.834 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -132.54 7.54 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.181 1.393 . . . . 0.0 112.671 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.99 154.48 12.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -150.39 173.82 13.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 111.211 -170.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.03 113.52 5.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.657 0.783 . . . . 0.0 110.573 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.71 -167.18 38.47 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.743 -0.598 . . . . 0.0 114.454 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.438 HD21 ' CG2' ' A' ' 80' ' ' VAL . 12.0 t-20 -113.43 134.8 54.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.944 1.698 . . . . 0.0 107.713 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -142.17 168.79 18.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.358 1.463 . . . . 0.0 111.001 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.2 pt -127.13 145.53 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 108.443 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.56 128.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.833 1.253 . . . . 0.0 108.304 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -141.8 151.23 42.63 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.797 0.839 . . . . 0.0 112.43 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -72.67 139.6 47.38 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.765 -0.585 . . . . 0.0 110.76 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -23.98 65.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.505 1.122 . . . . 0.0 113.92 -173.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.13 -19.28 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.481 1.112 . . . . 0.0 112.87 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 20.1 mt 56.63 -159.43 0.23 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.926 1.29 . . . . 0.0 111.074 -169.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.5 t -117.87 139.85 26.99 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.102 0.961 . . . . 0.0 111.656 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.33 -19.18 6.22 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.746 3.631 . . . . 0.0 115.659 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -60.9 -22.65 64.55 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.596 1.158 . . . . 0.0 113.795 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.5 15.92 17.61 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.951 1.739 . . . . 0.0 114.019 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.44 167.89 20.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.684 1.594 . . . . 0.0 111.692 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.03 152.46 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 0.0 111.645 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.08 86.57 2.57 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.649 1.58 . . . . 0.0 109.454 -172.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 152.27 20.3 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -167.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.54 128.03 33.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.257 . . . . 0.0 110.365 170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.6 m -131.29 128.65 40.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.723 1.209 . . . . 0.0 110.619 -170.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.75 131.49 88.77 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.531 1.532 . . . . 0.0 111.386 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.69 -8.85 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.115 2.544 . . . . 0.0 114.333 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.98 -9.14 61.5 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.58 1.086 . . . . 0.0 114.95 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -154.26 171.37 19.34 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.667 1.234 . . . . 0.0 114.131 -174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -74.92 163.6 27.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 49.63 33.59 6.17 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.602 1.961 . . . . 0.0 114.043 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -135.61 134.1 20.67 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.812 1.645 . . . . 0.0 109.823 -169.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.28 139.97 62.89 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.963 3.109 . . . . 0.0 113.991 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.23 142.92 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.338 0.655 . . . . 0.0 111.105 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -101.29 169.19 9.06 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.837 1.255 . . . . 0.0 110.958 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -138.44 128.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.858 1.663 . . . . 0.0 109.556 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.0 m -150.19 159.97 34.19 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.998 1.319 . . . . 0.0 111.588 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 140.12 36.29 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.326 2.684 . . . . 0.0 112.746 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.98 128.12 35.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.797 0.808 . . . . 0.0 111.791 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.13 -18.69 3.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.822 2.449 . . . . 0.0 111.429 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 23.24 61.19 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.488 -0.758 . . . . 0.0 114.67 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -66.02 171.72 4.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 0.0 112.932 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.9 p -59.17 -18.88 40.2 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.81 -3.23 58.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.034 1.334 . . . . 0.0 112.713 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -124.19 -15.26 6.81 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.924 1.29 . . . . 0.0 113.956 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.69 146.44 29.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -139.33 168.3 20.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.056 1.342 . . . . 0.0 109.202 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -122.84 148.25 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.616 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.86 133.09 55.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.984 1.713 . . . . 0.0 106.988 172.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.55 136.2 39.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.123 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 t -66.27 146.55 54.48 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.888 0.475 . . . . 0.0 111.523 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -126.46 -41.5 1.87 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.27 149.82 24.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.902 0.881 . . . . 0.0 112.42 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 p -105.73 -24.23 12.56 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 113.39 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -67.25 -22.67 65.67 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.131 1.372 . . . . 0.0 112.868 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.8 p -127.11 6.58 6.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.681 1.993 . . . . 0.0 114.182 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.1 t30 51.16 43.46 29.15 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.608 1.563 . . . . 0.0 114.119 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 p -109.63 145.45 36.42 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.204 1.478 . . . . 0.0 113.619 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.35 162.44 35.46 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.301 1.84 . . . . 0.0 110.099 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -106.55 152.58 23.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.476 0.71 . . . . 0.0 109.775 168.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.51 130.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.382 1.073 . . . . 0.0 109.256 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.3 m -140.34 146.6 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.524 1.13 . . . . 0.0 111.1 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 149.56 25.04 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.518 2.812 . . . . 0.0 111.476 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' CG2' HD21 ' A' ' 23' ' ' ASN . 71.0 t -68.37 -29.13 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.442 -0.786 . . . . 0.0 112.76 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.34 -20.03 75.66 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 123.993 0.806 . . . . 0.0 114.87 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -148.41 59.69 4.53 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.298 1.439 . . . . 0.0 112.751 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.67 -5.58 15.73 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.389 2.726 . . . . 0.0 113.68 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -65.18 -10.33 30.45 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.377 1.471 . . . . 0.0 113.336 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -137.6 167.76 21.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.106 2.162 . . . . 0.0 111.247 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.3 165.45 27.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.045 1.338 . . . . 0.0 111.804 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.0 mt -79.32 132.12 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 121.612 -0.68 . . . . 0.0 109.985 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.25 173.91 25.49 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.478 1.513 . . . . 0.0 112.372 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.71 154.06 40.88 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.305 1.053 . . . . 0.0 110.445 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.62 22.24 7.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.103 0.859 . . . . 0.0 114.469 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.35 0.15 0.09 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.962 2.505 . . . . 0.0 117.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.96 23.23 31.42 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 127.052 2.263 . . . . 0.0 113.549 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 51.51 39.52 24.84 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.38 1.872 . . . . 0.0 114.287 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.52 152.66 66.97 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.111 1.764 . . . . 0.0 109.728 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.55 145.44 20.75 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.31 2.007 . . . . 0.0 110.232 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.92 157.15 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.495 1.518 . . . . 0.0 111.066 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.28 127.8 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 109.406 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 tp -150.79 147.26 20.64 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 119.219 -0.419 . . . . 0.0 111.223 -176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 158.9 55.87 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.253 1.969 . . . . 0.0 112.764 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.73 121.77 9.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.295 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.43 40.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.499 1.92 . . . . 0.0 110.141 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 47.87 36.5 6.08 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.197 1.799 . . . . 0.0 114.579 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -65.76 126.06 27.26 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.699 -1.251 . . . . 0.0 109.711 170.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 m -128.48 157.84 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.965 0.906 . . . . 0.0 111.713 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -138.38 156.03 47.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.176 1.391 . . . . 0.0 109.806 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.3 m -102.1 136.02 42.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.688 1.595 . . . . 0.0 108.911 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.97 137.19 53.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.1 m -139.32 140.83 37.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.748 0.419 . . . . 0.0 110.723 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.86 142.33 44.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.184 0.994 . . . . 0.0 110.992 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.6 p -140.45 172.63 12.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.017 1.727 . . . . 0.0 111.855 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -6.7 2.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -131.05 4.95 5.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.163 1.363 . . . . 0.0 115.644 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.07 -176.22 26.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.163 1.481 . . . . 0.0 114.128 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -78.84 162.18 26.25 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.468 1.128 . . . . 0.0 111.41 168.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -137.26 159.15 42.75 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.99 2.116 . . . . 0.0 109.411 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -134.91 126.83 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.739 1.216 . . . . 0.0 107.98 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -138.66 177.66 7.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.356 1.862 . . . . 0.0 110.578 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.88 178.51 4.54 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.226 1.411 . . . . 0.0 112.111 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 -38.31 94.01 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.489 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -71.61 -19.22 62.15 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 119.174 1.487 . . . . 0.0 113.306 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.37 6.15 2.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.831 2.453 . . . . 0.0 114.563 -170.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p -79.49 -14.21 59.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.978 . . . . 0.0 113.319 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.09 168.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.129 1.372 . . . . 0.0 112.948 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.4 t -144.69 149.34 35.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.99 2.116 . . . . 0.0 110.612 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -72.39 144.52 48.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.858 -0.526 . . . . 0.0 111.393 174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.6 p -150.63 170.67 18.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.02 164.83 13.29 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.603 1.561 . . . . 0.0 112.093 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -105.14 -30.53 9.66 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -144.63 -8.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.979 1.712 . . . . 0.0 113.905 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.69 48.21 21.84 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.376 1.47 . . . . 0.0 114.214 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.0 p -130.85 170.2 14.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.404 1.081 . . . . 0.0 112.37 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.04 149.35 41.25 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.729 1.212 . . . . 0.0 114.026 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.17 81.65 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.294 0.949 . . . . 0.0 114.975 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.83 172.72 12.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.452 1.501 . . . . 0.0 112.322 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -124.25 134.42 53.25 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.8 -1.187 . . . . 0.0 109.552 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.83 145.75 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.317 0.579 . . . . 0.0 110.579 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 t -129.41 169.44 14.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.147 1.379 . . . . 0.0 111.394 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.45 134.74 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.99 1.316 . . . . 0.0 109.351 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.41 174.79 38.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.701 1.143 . . . . 0.0 111.59 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.54 73.1 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -168.62 167.8 11.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.067 2.547 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.83 139.83 26.65 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.356 -0.84 . . . . 0.0 112.429 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 t -81.33 -22.79 38.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.97 -12.48 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.6 p -135.13 7.35 3.4 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -167.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.83 29.21 9.51 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.206 1.384 . . . . 0.0 114.508 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -131.28 149.71 52.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.039 1.735 . . . . 0.0 110.8 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -139.33 168.32 20.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.673 1.189 . . . . 0.0 111.626 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.91 143.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.541 1.537 . . . . 0.0 107.898 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.69 140.8 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 108.4 -174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.93 146.31 37.21 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.89 0.876 . . . . 0.0 110.716 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -91.26 138.46 31.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.552 1.141 . . . . 0.0 110.437 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.259 1.824 . . . . 0.0 112.106 -173.607 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.54 175.21 46.19 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.009 0.814 . . . . 0.0 113.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -139.71 -0.79 1.7 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.127 1.371 . . . . 0.0 114.324 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -71.47 -6.27 39.19 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 114.089 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.99 170.49 17.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.406 2.282 . . . . 0.0 111.168 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -155.68 163.66 39.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 110.318 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -55.73 -20.54 14.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.461 1.904 . . . . 0.0 115.476 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -114.02 11.21 17.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.17 1.788 . . . . 0.0 112.985 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -131.65 3.37 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.871 1.668 . . . . 0.0 113.484 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -62.62 161.96 11.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.577 1.151 . . . . 0.0 112.83 169.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -130.95 8.2 4.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.738 1.215 . . . . 0.0 114.143 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.86 23.8 0.2 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.829 1.204 . . . . 0.0 114.297 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.38 -27.0 0.2 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -153.26 146.95 18.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 125.148 1.379 . . . . 0.0 110.827 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.86 168.22 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.212 3.275 . . . . 0.0 115.601 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.42 5.15 2.46 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.001 1.32 . . . . 0.0 114.091 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.42 162.05 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 0.0 111.266 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -152.95 159.89 42.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.393 1.477 . . . . 0.0 109.972 171.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.35 141.16 39.15 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.295 1.438 . . . . 0.0 110.687 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -159.02 168.72 26.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.69 2.396 . . . . 0.0 109.771 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 119.67 9.9 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.601 -0.687 . . . . 0.0 112.028 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.71 42.71 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.066 0.786 . . . . 0.0 115.066 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -88.97 136.53 32.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.959 1.303 . . . . 0.0 110.372 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -143.72 170.66 15.44 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.567 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.2 150.19 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.395 1.878 . . . . 0.0 108.714 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.87 125.65 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.421 1.089 . . . . 0.0 108.368 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -140.95 150.5 43.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.062 0.945 . . . . 0.0 110.989 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -76.99 159.98 29.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.544 -0.722 . . . . 0.0 111.736 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -73.57 -5.07 37.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.49 -25.03 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 112.597 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mp 55.67 -157.22 0.24 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.109 1.764 . . . . 0.0 111.059 -172.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.3 t -128.74 140.34 38.24 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.4 1.08 . . . . 0.0 111.876 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.31 -8.27 18.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.681 2.921 . . . . 0.0 113.757 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtp-105 -59.34 -25.56 64.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.287 1.035 . . . . 0.0 113.052 168.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.74 9.77 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.655 1.598 . . . . 0.0 114.261 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -136.07 163.93 29.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.586 1.554 . . . . 0.0 111.405 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -65.48 158.16 27.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 0.0 111.571 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.0 tp -131.54 114.55 15.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.502 1.521 . . . . 0.0 108.74 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.49 156.24 41.04 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.35 124.86 23.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.277 1.431 . . . . 0.0 110.755 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.4 m -131.68 128.67 39.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.476 1.111 . . . . 0.0 111.017 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -58.48 132.12 85.22 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.398 1.479 . . . . 0.0 110.816 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.59 -6.33 18.85 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.984 2.456 . . . . 0.0 114.646 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.16 62.58 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.189 1.376 . . . . 0.0 114.455 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.4 172.59 17.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.434 1.494 . . . . 0.0 113.281 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -81.58 166.92 19.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 113.719 -171.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 48.71 41.04 17.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.804 2.042 . . . . 0.0 113.512 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 m -142.27 140.18 18.83 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 109.887 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 147.01 72.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.799 2.333 . . . . 0.0 112.686 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.95 145.99 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.352 0.661 . . . . 0.0 111.17 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -111.58 171.77 7.29 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.974 1.31 . . . . 0.0 110.229 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -139.03 131.25 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.974 1.31 . . . . 0.0 109.596 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -146.63 159.73 43.37 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.468 1.507 . . . . 0.0 110.489 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.01 144.22 99.49 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.851 1.701 . . . . 0.0 111.357 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.24 125.92 28.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.652 0.739 . . . . 0.0 112.033 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -131.76 -19.17 2.66 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.433 2.293 . . . . 0.0 111.699 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.23 25.64 63.39 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 121.398 -0.814 . . . . 0.0 114.496 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.0 p -66.43 173.81 3.09 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.028 1.331 . . . . 0.0 113.265 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -60.33 -14.38 18.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -96.25 -1.19 48.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.969 1.308 . . . . 0.0 112.839 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -124.32 -15.66 6.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.004 1.321 . . . . 0.0 114.18 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.66 143.94 30.61 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.811 0.815 . . . . 0.0 110.111 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -134.8 175.35 9.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.549 1.54 . . . . 0.0 110.133 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.28 150.53 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.715 1.206 . . . . 0.0 109.436 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.54 124.77 39.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.073 1.749 . . . . 0.0 107.245 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.42 137.12 43.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.299 1.039 . . . . 0.0 110.738 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 t -66.07 147.12 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.978 0.511 . . . . 0.0 111.815 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -129.1 -42.57 1.37 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.823 0.849 . . . . 0.0 112.407 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.49 130.78 10.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 175.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.8 p -81.89 -28.03 33.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.011 1.724 . . . . 0.0 114.02 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -63.77 -25.3 68.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.27 1.028 . . . . 0.0 112.507 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 m -121.57 0.31 9.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.871 1.668 . . . . 0.0 113.389 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.9 t30 49.07 45.08 23.1 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.996 1.718 . . . . 0.0 113.115 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -108.1 142.42 38.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.589 1.556 . . . . 0.0 112.411 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -138.8 164.29 30.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.222 1.809 . . . . 0.0 109.582 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -110.32 148.67 31.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.53 1.132 . . . . 0.0 110.16 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.45 127.43 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 110.043 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -140.91 150.05 58.18 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.309 1.044 . . . . 0.0 111.575 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.34 146.9 28.5 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.097 2.531 . . . . 0.0 110.986 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.69 -25.31 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.04 -19.96 58.36 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.109 0.861 . . . . 0.0 114.734 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.3 m -142.48 56.85 5.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.67 1.188 . . . . 0.0 112.941 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.9 -1.81 8.43 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.588 2.859 . . . . 0.0 114.11 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -65.27 -7.13 11.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.709 1.603 . . . . 0.0 113.541 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.8 m -147.41 166.44 27.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.616 2.366 . . . . 0.0 110.288 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -143.6 164.74 29.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.032 1.333 . . . . 0.0 111.828 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mt -74.89 130.7 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.722 -0.611 . . . . 0.0 110.62 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.18 179.09 20.34 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.08 1.8 . . . . 0.0 111.869 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.81 21.33 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.472 -1.017 . . . . 0.0 110.594 173.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.57 23.2 3.44 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.073 0.844 . . . . 0.0 114.304 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.6 -1.47 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.948 2.499 . . . . 0.0 117.594 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.56 24.37 25.91 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.107 2.289 . . . . 0.0 113.342 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 50.84 44.18 28.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.389 1.876 . . . . 0.0 114.308 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.91 152.29 67.51 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.947 1.699 . . . . 0.0 110.22 171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 142.46 17.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.732 2.288 . . . . 0.0 110.832 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -138.6 138.82 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.969 2.108 . . . . 0.0 109.549 -171.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.09 122.75 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.836 -0.54 . . . . 0.0 110.044 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -141.12 157.19 67.35 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.04 1.336 . . . . 0.0 112.243 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.34 156.66 5.42 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.216 3.277 . . . . 0.0 114.697 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.86 105.84 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.924 3.083 . . . . 0.0 112.789 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.8 47.12 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.336 1.855 . . . . 0.0 110.328 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HB3' ' H82' ' A' ' 155' ' ' MAG . 27.2 m120 55.49 26.25 8.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.557 1.943 . . . . 0.0 115.839 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -66.03 120.64 13.5 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.558 -1.339 . . . . 0.0 110.699 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.84 159.51 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.698 1.199 . . . . 0.0 111.91 -173.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -140.89 154.13 46.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.483 1.113 . . . . 0.0 110.703 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -95.72 133.01 40.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.409 1.484 . . . . 0.0 109.522 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.51 135.88 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.657 0.783 . . . . 0.0 110.368 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.1 m -134.58 129.95 35.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 111.791 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.1 tp -87.26 147.96 25.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.161 0.984 . . . . 0.0 112.111 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -131.63 177.25 7.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.28 1.432 . . . . 0.0 111.322 169.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.4 p -62.99 -8.28 6.95 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.76 26.41 0.39 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.937 -0.924 . . . . 0.0 115.38 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.65 45.31 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 118.823 1.312 . . . . 0.0 114.088 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -123.03 164.31 18.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.236 1.814 . . . . 0.0 111.039 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -134.08 155.87 49.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.023 1.329 . . . . 0.0 111.49 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.8 112.22 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.524 1.53 . . . . 0.0 108.931 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -136.55 165.92 24.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.68 1.192 . . . . 0.0 112.168 -172.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -76.12 164.21 26.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.54 -7.21 5.54 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HE2' ' H61' ' A' ' 154' ' ' NAG . 1.9 mptp? -119.76 1.95 11.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.078 1.939 . . . . 0.0 113.059 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 60.85 17.24 7.56 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.525 1.93 . . . . 0.0 114.906 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.3 p -79.4 -17.58 54.07 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.003 -1.06 . . . . 0.0 113.645 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.45 174.1 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.686 1.594 . . . . 0.0 112.679 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -146.58 146.6 30.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.583 1.953 . . . . 0.0 111.108 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -70.17 137.68 51.2 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.915 -0.491 . . . . 0.0 111.055 173.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -149.37 171.89 15.81 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.11 170.72 9.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.978 2.111 . . . . 0.0 110.688 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -131.14 -30.66 1.73 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.01 -22.24 3.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 112.406 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.18 46.51 26.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.608 1.563 . . . . 0.0 114.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 p -139.29 169.18 18.24 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.868 2.067 . . . . 0.0 111.457 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.48 57.44 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.004 -1.06 . . . . 0.0 112.358 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.22 8.64 66.27 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.937 0.78 . . . . 0.0 113.94 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.93 165.5 5.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 114.37 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -132.87 124.58 28.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.047 1.339 . . . . 0.0 108.675 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.37 144.09 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.549 0.69 . . . . 0.0 110.85 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 t -135.29 175.25 9.76 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.656 1.583 . . . . 0.0 111.153 -174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.3 mt -135.69 135.9 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.62 1.168 . . . . 0.0 109.635 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -161.34 173.37 37.75 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.905 1.241 . . . . 0.0 111.582 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.4 80.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.7 166.28 11.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.4 2.28 . . . . 0.0 111.126 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.61 142.97 23.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.926 0.891 . . . . 0.0 112.096 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -85.75 -24.96 26.68 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -170.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -128.19 -8.81 5.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -133.62 3.99 3.59 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.44 6.43 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.106 1.336 . . . . 0.0 114.141 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -135.03 148.29 49.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.772 1.629 . . . . 0.0 110.803 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -137.11 175.8 9.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.077 0.951 . . . . 0.0 112.862 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.3 145.66 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.154 2.182 . . . . 0.0 107.468 171.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.5 mt -136.65 141.5 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.588 1.155 . . . . 0.0 107.907 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -148.45 144.48 27.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.057 0.543 . . . . 0.0 111.999 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -84.26 143.18 29.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.061 1.344 . . . . 0.0 111.009 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 125.432 1.493 . . . . 0.0 114.655 -178.185 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . 0.474 ' H61' ' HE2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . 0.547 ' H82' ' HB3' ' A' ' 102' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.507 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.16 -175.95 45.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.453 1.025 . . . . 0.0 112.688 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -63.52 -15.69 58.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.64 1.176 . . . . 0.0 114.092 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -144.72 145.42 31.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.186 1.794 . . . . 0.0 110.769 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -157.53 -27.53 0.09 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.661 1.184 . . . . 0.0 113.937 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -147.3 161.73 40.38 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.433 . . . . 0.0 111.611 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.27 166.3 29.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.937 1.295 . . . . 0.0 112.825 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -140.51 8.89 2.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.628 1.571 . . . . 0.0 113.227 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -151.26 157.39 42.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.591 1.556 . . . . 0.0 111.536 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -152.97 175.5 12.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.958 1.303 . . . . 0.0 111.986 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 m -130.93 5.55 4.57 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.33 0.11 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.243 1.401 . . . . 0.0 115.064 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -137.8 5.44 2.62 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.707 1.603 . . . . 0.0 112.978 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -155.34 151.13 21.93 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.957 1.703 . . . . 0.0 110.146 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -49.67 156.68 2.89 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.015 3.144 . . . . 0.0 116.042 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.27 -3.59 0.93 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.97 167.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 126.112 1.765 . . . . 0.0 111.219 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -147.7 170.2 18.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.039 1.336 . . . . 0.0 110.683 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.99 158.0 30.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.164 2.185 . . . . 0.0 111.523 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -154.62 173.49 16.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.938 1.695 . . . . 0.0 110.983 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.67 108.44 2.47 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.795 -0.566 . . . . 0.0 110.883 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.39 44.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.91 0.767 . . . . 0.0 113.986 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.66 133.26 35.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.479 1.111 . . . . 0.0 110.624 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -142.14 170.12 16.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.489 1.516 . . . . 0.0 111.241 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -129.97 151.6 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.52 1.928 . . . . 0.0 109.359 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.32 128.2 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.77 1.228 . . . . 0.0 108.09 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -142.6 154.18 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.029 0.932 . . . . 0.0 111.254 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -70.66 160.88 31.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.84 0.828 . . . . 0.0 112.162 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -78.68 3.45 16.38 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.61 1.164 . . . . 0.0 112.717 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.74 -19.69 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.287 1.835 . . . . 0.0 113.453 -167.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.6 mt 58.18 -159.27 0.28 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 111.548 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.6 p -147.9 162.5 31.06 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.985 0.914 . . . . 0.0 112.971 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -54.52 -16.17 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.351 3.367 . . . . 0.0 115.99 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.57 -17.64 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.234 1.413 . . . . 0.0 113.685 172.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.94 11.37 65.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.999 1.285 . . . . 0.0 113.484 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.57 171.15 14.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.027 1.731 . . . . 0.0 111.481 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.03 154.72 12.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.82 1.248 . . . . 0.0 111.436 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 tp -121.99 109.77 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.024 1.33 . . . . 0.0 108.879 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.2 151.51 25.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -167.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.69 121.11 12.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 110.193 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 m -127.84 135.05 49.52 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.058 0.943 . . . . 0.0 110.657 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.3 131.55 94.82 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.573 1.549 . . . . 0.0 111.164 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.59 -7.84 21.51 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.452 2.768 . . . . 0.0 114.53 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.27 -9.61 46.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.203 1.382 . . . . 0.0 115.064 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -153.28 -174.06 4.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.721 1.261 . . . . 0.0 113.245 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -89.21 160.41 16.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.92 1.688 . . . . 0.0 111.971 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 51.03 46.09 26.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.65 1.98 . . . . 0.0 113.654 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -136.43 147.52 60.31 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 126.339 1.856 . . . . 0.0 111.23 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.99 148.7 40.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.138 2.558 . . . . 0.0 112.227 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -76.91 150.37 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.576 0.75 . . . . 0.0 111.645 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 p -128.42 177.32 7.06 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.264 1.426 . . . . 0.0 112.213 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.87 148.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.718 0.807 . . . . 0.0 113.063 173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -147.85 163.27 28.09 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.429 1.892 . . . . 0.0 110.318 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 141.86 59.93 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.764 2.309 . . . . 0.0 112.058 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.37 119.3 8.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.312 0.577 . . . . 0.0 111.544 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -129.48 -19.73 3.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.678 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.74 15.36 71.12 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.0 m -65.13 174.48 1.98 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.048 1.424 . . . . 0.0 111.748 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 m -56.67 -23.37 41.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -75.54 -12.69 60.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.658 1.583 . . . . 0.0 113.428 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -124.66 -8.75 7.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.776 1.63 . . . . 0.0 113.725 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.4 136.94 34.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.687 0.795 . . . . 0.0 110.415 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -133.64 173.44 11.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 110.347 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 pt -122.68 154.26 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.806 1.243 . . . . 0.0 109.58 168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.08 139.56 53.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.323 1.849 . . . . 0.0 107.793 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -134.27 137.64 44.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.562 1.145 . . . . 0.0 110.622 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.2 m -74.54 59.01 0.8 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.708 2.403 . . . . 0.0 112.955 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -54.21 -41.9 69.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.066 1.346 . . . . 0.0 113.182 -172.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.54 -178.64 6.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.763 1.225 . . . . 0.0 110.354 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.7 p -140.19 -24.52 0.81 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.177 1.791 . . . . 0.0 113.233 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -70.6 -20.45 62.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.302 1.441 . . . . 0.0 112.869 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -124.51 8.21 8.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.973 1.709 . . . . 0.0 113.376 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 49.8 38.95 16.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.514 1.526 . . . . 0.0 113.676 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -102.05 144.55 30.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.007 1.384 . . . . 0.0 113.278 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -140.56 168.26 20.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.194 2.198 . . . . 0.0 110.006 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.1 p -120.8 148.15 44.38 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.043 0.937 . . . . 0.0 109.488 169.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.99 129.21 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.313 1.045 . . . . 0.0 109.315 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -143.28 140.32 17.59 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.633 1.173 . . . . 0.0 111.034 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.12 139.94 17.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.249 2.633 . . . . 0.0 111.421 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.76 -26.21 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.253 -0.905 . . . . 0.0 111.908 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.33 -26.87 74.2 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.95 -0.916 . . . . 0.0 114.869 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -144.44 65.76 13.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.989 1.316 . . . . 0.0 113.119 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.77 -16.11 14.6 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.316 3.344 . . . . 0.0 115.441 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -67.47 -0.17 3.52 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.218 1.807 . . . . 0.0 114.661 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.6 p -142.4 166.16 25.43 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.22 1.408 . . . . 0.0 113.058 -175.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -150.05 146.5 27.0 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.956 1.702 . . . . 0.0 110.01 -169.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mt -73.67 130.8 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.779 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.69 175.7 22.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.278 1.418 . . . . 0.0 111.539 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.04 173.4 9.39 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.34 -1.094 . . . . 0.0 110.605 174.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.37 23.75 2.2 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.237 0.923 . . . . 0.0 113.822 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.99 0.78 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.834 2.454 . . . . 0.0 117.339 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.68 23.44 31.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.876 2.179 . . . . 0.0 113.688 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 54.17 35.46 22.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 114.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.71 151.07 62.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.822 1.649 . . . . 0.0 110.219 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.54 146.76 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.629 2.22 . . . . 0.0 110.535 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.03 140.9 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.291 1.837 . . . . 0.0 109.564 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.55 111.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.373 1.069 . . . . 0.0 110.015 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.29 166.23 21.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.291 1.837 . . . . 0.0 110.686 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.59 154.67 73.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.07 1.846 . . . . 0.0 111.336 170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.74 135.41 35.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.939 2.426 . . . . 0.0 111.775 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -150.07 -87.71 0.08 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.939 1.296 . . . . 0.0 109.891 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.17 10.56 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.206 1.402 . . . . 0.0 112.581 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -68.49 123.23 20.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.818 -1.177 . . . . 0.0 111.078 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.53 158.73 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.941 0.897 . . . . 0.0 113.029 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -137.91 157.46 46.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.49 1.516 . . . . 0.0 110.219 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.6 m -110.95 135.49 51.39 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.746 1.218 . . . . 0.0 109.681 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.6 mt -116.84 71.18 0.79 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.313 1.054 . . . . 0.0 110.749 -172.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.2 m -70.2 132.44 45.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.589 1.155 . . . . 0.0 111.717 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 110' ' ' THR . 2.3 tm? -106.16 147.38 29.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.182 1.393 . . . . 0.0 111.112 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.461 ' H ' HD22 ' A' ' 109' ' ' LEU . 27.3 p -133.52 173.45 11.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 111.962 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -63.34 2.39 0.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.23 15.37 0.2 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.23 -174.41 46.99 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.614 1.707 . . . . 0.0 114.88 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.413 ' CZ ' HD23 ' A' ' 109' ' ' LEU . 14.9 m-85 -119.52 161.84 19.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.737 1.615 . . . . 0.0 111.964 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -137.67 156.5 47.96 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.332 1.453 . . . . 0.0 110.062 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -131.57 108.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.725 0.81 . . . . 0.0 109.607 -171.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -128.39 -178.23 4.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.688 1.595 . . . . 0.0 111.914 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.63 173.89 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.106 1.763 . . . . 0.0 111.974 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.46 -27.85 68.57 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 114.771 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.86 -19.31 52.28 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.777 1.288 . . . . 0.0 113.554 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 58.44 11.21 1.59 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.313 2.245 . . . . 0.0 115.148 -170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.1 p -78.83 -16.79 56.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.714 0.806 . . . . 0.0 112.949 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -144.88 169.69 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.022 1.329 . . . . 0.0 113.372 -171.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.8 t -144.9 155.34 43.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.318 2.647 . . . . 0.0 109.78 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -69.69 136.27 50.85 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.526 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.7 p -143.82 174.41 10.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.933 1.293 . . . . 0.0 113.854 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.8 172.16 7.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.833 2.453 . . . . 0.0 109.959 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -120.76 -30.68 4.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.508 1.123 . . . . 0.0 113.051 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.77 -8.31 5.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.199 1.799 . . . . 0.0 112.332 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.49 41.07 23.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.794 1.638 . . . . 0.0 113.8 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -135.71 163.82 29.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.859 1.664 . . . . 0.0 112.627 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.84 151.27 39.5 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.4 -4.42 68.16 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.363 1.459 . . . . 0.0 114.239 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -79.34 137.26 37.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.311 1.056 . . . . 0.0 113.07 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.06 123.26 24.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.517 1.527 . . . . 0.0 109.944 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.2 m -68.59 160.5 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.9 t -131.36 170.5 14.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.225 1.41 . . . . 0.0 111.666 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.7 mt -136.11 126.23 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.406 1.482 . . . . 0.0 108.818 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.03 -166.57 32.36 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.339 0.971 . . . . 0.0 112.164 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.04 156.46 3.89 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.19 159.63 9.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.537 1.135 . . . . 0.0 113.531 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.04 165.71 27.43 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.717 1.207 . . . . 0.0 112.532 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.1 t -100.39 -25.24 14.29 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -137.82 6.25 2.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.919 1.287 . . . . 0.0 114.072 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -145.16 9.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -173.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.6 38.28 0.88 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.247 0.927 . . . . 0.0 113.885 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -137.76 148.62 45.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.59 1.956 . . . . 0.0 109.57 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -137.36 175.07 9.94 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.25 1.024 . . . . 0.0 113.464 -167.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.7 t -143.44 145.44 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.63 2.372 . . . . 0.0 107.469 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.41 141.16 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.469 1.107 . . . . 0.0 108.709 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -143.08 153.07 42.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.823 1.249 . . . . 0.0 111.772 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -94.6 143.08 26.72 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.631 1.172 . . . . 0.0 110.82 -172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 125.389 1.475 . . . . 0.0 114.617 -177.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_